Patent Publication Number: US-2022220154-A1

Title: Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof

Description:
CROSS-REFERENCE TO RELATED APPLICATIONS 
     This application is a Continuation of U.S. patent application Ser. No. 16/892,141, filed Jun. 3, 2020, now U.S. Pat. No. 11,192,923, issued Dec. 7, 2021, which is a Continuation of PCT International Application No. PCT/US2019/055939, filed Oct. 11, 2019, which claims the benefit of U.S. Provisional Patent Application Ser. No. 62/744,941, filed Oct. 12, 2018; all of which are incorporated herein by reference in their entirety. 
    
    
     STATEMENT AS TO FEDERALLY SPONSORED RESEARCH 
     This invention was made with government support under grant numbers W81XWH-18-C-0182 and W81XWH-18-C-0325 awarded by the United States Army Medical Research and Materiel Command. The government has certain rights in the invention. 
    
    
     SEQUENCE LISTING 
     The instant application contains a Sequence Listing which has been submitted electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jul. 30, 2021, is named 50222-702_302_SL.txt and is 215,917 bytes in size. 
     TECHNICAL FIELD 
     The present disclosure relates generally to the field of molecular biology, and more specifically, to methods of treating bone and cartilage loss of defects in a mammal. 
     BACKGROUND 
     In the U.S., an average of six million people break a bone annually. Of these bone defects, the majority heal without problems. However, 5-10% will heal poorly or not at all (American Academy of Orthopaedic Surgeons). Large defects, also known as critical-sized bone defects, may not heal spontaneously and can lead to non-unions. A non-union occurs when there is no indication of healing for at least three months and no expectation of further healing (American Academy of Orthopaedic Surgeons). Currently, bone grafting is regarded as the “gold standard” for treating large or segmental bone defects. However, there are limitations with this treatment such as donor site pain, risk of rejection, limited donor supply and risk of transmission of infectious disease. 
     The repair of critical and complex bone and cartilage defects is also limited by poor tissue regrowth on implanted orthopedic substrates. Reasons for poor tissue regrowth include the loss of implanted progenitor cells within 48 hours post-implantation and the scarcity of progenitor cells. Another contributing factor is that current orthopedic substrates fail to facilitate sufficient tissue regeneration. 
     SUMMARY 
     The present invention is based on the discovery that the use of composition including β-tricalcium phosphate (β-TCP) and a chimeric polypeptide including at least one β-TCP binding sequence and a mammalian growth factor (e.g., bone morphogenetic protein 2 (BMP-2) can vastly improve bone healing and accelerate tissue regrowth. Thus, provided herein are chimeric polypeptides that include one or more β-TCP binding sequences, and a mammalian growth factor, compositions comprising any of these chimeric polypeptides (and optionally, β-TCP), and methods of promoting bone or cartilage formulation, methods of replacing and/or repairing bone or cartilage, and methods of treating a bone fraction or bone loss that include administration of any of these compositions. The compositions and methods provided herein can increase and sustain the number of progenitor cells at sites of bone and/or cartilage injury through stem cell capture. The compositions and methods provided herein can also be applied to soft tissue repair or localized delivery of a therapeutic. 
     Provided herein are chimeric polypeptides that include: (i) one or more β-tricalcium phosphate (βTCP)-binding sequence(s), wherein at least one of the one or more β-TCP-binding sequence(s) is selected from the group consisting of: VIGESTHHRPWS (SEQ ID NO: 2), LIADSTHHSPWT (SEQ ID NO: 3), ILAESTHHKPWT (SEQ ID NO: 4), ILAETTHHRPWS (SEQ ID NO: 5), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), VLGDTTHHKPWT (SEQ ID NO: 8), IVADSTHHRPWT (SEQ ID NO: 9); STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPST (SEQ ID NO: 14), VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT (SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18), and GGADTTHHRPGT (SEQ ID NO: 19); and (ii) a mammalian growth factor. 
     In some embodiments, the chimeric polypeptide includes two or more β-TCP-binding sequences. 
     In some embodiments, each neighboring pair of the two or more β-TCP binding sequences directly abut each other. 
     In some embodiments, each neighboring pair of the two or more β-TCP binding sequences are separated by a linker sequence. 
     In some embodiments, the chimeric polypeptide includes at least two different β-TCP-binding sequences. 
     In some embodiments, the chimeric polypeptide includes two or more copies of the same β-TCP-binding sequence. 
     In some embodiments, at least one of the two or more β-TCP-binding sequences is 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT 
               
               
                   
                 or 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 103) 
               
               
                   
                 GQVLPTTTPSSP. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 2) 
               
               
                   
                 VIGESTHHRPWS. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 20) 
               
               
                   
                 LLADTTHHRPWTVIGESTHHRPWS. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 2) 
               
               
                   
                 VIGESTHHRPWS, 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 6) 
               
               
                   
                 IIGESSHHKPFT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 21) 
               
               
                   
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFT. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 2) 
               
               
                   
                 VIGESTHHRPWS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 6) 
               
               
                   
                 IIGESSHHKPFT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 7) 
               
               
                   
                 GLGDTTHHRPWG, 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 4) 
               
               
                   
                 ILAESTHHKPWT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 22) 
               
               
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFTGLGDTTHEIRPWGI 
               
               
                   
               
               
                 LAESTHHKPWT. 
               
            
           
         
       
     
     In some embodiments, the at least two β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 4) 
               
               
                   
                 ILAESTHHKPWT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes at least one copy of the sequence LLADTTHHRPWTILAESTHHKPWT (SEQ ID NO: 23). 
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 24) 
               
               
                 LLADTTHHRPWTILAESTHHKPWTLLADTTHHRPWTILAESTHHKPWTL 
               
               
                   
               
               
                 LADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the at least two β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 7) 
               
               
                   
                 GLGDTTHHRPWG. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes at least one copy of the sequence of LLADTTHHRPWTGLGDTTHHRPWG (SEQ ID NO: 25). 
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 26) 
               
               
                   
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 27) 
               
               
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWG 
               
               
                   
               
               
                 LLADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 28) 
               
               
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLL 
               
               
                   
               
               
                 ADTTHHRPWTGLGDTTHERPWGLLADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the at least two β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 10) 
               
               
                   
                 STADTSHHRPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 11) 
               
               
                   
                 TSGGESTHHRPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 12) 
               
               
                   
                 TSGGESSHHKPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 13) 
               
               
                   
                 TGSGDSSHHRPS, 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 14) 
               
               
                   
                 GSSGESTHHKPST. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 29) 
               
               
                 STADTSHHRPSTSGGESTHHRPSTSGGESSHHKPSTGSGDSSHHRPSGSS 
               
               
                   
               
               
                 GESTHHKPST. 
               
            
           
         
       
     
     In some embodiments, the at least two β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 15) 
               
               
                   
                 VGADSTHHRPVT, 
               
               
                   
                   
               
               
                   
                 SEQ ID NO: 16) 
               
               
                   
                 GAADTTHHRPVT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 17) 
               
               
                   
                 AGADTTHHRPVT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 18) 
               
               
                   
                 GGADTTHHRPAT 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 19) 
               
               
                   
                 GGADTTHHRPGT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 30) 
               
               
                 VGADSTHHRPVTGAADTTHHRPVTAGADTTHHRPVTGGADTTHHRPATG 
               
               
                   
               
               
                 GADTTHHRPGT. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 10) 
               
               
                   
                 STADTSHHRPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHHRPWT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 11) 
               
               
                   
                 TSGGESTHHRPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 15) 
               
               
                   
                 VGADSTHHRPVT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 12) 
               
               
                   
                 TSGGESSHHKPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 16) 
               
               
                   
                 GAADTTHHRPVT, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 13) 
               
               
                   
                 TGSGDSSHHRPS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 101) 
               
               
                   
                 GSSGESTHHKPS, 
               
               
                   
                 and 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 102) 
               
               
                   
                 TGGADTTHHRPAT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 31) 
               
               
                 STADTSHHRPSLLADTTHHRPWTTSGGESTHHRPSVGADSTHHRPVTTSG 
               
               
                   
               
               
                 GESSHHKPSGAADTTHHRPVTTGSGDSSHHRPSGSSGESTHHKPSTGGAD 
               
               
                   
               
               
                 TTHHRPAT. 
               
            
           
         
       
     
     In some embodiments of any the chimeric polypeptides described herein, the mammalian growth factor is selected from the group consisting of: epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin like growth factor (IGF-1), fibroblast growth factor (FGF), fibroblast growth factor 2 (FGF2), fibroblast growth factor 18 (FGF18), transforming growth factor alpha (TGF-α), transforming growth factor beta (TGF-β), transforming growth factor beta 1 (TGF-β1), transforming growth factor beta 3 (TGF-β3), osteogenic protein 1 (OP-1), osteogenic protein 2 (OP-2), osteogenic protein 3 (OP-3), bone morphogenetic protein 2 (BMP-2), bone morphogenetic protein 3 (BMP-3), bone morphogenetic protein 4 (BMP-4), bone morphogenetic protein 5 (BMP-5), bone morphogenetic protein 6 (BMP-6), bone morphogenetic protein 7 (BMP-7), bone morphogenetic protein (BMP-9), bone morphogenetic protein 10 (BMP-10), bone morphogenetic protein 11 (BMP-11), bone morphogenetic protein 12 (BMP-12) bone morphogenetic protein 13 (BMP-13), bone morphogenetic protein 15 (BMP-15), dentin phosphoprotein (DPP), vegetal related growth factor (Vgr), growth differentiation factor 1 (GDF-1), growth differentiation factor 3 (GDF-3), growth differentiation factor 5 (GDF-5), growth differentiation factor 6 (GDF-6), growth differentiation factor 7 (GDF-7), growth differentiation factor 8 (GDF8), growth differentiation factor 11 (GDF11), growth differentiation factor 15 (GDF15), vascular endothelial growth factor (VEGF), hyaluronic acid binding protein (HABP), collagen binding protein (CBP), fibroblast growth factor 18 (FGF-18), keratinocyte growth factor (KGF), tumor necrosis factor alpha (TNFα), tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL), wnt family member 1 (WNT1), wnt family member 2 (WNT2), wnt family member 2B (WNT2B), wnt family member 3 (WNT3), wnt family member 3A (WNT3A), wnt family member 4 (WNT4), wnt family member 5A (WNT5A), wnt family member 5B (WNT5B), wnt family member 6 (WNT6), wnt family member 7A (WNT7A), wnt family member 7B (WNT7B), wnt family member 8A (WNT8A), wnt family member 8B (WNT8B), wnt family member 9A (WNT9A), wnt family member 9B (WNT9B), wnt family member 10A (WNT10A), wnt family member 10B (WNT10B), wnt family member 11 (WNT11), and wnt family member 16 (WNT16). 
     In some embodiments, the mammalian growth factor is BMP-2. 
     In some embodiments, the BMP-2 includes an amino acid sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 32) 
               
               
                 MVAGTRCLLALLLPQVLLGGAAGLVPELGRRKFAAASSGRPSSQPSDEVL 
               
               
                   
               
               
                 SEFELRLLSMFGLKQRPTPSRDAVVPPYMLDLYRRHSGQPGSPAPDHRLE 
               
               
                   
               
               
                 RAASRANTVRSFHHEESLEELPETSGKTTRRFFFNLSSIPTEEFITSAEL 
               
               
                   
               
               
                 QVFREQMQDALGNNSSFHHRINIYEIIKPATANSKFPVTRLLDTRLVNQN 
               
               
                   
               
               
                 ASRWESFDVTPAVMRWTAQGHANHGFVVEVAHLEEKQGVSKRHVRISRSL 
               
               
                   
               
               
                 HQDEHSWSQIRPLLVTFGHDGKGHPLHKREKRQAKHKQRKRLKSSCKRHP 
               
               
                   
               
               
                 LYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPLADHLNSTNHAIVQTLVN 
               
               
                   
               
               
                 SVNSKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR. 
               
            
           
         
       
     
     In some embodiments, the BMP-2 consists of the amino acid of SEQ ID NO: 32. 
     In some embodiments of any of the chimeric polypeptides described herein, the chimeric polypeptide further comprises a linker sequence between a neighboring pair of a β-TCP-binding sequence and the growth factor. 
     In some embodiments, the linker sequence includes 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 33) 
               
               
                   
                 TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG. 
               
            
           
         
       
     
     In some embodiments, the linker sequence consists of SEQ ID NO: 33. 
     In some embodiments, the linker sequence includes GAGTG (SEQ ID NO: 104). 
     In some embodiments, the linker sequence consists of SEQ ID NO: 34. 
     In some embodiments of any of the chimeric polypeptides described herein, chimeric polypeptide binds to β-TCP with a K D  of about 1 picomolar to about 100 micromolar. 
     Also provided herein are compositions includes any of one of the chimeric polypeptides described herein. 
     In some embodiments, the composition further includes β-TCP. In some embodiments, the β-TCP is formulated as a powder, a putty, or a paste. In some embodiments, the β-TCP is disposed on or in a scaffold, a mesh, or a sponge. 
     In some embodiments of any of the compositions described herein, the composition is a pharmaceutical composition. 
     Also provided herein are kits that include any of the compositions described herein. 
     Provided herein are chimeric polypeptides that include: (i) one or more β-TCP-binding sequence(s) comprising an amino acid sequence of Formula I: A 0 B 0 C 0 D 0 E 0 F 0 G 0 H 0 I 0 J 0 K 0 L 0  (Formula I) (SEQ ID NO: 35), wherein: A 0  is V, L, I, G, S, T or A; B 0  is I, L, V, Q, T, S, G or A; C 0  is G, A, V or S; D 0  is E, D, L or G; E 0  is S, T, P T, E or D; F 0  is T or S; G 0  is H, T or S; H 0  is H or T; I 0  is R, S, K, P or H; J 0  is P, S, R or K; K 0  is W, F, S, P, V, A or G; and L 0  is absent or is S, T G, (or A); and (ii) a mammalian growth factor, wherein Formula I does not include 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 1) 
               
               
                   
                 LLADTTHEIRPWT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptide includes two or more β-TCP-binding sequences of Formula I. 
     In some embodiments, each neighboring pair of the two or more β-TCP binding sequences of Formula I directly abut each other. 
     In some embodiments, each neighboring pair of the two or more β-TCP binding sequences of Formula I are separated by a linker sequence. 
     In some embodiments, the chimeric polypeptide includes at least two different β-TCP-binding sequences of Formula I. 
     In some embodiments, the chimeric polypeptide includes two or more copies of the same β-TCP-binding sequence of Formula I. 
     In some embodiments, the chimeric polypeptide further includes a β-TCP-binding sequence that does not includes a sequence of Formula I. 
     In some embodiments of any of the chimeric polypeptides described herein, the mammalian growth factor is selected from the group consisting of: EGF, PDGF, IGF-1, FGF, FGF2, FGF18, TGF-α, TGF-β, TGF-β1, TGF-β3, OP-1, OP-2, OP-3, BMP-2, BMP-3, BMP-4, BMP-5, BMP-6, BMP-7, BMP-9, BMP-10, BMP-12, BMP-11, BMP-13, BMP-15, DPP, Vgr, GDF-1, GDF-3, GDF-5, GDF-6, GDF-7, GDF8, GDF11, GDF15, VEGF, HABP, CBP, FGF-18, KGF, TNFα, TRAIL, WNT1, WNT2, WNT2B, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, and WNT16. 
     In some embodiments, the mammalian growth factor is BMP-2. In some embodiments, the BMP-2 includes an amino acid sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 32) 
               
               
                 MVAGTRCLLALLLPQVLLGGAAGLVPELGRRKFAAASSGRPSSQPSDEVL 
               
               
                   
               
               
                 SEFELRLLSMFGLKQRPTPSRDAVVPPYMLDLYRRHSGQPGSPAPDHRLE 
               
               
                   
               
               
                 RAASRANTVRSFHHEESLEELPETSGKTTRRFFFNLSSIPTEEFITSAEL 
               
               
                   
               
               
                 QVFREQMQDALGNNSSFHHRINIYEIIKPATANSKFPVTRLLDTRLVNQN 
               
               
                   
               
               
                 ASRWESFDVTPAVMRWTAQGHANHGFVVEVAHLEEKQGVSKRHVRISRSL 
               
               
                   
               
               
                 HQDEHSWSQIRPLLVTFGHDGKGHPLHKREKRQAKHKQRKRLKSSCKRHP 
               
               
                   
               
               
                 LYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPLADHLNSTNHAIVQTLVN 
               
               
                   
               
               
                 SVNSKIPKACCVPTELSAISMLYLDENEKVVLKNYQDMVVEGCGCR. 
               
            
           
         
       
     
     In some embodiments, the BMP-2 consists of the amino acid of SEQ ID NO: 32. 
     In some embodiments of any of the chimeric polypeptides described herein, the chimeric polypeptide further includes a linker sequence between a neighboring pair of a β-TCP-binding sequence and the growth factor. 
     In some embodiments, the linker sequence includes 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 33) 
               
               
                   
                 TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG. 
               
            
           
         
       
     
     In some embodiments, the linker sequence consists of SEQ ID NO: 33. 
     In some embodiments, the linker sequence includes GSGATG (SEQ ID NO: 34). 
     In some embodiments, the linker sequence consists of SEQ ID NO: 34. 
     In some embodiments of any of the chimeric polypeptides described herein, the chimeric polypeptide binds to β-TCP with a K D  of about 1 picomolar to about 100 micromolar. 
     Also provided herein are compositions including any of one of the chimeric polypeptides described herein. 
     In some embodiments, the composition further includes β-TCP. In some embodiments, the β-TCP is formulated as a powder, a putty, or a paste. In some embodiments, the β-TCP is disposed on or in a scaffold, a mesh, or a sponge. 
     In some embodiments of any of the compostions described herein, the composition is a pharmaceutical composition. 
     Also provided herein are kits includes any of the compositions described herein. 
     Provided herein are methods of promoting bone or cartilage formation in a subject in need thereof that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. 
     Also provided herein are methods of replacing and/or repairing bone or cartilage in a subject in need thereof that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. 
     Also provided herein are methods of treating a bone fracture or bone loss in a subject in need thereof, that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. 
     In some embodiments of any of the methods described herein, the subject has a bone fracture. In some embodiments of any of the methods described herein, the subject has a bone defect. In some embodiments of any of the methods described herein, the subject has a cartilage tear or cartilage defect. In some embodiments of any of the methods described herein, the subject has cartilage loss. 
     Also provided herein are β-tricalcium phosphate-binding polypeptides including at least one sequence selected from the group consisting of: VIGESTHHRPWS (SEQ ID NO: 2), LIADSTHHSPWT (SEQ ID NO: 3), ILAESTHHKPWT (SEQ ID NO: 4), ILAETTHHRPWS (SEQ ID NO: 5), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), VLGDTTHHKPWT (SEQ ID NO: 8), IVADSTHHRPWT (SEQ ID NO: 9); STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPST (SEQ ID NO: 14), VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT (SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18), and GGADTTHHRPGT (SEQ ID NO: 19). 
     Also provided herein are β-tricalcium phosphate-binding polypeptides including an amino acid sequence of Formula I: A 0 B 0 C 0 D 0 E 0 F 0 G 0 H 0 I 0 J 0 K 0 L 0  (Formula I) (SEQ ID NO: 35), wherein: A 0  is V, L, I, G, S, T or A; B 0  is I, L, V, Q, T, S, G or A; C 0  is G, A, V or S; D 0  is E, D, L or G; E 0  is S, T, P T, E or D; F 0  is T or S; G 0  is H, T or S; H 0  is H or T; I 0  is R, S, K, P or H; J 0  is P, S, R or K; K 0  is W, F, S, P, V, A or G; and L 0  is absent or is S, T G, (or A); wherein Formula I does not include LLADTTHHRPWT (SEQ ID NO: 1). 
     The term “subject” as used herein refers to any mammal. A subject therefore refers to, for example, mice, rats, dogs, cats, horses, cows, pigs, guinea pigs, rats, humans, monkeys, and the like. When the subject is a human, the subject may be referred to herein as a patient. In some embodiments, the subject or “subject in need of treatment” may be a canine (e.g., a dog), feline (e.g., a cat), equine (e.g., a horse), ovine, bovine, porcine, caprine, primate, e.g., a simian (e.g., a monkey (e.g., marmoset, baboon), or an ape (e.g., a gorilla, chimpanzee, orangutan, or gibbon), a human, or a rodent (e.g., a mouse, a guinea pig, a hamster, or a rat). In some embodiments, the subject or “subject in need of treatment” may be a non-human mammal, especially mammals that are conventionally used as models for demonstrating therapeutic efficacy in humans (e.g., murine, lapine, porcine, canine, or primate animals) may be employed. 
     The term “bone defect” refers to the absence or loss (e.g., partial loss) of bone at an anatomical location in a subject where it would otherwise be present in a control healthy subject. A bone defect may be the result of, e.g., an infection (e.g., osteomyelitis), a tumor, a trauma, or an adverse event of a treatment. A bone defect may also affect the muscles, soft tissue, tendons, or joints surrounding the bone defect and cause injury. In some embodiments, a bone defect includes damage to a soft tissue. 
     The term “cartilage defect” refers to the absence or loss (e.g., partial loss) of cartilage at an anatomical location in a subject where it would otherwise be present in a control healthy subject. A cartilage defect may be the result of, e.g., disease, osteochondritis, osteonecrosis, or trauma. For example, a cartilage defect may affect the knee joint. 
     “Affinity” refers to the strength of the sum total of non-covalent interactions between a β-TCP binding sequence (or a chimeric polypeptide or polypeptide comprising a β-TCP binding sequence) and its binding partner (e.g., β-TCP). Affinity can be measured by common methods known in the art, including those described herein. Affinity can be determined, for example, using surface plasmon resonance (SPR) technology (e.g., BIACORE®) or biolayer interferometry (e.g., FORTEBIO®). Additional methods for determining affinity are known in the art. 
     Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Methods and materials are described herein for use in the present invention; other, suitable methods and materials known in the art can also be used. The materials, methods, and examples are illustrative only and not intended to be limiting. All publications, patent applications, patents, sequences, database entries, and other references mentioned herein are incorporated by reference in their entirety. In case of conflict, the present specification, including definitions, will control. 
     Other features and advantages of the invention will be apparent from the following detailed description and figures, and from the claims. 
    
    
     
       DESCRIPTION OF DRAWINGS 
         FIG. 1A  are representative in vivo radiographs (lateromedial orientation) of animals from experimental Group A. 
         FIG. 1B  are representative in vivo radiographs (lateromedial orientation) of animals from experimental Group B. 
         FIG. 1C  are representative in vivo radiographs (lateromedial orientation) of animals from experimental Group C. 
         FIG. 2  is a representative graph of the mean radiographic score (+SEM, n=9-10) of animals from each Group at four weeks- and eight weeks-post-surgery. * P&lt;0.01 vs Group Cl # P&lt;0.01 vs Group V; † P&lt;0.01 vs Group C at 4 weeks. 
         FIG. 3A  are representative radiographs, sagittal, and transverse micro-CT images at 4-weeks post-operation from animals in Group A, B, or C. 
         FIG. 3B  are representative radiographs, sagittal, and transverse micro-CT images at 4-weeks post-operation from animals in Group A, B, or C. 
         FIG. 4  is a schematic representation of the varied callus formation in animals from Group A, B, or C at 4 weeks post-surgery. The red-shaded area is an approximation of the mineralized callus volume. 
         FIG. 5A  is a representative graph of micro-CT analyses showing total callus volume in bone specimens obtained at 8 weeks post-surgery from animals in Group A (n=9), B (=n−7), or C (n=8). The data are represented as Mean±SEM; * P&lt;0.01 vs B, # P&lt;0.0.1 vs C. 
         FIG. 5B  is a representative graph of micro-CT analyses showing bone mineral volume in bone specimens obtained 8 weeks post-surgery from animals in Group A (n=9), B (=n−7), or C (n=8). The data are represented as Mean±SEM; * P&lt;0.01 vs B, # P&lt;0.0.1 vs C. 
         FIG. 6A  is a representative graph of micro-CT analyses of the diaphyseal region volume of bone speciments obtained 4 weeks post-surgery in animals from Group A (n=10), B (n=8), or C (n=7). Bone mineral volume is expressed as the percentage of bone mineral volume to total volume. The data are represented as Mean±SEM; * P&lt;0.05 vs B, # P&lt;0.0.5 vs C. A1 vs B1; p=0.059. 
         FIG. 6B  is a representative graph of micro-CT analyses of the cortical bone volume of bone specimens obtained 4 weeks post-surgery in animals from Group A (n=10), B (n=8), or C (n=7). Bone mineral volume is expressed as the percentage of bone mineral volume to total volume. The data are represented as Mean±SEM; * P&lt;0.05 vs B, # P&lt;0.0.5 vs C. 
         FIG. 7A  is a representative graph of micro-CT analyses of total callus volume in bone specimens obtained 8 weeks post-surgery from animals in Group A (n=9), B (n=7), or C (n=8). The data are represented as Mean±SEM; * P&lt;0.01 vs B, # P&lt;0.0.1 vs C. 
         FIG. 7B  is a representative graph of micro-CT analyses of bone mineral volume in bone specimens obtained 8 weeks post-surgery from animals in Group A (n=9), B (n=7), or C (n=8). The data are represented as Mean±SEM; * P&lt;0.01 vs B, # P&lt;0.0.1 vs C. 
         FIG. 8  is a representative graph of ultimate load to failure (ULF) at 4- and 8-weeks post-surgery for animals in Group A, B, or C. Data are represented as the mean+/−S.E.M. *P&lt;0.05 vs 4-week groups; #P&lt;0.01 vs 8-week groups. 
         FIG. 9A  are representative histological images of Von Kossa- and H&amp;E-stained bone specimens obtained at 4 weeks post-surgery from animals in Group A, B, or C. 
         FIG. 9B  are representative histological images of TRAP+ osteoclast-stained bone specimens obtained at 4 weeks post-surgery from animals in Groups A, B, or C. White arrows indicate osteoclasts, and yellow arrows indicate osteocytes. 
         FIG. 10A  are representative Von Kossa- and H&amp;E-stained histological images of bone specimens obtained at 8 weeks post-surgery from animals in Group A, B, or C. 
         FIG. 10B  are representative TRAP+ osteoclast-stained histological images of bone specimens obtained at 8 weeks post-surgery from animals in Group A, B, or C. White arrows indicate osteoclasts, and yellow arrows indicate osteocytes. 
         FIG. 11  is a representative immunoblot of MCF-7 cell lysate probed with an anti-P-Akt antibody, wherein the MCF-7 cells were incubated with β-TCBP-HRG. 
         FIG. 12  is a representative immunoblot of MCF-7 lysate probed with an anti-P-Akt antibody, wherein the MCF-7 cells were incubated with β-TCBP-HRG (free) or β-TCBP-HRG (β-TCP-bound). 
     
    
    
     DETAILED DESCRIPTION 
     Provided herein are chimeric polypeptides that include: (i) one or more (e.g., two, three, four, five, six, seven, eight, nine, or ten) β-tricalcium phosphate (βTCP)-binding sequence(s), where at least one of the one or more β-TCP-binding sequence(s) is selected from the group of: VIGESTHHRPWS (SEQ ID NO: 2), LIADSTHHSPWT (SEQ ID NO: 3), ILAESTHHKPWT (SEQ ID NO: 4), ILAETTHHRPWS (SEQ ID NO: 5), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), VLGDTTHHKPWT (SEQ ID NO: 8), IVADSTHHRPWT (SEQ ID NO: 9); STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPST (SEQ ID NO: 14), VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT (SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18), and GGADTTHHRPGT (SEQ ID NO: 19); and (ii) a mammalian growth factor (e.g., any of the exemplary mammalian growth factors described herein or known in the art). 
     Also provided herein are chimeric polypeptides that include (i) one or more β-TCP-binding sequence(s) including an amino acid sequence of Formula I: A 0 B 0 C 0 D 0 E 0 F 0 G 0 H 0 I 0 J 0 K 0 L 0  (Formula I) (SEQ ID NO: 35), where:
         A 0  is V, L, I, G, S, T or A;   B 0  is I, L, V, Q, T, S, G or A;   C 0  is G, A, V or S;   D 0  is E, D, L or G;   E 0  is S, T, P T, E or D;   F 0  is T or S;   G 0  is H, T or S;   H 0  is H or T;   I 0  is R, S, K, P or H;   J 0  is P, S, R or K;   K 0  is W, F, S, P, V, A or G; and   L 0  is absent or is S, T G, (or A); and       

     (ii) a mammalian growth factor (e.g., any of the exemplary mammalian growth factors described herein or known in the art), 
     where Formula I does not include LLADTTHHRPWT (SEQ ID NO: 1). 
     Also provided herein are β-tricalcium phosphate-binding polypeptides that include at least one (e.g., two, three, four, five, six, seven, eight, nine, or ten) sequence selected from the group of: VIGESTHHRPWS (SEQ ID NO: 2), LIADSTHHSPWT (SEQ ID NO: 3), ILAESTHHKPWT (SEQ ID NO: 4), ILAETTHHRPWS (SEQ ID NO: 5), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), VLGDTTHHKPWT (SEQ ID NO: 8), IVADSTHHRPWT (SEQ ID NO: 9); STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPST (SEQ ID NO: 14), VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT (SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18), and GGADTTHHRPGT (SEQ ID NO: 19). Some embodiments of these polypeptides can further include a mammalian growth factor (e.g., any of the exemplary mammalian growth factors described herein or known in the art). 
     Also provided herein are β-tricalcium phosphate-binding polypeptides that include an amino acid sequence of Formula I: 
     A 0 B 0 C 0 D 0 E 0 F 0 G 0 H 0 I 0 J 0 K 0 L 0  (Formula I) (SEQ ID NO: 35), where:
         A 0  is V, L, I, G, S, T or A;   B 0  is I, L, V, Q, T, S, G or A;   C 0  is G, A, V or S;   D 0  is E, D, L or G;   E 0  is S, T, P T, E or D;   F 0  is T or S;   G 0  is H, T or S;   H 0  is H or T;   I 0  is R, S, K, P or H;   J 0  is P, S, R or K;   K 0  is W, F, S, P, V, A or G; and   L 0  is absent or is S, T G, (or A);       

     where Formula I does not include LLADTTHHRPWT (SEQ ID NO: 1). Some embodiments of these polypeptides can further include a mammalian growth factor (e.g., any of the exemplary mammalian growth factors described herein or known in the art). In some embodiments, any of the chimeric polypeptides described herein can bind to one or more substrates comprising ϑTCP (e.g., a Mastergraft strip, Vitoss Foam Pack, chronOS Strip, Vitoss Micromorsels, LifeInk500, Hyperelastic Bone, bioactive glass, ϑTCP powder, ϑTCP spray dried powder, hydroxyapaptite powder, hydroxyapatite-coated bone screw, ϑTCP granules, hydroxyapatite granules, and ReBOSSIS). In some embodiments, any of the chimeric polypeptides described herein can bind to silicon nitride or a substrate comprising silicon nitride. 
     Also provided herein are compositions that include any of the chimeric polypeptides or β-tricalcium phosphate-binding polypeptides described herein. In some embodiments, the compositions can further include a substrate including ϑTCP (e.g., (e.g., a Mastergraft strip, Vitoss Foam Pack, chronOS Strip, Vitoss Micromorsels, LifeInk500, Hyperelastic Bone, bioactive glass, ϑTCP powder, ϑTCP spray dried powder, hydroxyapaptite powder, hydroxyapatite-coated bone screw, ϑTCP granules, hydroxyapatite granules, and ReBOSSIS). In some embodiments, the compositions can further include a substrante comprising silicon nitride. 
     Also provided herein are kits that include any of these compositions. Also provided are methods of promoting bone or cartilage formation in a subject in need thereof, methods of replacing and/or repairing bone or cartilage in a subject in need thereof, and methods of treating a bone fraction or bone loss in a subject in need thereof that include administering to the subject any of the compositions described herein. 
     Non-limiting aspects of these polypeptides, compositions, kits, and methods are described below, and can be used in any combination without limitation. Additional aspects of these polypeptides, compositions, kits, and methods are known in the art. 
     Chimeric Polypeptides 
     The chimeric polypeptides described herein include a β-TCP binding sequence and can bind β-TCP (e.g., any of the exemplary types of β-TCP described herein or known in the art). In some examples, the chimeric polypeptides can include: (i) one or more (e.g., two, three, four, five, six, seven, eight, nine, or ten) β-tricalcium phosphate (βTCP)-binding sequence(s), where at least one of the one or more β-TCP-binding sequence(s) is selected from the group of: VIGESTHHRPWS (SEQ ID NO: 2), LIADSTHHSPWT (SEQ ID NO: 3), ILAESTHHKPWT (SEQ ID NO: 4), ILAETTHHRPWS (SEQ ID NO: 5), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), VLGDTTHHKPWT (SEQ ID NO: 8), IVADSTHHRPWT (SEQ ID NO: 9); STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPST (SEQ ID NO: 14), VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT (SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18), and GGADTTHHRPGT (SEQ ID NO: 19); and (ii) a mammalian growth factor (e.g., any of the exemplary mammalian growth factors described herein or known in the art). 
     In some examples, the chimeric polypeptides can include: (i) one or more β-TCP-binding sequence(s) including an amino acid sequence of Formula I: A 0 B 0 C 0 D 0 E 0 F 0 G 0 H 0 I 0 J 0 K 0 L 0  (Formula I) (SEQ ID NO: 35), wherein: 
     A 0  is V, L, I, G, S, T, or A; 
     B 0  is I, L, V, Q, T, S, G, or A; 
     C 0  is G, A, V, or S; 
     D 0  is E, D, L, or G; 
     E 0  is S, T, PT, E, or D; 
     F 0  is T or S; 
     G 0  is H, T, or S; 
     H 0  is H or T; 
     I 0  is R, S, K, P, or H; 
     J 0  is P, S, R, or K; 
     K 0  is W, F, S, P, V, A, or G; and 
     L 0  is absent or is S, T, G, or A; and (ii) a mammalian growth factor (e.g., any of the exemplary mammalian growth factors described herein or known in the art), where Formula I does not include LLADTTHHRPWT (SEQ ID NO: 1). 
     Non-limiting examples of β-TCP binding sequences that may be present in any of the chimeric polypeptides described herein are listed in Table A below. 
     
       
         
           
               
             
               
                 TABLE A 
               
             
            
               
                   
               
               
                 Exemplary β-TCP binding sequences 
               
            
           
           
               
               
            
               
                   
                 SEQ 
               
               
                 β-TCP binding sequence 
                 ID NO: 
               
               
                   
               
               
                 LLADTTHHRPWT 
                  1 
               
               
                   
               
               
                 VIGESTHHRPWS 
                  2 
               
               
                   
               
               
                 LIADSTHESPWT 
                  3 
               
               
                   
               
               
                 ILAESTHHKPWT 
                  4 
               
               
                   
               
               
                 ILAETTHHRPWS 
                  5 
               
               
                   
               
               
                 IIGESSHHKPFT 
                  6 
               
               
                   
               
               
                 GLGDTTHHRPWG 
                  7 
               
               
                   
               
               
                 VLGDTTHHKPWT 
                  8 
               
               
                   
               
               
                 IVADSTHHRPWT 
                  9 
               
               
                   
               
               
                 STADTSHHRPS 
                 10 
               
               
                   
               
               
                 TSGGESTHHRPS 
                 11 
               
               
                   
               
               
                 TSGGESSHHKPS 
                 12 
               
               
                   
               
               
                 TGSGDSSHHRPS 
                 13 
               
               
                   
               
               
                 GSSGESTHHKPST 
                 14 
               
               
                   
               
               
                 VGADSTHHRPVT 
                 15 
               
               
                   
               
               
                 GAADTTHHRPVT 
                 16 
               
               
                   
               
               
                 AGADTTHHRPVT 
                 17 
               
               
                   
               
               
                 GGADTTHHRPAT 
                 18 
               
               
                   
               
               
                 GGADTTHHRPGT 
                 19 
               
               
                   
               
               
                 LLADTTHHRPWTVIGESTHHRPWS 
                 20 
               
               
                   
               
               
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFT 
                 21 
               
               
                   
               
               
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFTGLGD 
                 22 
               
               
                 TTHHRPWGILAESTHHKPWT 
                   
               
               
                   
               
               
                 LLADTTHHRPWTILAESTHHKPWT 
                 23 
               
               
                   
               
               
                 LLADTTHHRPWTILAESTHHKPWTLLADTTHHRPWTILAE 
                 24 
               
               
                 STHHKPWTLLADTTHHRPWT 
                   
               
               
                   
               
               
                 LLADTTHHRPWTGLGDTTHHRPWG 
                 25 
               
               
                   
               
               
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT 
                 26 
               
               
                   
               
               
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGD 
                 27 
               
               
                 TTHHRPWGLLADTTHHRPWT 
                   
               
               
                   
               
               
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGD 
                 28 
               
               
                 TTHHRPWGLLADTTHHRPWTGLGDTTHEIRPWGLLADTTH 
                   
               
               
                 HRPWT 
                   
               
               
                   
               
               
                 STADTSHEIRPSTSGGESTHHRPSTSGGESSHHKPSTGSG 
                 29 
               
               
                 DSSHHRPSGSSGESTHHKPST 
                   
               
               
                   
               
               
                 VGADSTHEIRPVTGAADTTHHRPVTAGADTTHHRPVTGGA 
                 30 
               
               
                 DTTHHRPATGGADTTHHRPGT 
                   
               
               
                   
               
               
                 STADTSHEIRPSLLADTTHHRPWTTSGGESTHHRPSVGAD 
                 31 
               
               
                 STHHRPVTTSGGESSHHKPSGAADTTHHRPVTTGSGDSSH 
                   
               
               
                 HRPSGSSGESTHHKPSTGGADTTHHRPAT 
                   
               
               
                   
               
               
                 AAADTTHHRPWT 
                 36 
               
               
                   
               
               
                 AAADTTHHRPWTAAADTTHHRPWTAAADTTHHRPWTAAAD 
                 37 
               
               
                 TTHHRPWTAAADTTHHRPWT 
                   
               
               
                   
               
               
                 LLADAAHHRPWTLLADAAHHRPWTLLADAAHHRPWTLLAD 
                 38 
               
               
                 AAHHRPWTLLADAAHHRPWT 
                   
               
               
                   
               
               
                 LLADTTAARPWTLLADTTAARPWTLLADTTAARPWTLLAD 
                 39 
               
               
                 TTAARPWTLLADTTAARPWT 
                   
               
               
                   
               
               
                 LLADTTHHRPWTLLADTTHHRPWT 
                 40 
               
               
                   
               
               
                 LLADTTHHRPWTLLADTTHHRPWTLLADTTHHRPWT 
                 41 
               
               
                   
               
               
                 LLADTTHHRPWTLLADTTHHRPWTLLADTTHHRPWTLLAD 
                 42 
               
               
                 TTHHRPWTLLADTTHHRPWT 
                   
               
               
                   
               
               
                 STSGSTVIGESTHHRPWSLIADSTHHSPWTILAESTHHKP 
                 43 
               
               
                 WTILAETTHHRPWSIIGESSHHKPFTGLGDTTHHRPWGVL 
                   
               
               
                 GDTTHHKPWTIVADSTHHRPWTGQVLPTTTPSSPSTTSGS 
                   
               
               
                   
               
            
           
         
       
     
     In some embodiments, any of the chimeric polypeptides described herein can includes two or more (e.g., three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, ten or more, eleven or more, twelve or more, thirteen or more, fourteen or more, fifteen or more, sixteen or more, seventeen or more, eighteen or more, nineteen or more, or twenty or more; or 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22) β-TCP-binding sequences (e.g., any of the exemplary β-TCP-binding sequences described herein). In some embodiments, each neighboring pair of the two or more β-TCP binding sequences directly abut each other. In some embodiments, each neighboring pair of the two or more β-TCP binding sequences (e.g., any of the exemplary β-TCP-binding sequences described herein) are separated by a linker sequence. 
     In some embodiments, the chimeric polypeptides can include at least two (e.g., at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, or at least ten; or 2, 3, 4, 5, 6, 7, 8, 9, or 10) different β-TCP-binding sequences (e.g., any of the exemplary β-TCP-binding sequences described herein). 
     In some embodiments, at least one of the two or more different β-TCP-binding sequences is LLADTTHHRPWT (SEQ ID NO: 1) or GQVLPTTTPSSP (SEQ ID NO: 103). In some embodiments, the at least two different β-TCP-binding sequences include LLADTTHHRPWT (SEQ ID NO: 1) and VIGESTHHRPWS (SEQ ID NO: 2). In some embodiments, the chimeric polypeptide includes the sequence of LLADTTHHRPWTVIGESTHHRPWS (SEQ ID NO: 20). 
     In some embodiments, the at least two different β-TCP-binding sequences include LLADTTHHRPWT (SEQ ID NO: 1), VIGESTHHRPWS (SEQ ID NO: 2), and IIGESSHHKPFT (SEQ ID NO: 6). In some embodiments, the chimeric polypeptide includes the sequence of LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFT (SEQ ID NO: 21). 
     In some embodiments, the at least two different β-TCP-binding sequences include LLADTTHHRPWT (SEQ ID NO: 1), VIGESTHHRPWS (SEQ ID NO: 2), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), and ILAESTHHKPWT (SEQ ID NO: 4). In some embodiments, the chimeric polypeptide includes the sequence of: 
     
       
         
           
               
            
               
                 (SEQ ID NO: 22) 
               
               
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFTGLGDTTHEIRPWGI 
               
               
                   
               
               
                 LAESTHHKPWT. 
               
            
           
         
       
     
     In some embodiments, the at least two β-TCP-binding sequences include LLADTTHHRPWT (SEQ ID NO: 1) and ILAESTHHKPWT (SEQ ID NO: 4). In some embodiments, the chimeric polypeptide includes at least one copy of the sequence LLADTTHHRPWTILAESTHHKPWT (SEQ ID NO: 23). In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 24) 
               
               
                 LLADTTHEIRPWTILAESTHHKPWTLLADTTHHRPWTILAESTHHKPWTL 
               
               
                   
               
               
                 LADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the at least two β-TCP-binding sequences include LLADTTHHRPWT (SEQ ID NO: 1) and GLGDTTHHRPWG (SEQ ID NO: 7). In some embodiments, the chimeric polypeptide includes at least one copy of the sequence of LLADTTHHRPWTGLGDTTHHRPWG (SEQ ID NO: 25). In some embodiments, the chimeric polypeptide includes the sequence of LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT (SEQ ID NO: 26). In some embodiments, the chimeric polypeptide includes the sequence of LLADTTHEIRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT (SEQ ID NO: 27). In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 28) 
               
               
                 LLADTTHERPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLL 
               
               
                   
               
               
                 ADTTHHRPWTGLGDTTHERPWGLLADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), and GSSGESTHHKPST (SEQ ID NO: 14). In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 29) 
               
               
                 STADTSHHRPSTSGGESTHHRPSTSGGESSHHKPSTGSGDSSHHRPSGSS 
               
               
                   
               
               
                 GESTHHKPST. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18) and GGADTTHHRPGT (SEQ ID NO: 19). In some embodiments, the chimeric polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 30) 
               
               
                 VGADSTHHRPVTGAADTTHHRPVTAGADTTHHRPVTGGADTTHHRPATGG 
               
               
                   
               
               
                 ADTTHHRPGT. 
               
            
           
         
       
     
     In some embodiments, the at least two different β-TCP-binding sequences include STADTSHHRPS (SEQ ID NO: 10), LLADTTHHRPWT (SEQ ID NO: 1), TSGGESTHHRPS (SEQ ID NO: 11), VGADSTHHRPVT (SEQ ID NO: 15), TSGGESSHHKPS (SEQ ID NO: 12), GAADTTHHRPVT (SEQ ID NO: 16), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPS (SEQ ID NO: 101), and TGGADTTHHRPAT (SEQ ID NO: 102). In some embodiments, the chimeric polypeptide includes the sequence of: 
     
       
         
           
               
            
               
                 (SEQ ID NO: 31) 
               
               
                 STADTSHHRPSLLADTTHHRPWTTSGGESTHHRPSVGADSTHHRPVTTSG 
               
               
                   
               
               
                 GESSHHKPSGAADTTHHRPVTTGSGDSSHHRPSGSSGESTHHKPSTGGAD 
               
               
                   
               
               
                 TTHHRPAT. 
               
            
           
         
       
     
     In some embodiments, the chimeric polypeptides can include two or more (e.g., three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, ten or more, eleven or more, twelve or more, thirteen or more, fourteen or more, fifteen or more, sixteen or more, seventeen or more, eighteen or more, nineteen or more, or twenty or more; or 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20) copies of the same β-TCP-binding sequence (e.g., any of the exemplary β-TCP-binding sequences described herein). 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 1. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 2. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 3. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 4. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 5. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 6. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 7. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 8. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 9. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 10. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 11. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 12. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 13. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 14. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 15. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 16. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 17. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 18. 
     In some embodiments, the chimeric polypeptides can include a β-TCP-binding sequence that has or includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 19. 
     In some embodiments, the chimeric polypeptide further comprises a linker sequence (e.g., any of the exemplary linker sequences described herein or known in the art) between a neighboring pair of a β-TCP-binding sequence (e.g., any of the exemplary β-TCP binding sequences described herein) and the mammalian growth factor (e.g., any of the exemplary mammalian growth factor described herein). In some embodiments, the linker sequence can include the sequence of TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 33). In some embodiments, the linker sequence consists of TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 33). In some embodiments, the linker sequence includes the sequence of GSGATG (SEQ ID NO: 34). In some embodiments, the linker sequence consists of GSGATG (SEQ ID NO: 34). 
     In some embodiments, where the chimeric polypeptide comprises two or more β-TCP-binding sequences, a linker sequence (e.g., any of the exemplary linker sequences described herein or known in the art) can be between any of the pairs (e.g., all of the pairs) of neighboring β-TCP-binding sequences. 
     In some embodiments, the chimeric polypeptide can include a signal sequence at its N-terminus. In some embodiments, the chimeric polypeptide can further include a tag sequence (e.g., a poly-His tag, chitin-binding protein (CBP), maltose-binding protein (MBP), strep-tag, glutathione-S-transferase (GST), thioredoxin, or Fc region). Additional examples of tags are known in the art. 
     The chimeric polypeptide described herein can bind to β-TCP (e.g., any of the types of (3-TCP described herein) with a dissociation equilibrium constant (K d ) of about 1 pM to about 100 μM (e.g., about 1 pM to about 95 μM, about 1 pM to about 90 μM, about 1 pM to about 85 μM, about 1 pM to about 80 μM, about 1 pM to about 75 μM, about 1 pM to about 70 μM, about 1 pM to about 65 μM, about 1 pM to about 60 μM, about 1 pM to about 55 μM, about 1 pM to about 50 μM, about 1 pM to about 45 μM, about 1 pM to about 40 μM, about 1 pM to about 45 μM, about 1 pM to about 40 μM, about 1 pM to about 35 μM, about 1 pM to about 30 μM, about 1 pM to about 25 μM, about 1 pM to about 20 μM, about 1 pM to about 15 μM, about 1 pM to about 10 μM, about 1 pM to about 5 μM, about 1 pM to about 2 μM, about 1 pM to about 1 μM, about 1 pM to about 950 nM, about 1 pM to about 900 nM, about 1 pM to about 850 nM, about 1 pM to about 800 nM, about 1 pM to about 750 nM, about 1 pM to about 700 nM, about 1 pM to about 650 nM, about 1 pM to about 600 nM, about 1 pM to about 550 nM, about 1 pM to about 500 nM, about 1 pM to about 450 nM, about 1 pM to about 400 nM, about 1 pM to about 350 nM, about 1 pM to about 300 nM, about 1 pM to about 250 nM, about 1 pM to about 200 nM, about 1 pM to about 150 nM, about 1 pM to about 100 nM, about 1 pM to about 95 nM, about 1 pM to about 90 nM, about 1 pM to about 85 nM, about 1 pM to about 80 nM, about 1 pM to about 75 nM, about 1 pM to about 70 nM, about 1 pM to about 75 nM, about 1 pM to about 70 nM, about 1 pM to about 65 nM, about 1 pM to about 60 nM, about 1 pM to about 55 nM, about 1 pM to about 50 nM, about 1 pM to about 45 nM, about 1 pM to about 40 nM, about 1 pM to about 35 nM, about 1 pM to about 30 nM, about 1 pM to about 25 nM, about 1 pM to about 20 nM, about 1 pM to about 15 nM, about 1 pM to about 10 nM, about 1 pM to about 5 nM, about 1 pM to about 2 nM, about 1 pM to about 1 nM, about 1 pM to about 950 pM, about 1 pM to about 900 pM, about 1 pM to about 850 pM, about 1 pM to about 800 pM, about 1 pM to about 750 pM, about 1 pM to about 700 pM, about 1 pM to about 650 pM, about 1 pM to about 600 pM, about 1 pM to about 550 pM, about 1 pM to about 500 pM, about 1 pM to about 450 pM, about 1 pM to about 400 pM, about 1 pM to about 350 pM, about 1 pM to about 300 pM, about 1 pM to about 250 pM, about 1 pM to about 200 pM, about 1 pM to about 150 pM, about 1 pM to about 100 pM, about 1 pM to about 95 pM, about 1 pM to about 90 pM, about 1 pM to about 85 pM, about 1 pM to about 80 pM, about 1 pM to about 75 pM, about 1 pM to about 70 pM, about 1 pM to about 75 pM, about 1 pM to about 70 pM, about 1 pM to about 65 pM, about 1 pM to about 60 pM, about 1 pM to about 55 pM, about 1 pM to about 50 pM, about 1 pM to about 45 pM, about 1 pM to about 40 pM, about 1 pM to about 35 pM, about 1 pM to about 30 pM, about 1 pM to about 25 pM, about 1 pM to about 20 pM, about 1 pM to about 15 pM, about 1 pM to about 10 pM, about 1 pM to about 5 pM, about 1 pM to about 2 pM, about 2 pM to about 100 μM, about 2 pM to about 95 μM, about 2 pM to about 90 μM, about 2 pM to about 85 μM, about 2 pM to about 80 μM, about 2 pM to about 75 μM, about 2 pM to about 70 μM, about 2 pM to about 65 μM, about 2 pM to about 60 μM, about 2 pM to about 55 μM, about 2 pM to about 50 μM, about 2 pM to about 45 μM, about 2 pM to about 40 μM, about 2 pM to about 45 μM, about 2 pM to about 40 μM, about 2 pM to about 35 μM, about 2 pM to about 30 μM, about 2 pM to about 25 μM, about 2 pM to about 20 μM, about 2 pM to about 15 μM, about 2 pM to about 10 μM, about 2 pM to about 5 μM, about 2 pM to about 2 μM, about 2 pM to about 1 μM, about 2 pM to about 950 nM, about 2 pM to about 900 nM, about 2 pM to about 850 nM, about 2 pM to about 800 nM, about 2 pM to about 750 nM, about 2 pM to about 700 nM, about 2 pM to about 650 nM, about 2 pM to about 600 nM, about 2 pM to about 550 nM, about 2 pM to about 500 nM, about 2 pM to about 450 nM, about 2 pM to about 400 nM, about 2 pM to about 350 nM, about 2 pM to about 300 nM, about 2 pM to about 250 nM, about 2 pM to about 200 nM, about 2 pM to about 150 nM, about 2 pM to about 100 nM, about 2 pM to about 95 nM, about 2 pM to about 90 nM, about 2 pM to about 85 nM, about 2 pM to about 80 nM, about 2 pM to about 75 nM, about 2 pM to about 70 nM, about 2 pM to about 75 nM, about 2 pM to about 70 nM, about 2 pM to about 65 nM, about 2 pM to about 60 nM, about 2 pM to about 55 nM, about 2 pM to about 50 nM, about 2 pM to about 45 nM, about 2 pM to about 40 nM, about 2 pM to about 35 nM, about 2 pM to about 30 nM, about 2 pM to about 25 nM, about 2 pM to about 20 nM, about 2 pM to about 15 nM, about 2 pM to about 10 nM, about 2 pM to about 5 nM, about 2 pM to about 2 nM, about 2 pM to about 1 nM, about 2 pM to about 950 pM, about 2 pM to about 900 pM, about 2 pM to about 850 pM, about 2 pM to about 800 pM, about 2 pM to about 750 pM, about 2 pM to about 700 pM, about 2 pM to about 650 pM, about 2 pM to about 600 pM, about 2 pM to about 550 pM, about 2 pM to about 500 pM, about 2 pM to about 450 pM, about 2 pM to about 400 pM, about 2 pM to about 350 pM, about 2 pM to about 300 pM, about 2 pM to about 250 pM, about 2 pM to about 200 pM, about 2 pM to about 150 pM, about 2 pM to about 100 pM, about 2 pM to about 95 pM, about 2 pM to about 90 pM, about 2 pM to about 85 pM, about 2 pM to about 80 pM, about 2 pM to about 75 pM, about 2 pM to about 70 pM, about 2 pM to about 75 pM, about 2 pM to about 70 pM, about 2 pM to about 65 pM, about 2 pM to about 60 pM, about 2 pM to about 55 pM, about 2 pM to about 50 pM, about 2 pM to about 45 pM, about 2 pM to about 40 pM, about 2 pM to about 35 pM, about 2 pM to about 30 pM, about 2 pM to about 25 pM, about 2 pM to about 20 pM, about 2 pM to about 15 pM, about 2 pM to about 10 pM, about 2 pM to about 5 pM, about 5 pM to about 100 μM, about 5 pM to about 95 μM, about 5 pM to about 90 μM, about 5 pM to about 85 μM, about 5 pM to about 80 μM, about 5 pM to about 75 μM, about 5 pM to about 70 μM, about 5 pM to about 65 μM, about 5 pM to about 60 μM, about 5 pM to about 55 μM, about 5 pM to about 50 μM, about 5 pM to about 45 μM, about 5 pM to about 40 μM, about 5 pM to about 45 μM, about 5 pM to about 40 μM, about 5 pM to about 35 μM, about 5 pM to about 30 μM, about 5 pM to about 25 μM, about 5 pM to about 20 μM, about 5 pM to about 15 μM, about 5 pM to about 10 μM, about 5 pM to about 5 μM, about 5 pM to about 2 μM, about 5 pM to about 1 μM, about 5 pM to about 950 nM, about 5 pM to about 900 nM, about 5 pM to about 850 nM, about 5 pM to about 800 nM, about 5 pM to about 750 nM, about 5 pM to about 700 nM, about 5 pM to about 650 nM, about 5 pM to about 600 nM, about 5 pM to about 550 nM, about 5 pM to about 500 nM, about 5 pM to about 450 nM, about 5 pM to about 400 nM, about 5 pM to about 350 nM, about 5 pM to about 300 nM, about 5 pM to about 250 nM, about 5 pM to about 200 nM, about 5 pM to about 150 nM, about 5 pM to about 100 nM, about 5 pM to about 95 nM, about 5 pM to about 90 nM, about 5 pM to about 85 nM, about 5 pM to about 80 nM, about 5 pM to about 75 nM, about 5 pM to about 70 nM, about 5 pM to about 75 nM, about 5 pM to about 70 nM, about 5 pM to about 65 nM, about 5 pM to about 60 nM, about 5 pM to about 55 nM, about 5 pM to about 50 nM, about 5 pM to about 45 nM, about 5 pM to about 40 nM, about 5 pM to about 35 nM, about 5 pM to about 30 nM, about 5 pM to about 25 nM, about 5 pM to about 20 nM, about 5 pM to about 15 nM, about 5 pM to about 10 nM, about 5 pM to about 5 nM, about 5 pM to about 2 nM, about 5 pM to about 1 nM, about 5 pM to about 950 pM, about 5 pM to about 900 pM, about 5 pM to about 850 pM, about 5 pM to about 800 pM, about 5 pM to about 750 pM, about 5 pM to about 700 pM, about 5 pM to about 650 pM, about 5 pM to about 600 pM, about 5 pM to about 550 pM, about 5 pM to about 500 pM, about 5 pM to about 450 pM, about 5 pM to about 400 pM, about 5 pM to about 350 pM, about 5 pM to about 300 pM, about 5 pM to about 250 pM, about 5 pM to about 200 pM, about 5 pM to about 150 pM, about 5 pM to about 100 pM, about 5 pM to about 95 pM, about 5 pM to about 90 pM, about 5 pM to about 85 pM, about 5 pM to about 80 pM, about 5 pM to about 75 pM, about 5 pM to about 70 pM, about 5 pM to about 75 pM, about 5 pM to about 70 pM, about 5 pM to about 65 pM, about 5 pM to about 60 pM, about 5 pM to about 55 pM, about 5 pM to about 50 pM, about 5 pM to about 45 pM, about 5 pM to about 40 pM, about 5 pM to about 35 pM, about 5 pM to about 30 pM, about 5 pM to about 25 pM, about 5 pM to about 20 pM, about 5 pM to about 15 pM, about 5 pM to about 10 pM, about 10 pM to about 100 μM, about 10 pM to about 95 μM, about 10 pM to about 90 μM, about 10 pM to about 85 μM, about 10 pM to about 80 μM, about 10 pM to about 75 μM, about 10 pM to about 70 μM, about 10 pM to about 65 μM, about 10 pM to about 60 μM, about 10 pM to about 55 μM, about 10 pM to about 50 μM, about 10 pM to about 45 μM, about 10 pM to about 40 μM, about 10 pM to about 45 μM, about 10 pM to about 40 μM, about 10 pM to about 35 μM, about 10 pM to about 30 μM, about 10 pM to about 25 μM, about 10 pM to about 20 μM, about 10 pM to about 15 μM, about 10 pM to about 10 μM, about 10 pM to about 5 μM, about 10 pM to about 2 μM, about 10 pM to about 1 μM, about 10 pM to about 950 nM, about 10 pM to about 900 nM, about 10 pM to about 850 nM, about 10 pM to about 800 nM, about 10 pM to about 750 nM, about 10 pM to about 700 nM, about 10 pM to about 650 nM, about 10 pM to about 600 nM, about 10 pM to about 550 nM, about 10 pM to about 500 nM, about 10 pM to about 450 nM, about 10 pM to about 400 nM, about 10 pM to about 350 nM, about 10 pM to about 300 nM, about 10 pM to about 250 nM, about 10 pM to about 200 nM, about 10 pM to about 150 nM, about 10 pM to about 100 nM, about 10 pM to about 95 nM, about 10 pM to about 90 nM, about 10 pM to about 85 nM, about 10 pM to about 80 nM, about 10 pM to about 75 nM, about 10 pM to about 70 nM, about 10 pM to about 75 nM, about 10 pM to about 70 nM, about 10 pM to about 65 nM, about 10 pM to about 60 nM, about 10 pM to about 55 nM, about 10 pM to about 50 nM, about 10 pM to about 45 nM, about 10 pM to about 40 nM, about 10 pM to about 35 nM, about 10 pM to about 30 nM, about 10 pM to about 25 nM, about 10 pM to about 20 nM, about 10 pM to about 15 nM, about 10 pM to about 10 nM, about 10 pM to about 5 nM, about 10 pM to about 2 nM, about 10 pM to about 1 nM, about 10 pM to about 950 pM, about 10 pM to about 900 pM, about 10 pM to about 850 pM, about 10 pM to about 800 pM, about 10 pM to about 750 pM, about 10 pM to about 700 pM, about 10 pM to about 650 pM, about 10 pM to about 600 pM, about 10 pM to about 550 pM, about 10 pM to about 500 pM, about 10 pM to about 450 pM, about 10 pM to about 400 pM, about 10 pM to about 350 pM, about 10 pM to about 300 pM, about 10 pM to about 250 pM, about 10 pM to about 200 pM, about 10 pM to about 150 pM, about 10 pM to about 100 pM, about 10 pM to about 95 pM, about 10 pM to about 90 pM, about 10 pM to about 85 pM, about 10 pM to about 80 pM, about 10 pM to about 75 pM, about 10 pM to about 70 pM, about 10 pM to about 75 pM, about 10 pM to about 70 pM, about 10 pM to about 65 pM, about 10 pM to about 60 pM, about 10 pM to about 55 pM, about 10 pM to about 50 pM, about 10 pM to about 45 pM, about 10 pM to about 40 pM, about 10 pM to about 35 pM, about 10 pM to about 30 pM, about 10 pM to about 25 pM, about 10 pM to about 20 pM, about 10 pM to about 15 pM, about 20 pM to about 100 μM, about 20 pM to about 95 μM, about 20 pM to about 90 μM, about 20 pM to about 85 μM, about 20 pM to about 80 μM, about 20 pM to about 75 μM, about 20 pM to about 70 μM, about 20 pM to about 65 μM, about 20 pM to about 60 μM, about 20 pM to about 55 μM, about 20 pM to about 50 μM, about 20 pM to about 45 μM, about 20 pM to about 40 μM, about 20 pM to about 45 μM, about 20 pM to about 40 μM, about 20 pM to about 35 μM, about 20 pM to about 30 μM, about 20 pM to about 25 μM, about 20 pM to about 20 μM, about 20 pM to about 15 μM, about 20 pM to about 10 μM, about 20 pM to about 5 μM, about 20 pM to about 2 μM, about 20 pM to about 1 μM, about 20 pM to about 950 nM, about 20 pM to about 900 nM, about 20 pM to about 850 nM, about 20 pM to about 800 nM, about 20 pM to about 750 nM, about 20 pM to about 700 nM, about 20 pM to about 650 nM, about 20 pM to about 600 nM, about 20 pM to about 550 nM, about 20 pM to about 500 nM, about 20 pM to about 450 nM, about 20 pM to about 400 nM, about 20 pM to about 350 nM, about 20 pM to about 300 nM, about 20 pM to about 250 nM, about 20 pM to about 200 nM, about 20 pM to about 150 nM, about 20 pM to about 100 nM, about 20 pM to about 95 nM, about 20 pM to about 90 nM, about 20 pM to about 85 nM, about 20 pM to about 80 nM, about 20 pM to about 75 nM, about 20 pM to about 70 nM, about 20 pM to about 75 nM, about 20 pM to about 70 nM, about 20 pM to about 65 nM, about 20 pM to about 60 nM, about 20 pM to about 55 nM, about 20 pM to about 50 nM, about 20 pM to about 45 nM, about 20 pM to about 40 nM, about 20 pM to about 35 nM, about 20 pM to about 30 nM, about 20 pM to about 25 nM, about 20 pM to about 20 nM, about 20 pM to about 15 nM, about 20 pM to about 10 nM, about 20 pM to about 5 nM, about 20 pM to about 2 nM, about 20 pM to about 1 nM, about 20 pM to about 950 pM, about 20 pM to about 900 pM, about 20 pM to about 850 pM, about 20 pM to about 800 pM, about 20 pM to about 750 pM, about 20 pM to about 700 pM, about 20 pM to about 650 pM, about 20 pM to about 600 pM, about 20 pM to about 550 pM, about 20 pM to about 500 pM, about 20 pM to about 450 pM, about 20 pM to about 400 pM, about 20 pM to about 350 pM, about 20 pM to about 300 pM, about 20 pM to about 250 pM, about 20 pM to about 200 pM, about 20 pM to about 150 pM, about 20 pM to about 100 pM, about 20 pM to about 95 pM, about 20 pM to about 90 pM, about 20 pM to about 85 pM, about 20 pM to about 80 pM, about 20 pM to about 75 pM, about 20 pM to about 70 pM, about 20 pM to about 75 pM, about 20 pM to about 70 pM, about 20 pM to about 65 pM, about 20 pM to about 60 pM, about 20 pM to about 55 pM, about 20 pM to about 50 pM, about 20 pM to about 45 pM, about 20 pM to about 40 pM, about 20 pM to about 35 pM, about 20 pM to about 30 pM, about 20 pM to about 25 pM, about 50 pM to about 100 μM, about 50 pM to about 95 μM, about 50 pM to about 90 μM, about 50 pM to about 85 μM, about 50 pM to about 80 μM, about 50 pM to about 75 μM, about 50 pM to about 70 μM, about 50 pM to about 65 μM, about 50 pM to about 60 μM, about 50 pM to about 55 μM, about 50 pM to about 50 μM, about 50 pM to about 45 μM, about 50 pM to about 40 μM, about 50 pM to about 45 μM, about 50 pM to about 40 μM, about 50 pM to about 35 μM, about 50 pM to about 30 μM, about 50 pM to about 25 μM, about 50 pM to about 20 μM, about 50 pM to about 15 μM, about 50 pM to about 10 μM, about 50 pM to about 5 μM, about 50 pM to about 2 μM, about 50 pM to about 1 μM, about 50 pM to about 950 nM, about 50 pM to about 900 nM, about 50 pM to about 850 nM, about 50 pM to about 800 nM, about 50 pM to about 750 nM, about 50 pM to about 700 nM, about 50 pM to about 650 nM, about 50 pM to about 600 nM, about 50 pM to about 550 nM, about 50 pM to about 500 nM, about 50 pM to about 450 nM, about 50 pM to about 400 nM, about 50 pM to about 350 nM, about 50 pM to about 300 nM, about 50 pM to about 250 nM, about 50 pM to about 200 nM, about 50 pM to about 150 nM, about 50 pM to about 100 nM, about 50 pM to about 95 nM, about 50 pM to about 90 nM, about 50 pM to about 85 nM, about 50 pM to about 80 nM, about 50 pM to about 75 nM, about 50 pM to about 70 nM, about 50 pM to about 75 nM, about 50 pM to about 70 nM, about 50 pM to about 65 nM, about 50 pM to about 60 nM, about 50 pM to about 55 nM, about 50 pM to about 50 nM, about 50 pM to about 45 nM, about 50 pM to about 40 nM, about 50 pM to about 35 nM, about 50 pM to about 30 nM, about 50 pM to about 25 nM, about 50 pM to about 20 nM, about 50 pM to about 15 nM, about 50 pM to about 10 nM, about 50 pM to about 5 nM, about 50 pM to about 2 nM, about 50 pM to about 1 nM, about 50 pM to about 950 pM, about 50 pM to about 900 pM, about 50 pM to about 850 pM, about 50 pM to about 800 pM, about 50 pM to about 750 pM, about 50 pM to about 700 pM, about 50 pM to about 650 pM, about 50 pM to about 600 pM, about 50 pM to about 550 pM, about 50 pM to about 500 pM, about 50 pM to about 450 pM, about 50 pM to about 400 pM, about 50 pM to about 350 pM, about 50 pM to about 300 pM, about 50 pM to about 250 pM, about 50 pM to about 200 pM, about 50 pM to about 150 pM, about 50 pM to about 100 pM, about 50 pM to about 95 pM, about 50 pM to about 90 pM, about 50 pM to about 85 pM, about 50 pM to about 80 pM, about 50 pM to about 75 pM, about 50 pM to about 70 pM, about 50 pM to about 75 pM, about 50 pM to about 70 pM, about 50 pM to about 65 pM, about 50 pM to about 60 pM, about 50 pM to about 55 pM, about 100 pM to about 100 μM, about 100 pM to about 95 μM, about 100 pM to about 90 μM, about 100 pM to about 85 μM, about 100 pM to about 80 μM, about 100 pM to about 75 μM, about 100 pM to about 70 μM, about 100 pM to about 65 μM, about 100 pM to about 60 μM, about 100 pM to about 55 μM, about 100 pM to about 50 μM, about 100 pM to about 45 μM, about 100 pM to about 40 μM, about 100 pM to about 45 μM, about 100 pM to about 40 μM, about 100 pM to about 35 μM, about 100 pM to about 30 μM, about 100 pM to about 25 μM, about 100 pM to about 20 μM, about 100 pM to about 15 μM, about 100 pM to about 10 μM, about 100 pM to about 5 μM, about 100 pM to about 2 μM, about 100 pM to about 1 μM, about 100 pM to about 950 nM, about 100 pM to about 900 nM, about 100 pM to about 850 nM, about 100 pM to about 800 nM, about 100 pM to about 750 nM, about 100 pM to about 700 nM, about 100 pM to about 650 nM, about 100 pM to about 600 nM, about 100 pM to about 550 nM, about 100 pM to about 500 nM, about 100 pM to about 450 nM, about 100 pM to about 400 nM, about 100 pM to about 350 nM, about 100 pM to about 300 nM, about 100 pM to about 250 nM, about 100 pM to about 200 nM, about 100 pM to about 150 nM, about 100 pM to about 100 nM, about 100 pM to about 95 nM, about 100 pM to about 90 nM, about 100 pM to about 85 nM, about 100 pM to about 80 nM, about 100 pM to about 75 nM, about 100 pM to about 70 nM, about 100 pM to about 75 nM, about 100 pM to about 70 nM, about 100 pM to about 65 nM, about 100 pM to about 60 nM, about 100 pM to about 55 nM, about 100 pM to about 50 nM, about 100 pM to about 45 nM, about 100 pM to about 40 nM, about 100 pM to about 35 nM, about 100 pM to about 30 nM, about 100 pM to about 25 nM, about 100 pM to about 20 nM, about 100 pM to about 15 nM, about 100 pM to about 10 nM, about 100 pM to about 5 nM, about 100 pM to about 2 nM, about 100 pM to about 1 nM, about 100 pM to about 950 pM, about 100 pM to about 900 pM, about 100 pM to about 850 pM, about 100 pM to about 800 pM, about 100 pM to about 750 pM, about 100 pM to about 700 pM, about 100 pM to about 650 pM, about 100 pM to about 600 pM, about 100 pM to about 550 pM, about 100 pM to about 500 pM, about 100 pM to about 450 pM, about 100 pM to about 400 pM, about 100 pM to about 350 pM, about 100 pM to about 300 pM, about 100 pM to about 250 pM, about 100 pM to about 200 pM, about 100 pM to about 150 pM, about 200 pM to about 100 μM, about 200 pM to about 95 μM, about 200 pM to about 90 μM, about 200 pM to about 85 μM, about 200 pM to about 80 μM, about 200 pM to about 75 μM, about 200 pM to about 70 μM, about 200 pM to about 65 μM, about 200 pM to about 60 μM, about 200 pM to about 55 μM, about 200 pM to about 50 μM, about 200 pM to about 45 μM, about 200 pM to about 40 μM, about 200 pM to about 45 μM, about 200 pM to about 40 μM, about 200 pM to about 35 μM, about 200 pM to about 30 μM, about 200 pM to about 25 μM, about 200 pM to about 20 μM, about 200 pM to about 15 μM, about 200 pM to about 10 μM, about 200 pM to about 5 μM, about 200 pM to about 2 μM, about 200 pM to about 1 μM, about 200 pM to about 950 nM, about 200 pM to about 900 nM, about 200 pM to about 850 nM, about 200 pM to about 800 nM, about 200 pM to about 750 nM, about 200 pM to about 700 nM, about 200 pM to about 650 nM, about 200 pM to about 600 nM, about 200 pM to about 550 nM, about 200 pM to about 500 nM, about 200 pM to about 450 nM, about 200 pM to about 400 nM, about 200 pM to about 350 nM, about 200 pM to about 300 nM, about 200 pM to about 250 nM, about 200 pM to about 200 nM, about 200 pM to about 150 nM, about 200 pM to about 100 nM, about 200 pM to about 95 nM, about 200 pM to about 90 nM, about 200 pM to about 85 nM, about 200 pM to about 80 nM, about 200 pM to about 75 nM, about 200 pM to about 70 nM, about 200 pM to about 75 nM, about 200 pM to about 70 nM, about 200 pM to about 65 nM, about 200 pM to about 60 nM, about 200 pM to about 55 nM, about 200 pM to about 50 nM, about 200 pM to about 45 nM, about 200 pM to about 40 nM, about 200 pM to about 35 nM, about 200 pM to about 30 nM, about 200 pM to about 25 nM, about 200 pM to about 20 nM, about 200 pM to about 15 nM, about 200 pM to about 10 nM, about 200 pM to about 5 nM, about 200 pM to about 2 nM, about 200 pM to about 1 nM, about 200 pM to about 950 pM, about 200 pM to about 900 pM, about 200 pM to about 850 pM, about 200 pM to about 800 pM, about 200 pM to about 750 pM, about 200 pM to about 700 pM, about 200 pM to about 650 pM, about 200 pM to about 600 pM, about 200 pM to about 550 pM, about 200 pM to about 500 pM, about 200 pM to about 450 pM, about 200 pM to about 400 pM, about 200 pM to about 350 pM, about 200 pM to about 300 pM, about 200 pM to about 250 pM, about 300 pM to about 100 μM, about 300 pM to about 95 μM, about 300 pM to about 90 μM, about 300 μM to about 85 μM, about 300 pM to about 80 μM, about 300 pM to about 75 μM, about 300 μM to about 70 μM, about 300 pM to about 65 μM, about 300 pM to about 60 μM, about 300 pM to about 55 μM, about 300 pM to about 50 μM, about 300 pM to about 45 μM, about 300 pM to about 40 μM, about 300 pM to about 45 μM, about 300 pM to about 40 μM, about 300 pM to about 35 μM, about 300 pM to about 30 μM, about 300 pM to about 25 μM, about 300 pM to about 20 μM, about 300 pM to about 15 μM, about 300 pM to about 10 μM, about 300 pM to about 5 μM, about 300 pM to about 2 μM, about 300 pM to about 1 μM, about 300 pM to about 950 nM, about 300 pM to about 900 nM, about 300 pM to about 850 nM, about 300 pM to about 800 nM, about 300 pM to about 750 nM, about 300 pM to about 700 nM, about 300 pM to about 650 nM, about 300 pM to about 600 nM, about 300 pM to about 550 nM, about 300 pM to about 500 nM, about 300 pM to about 450 nM, about 300 pM to about 400 nM, about 300 pM to about 350 nM, about 300 pM to about 300 nM, about 300 pM to about 250 nM, about 300 pM to about 200 nM, about 300 pM to about 150 nM, about 300 pM to about 100 nM, about 300 pM to about 95 nM, about 300 pM to about 90 nM, about 300 pM to about 85 nM, about 300 pM to about 80 nM, about 300 pM to about 75 nM, about 300 pM to about 70 nM, about 300 pM to about 75 nM, about 300 pM to about 70 nM, about 300 pM to about 65 nM, about 300 pM to about 60 nM, about 300 pM to about 55 nM, about 300 pM to about 50 nM, about 300 pM to about 45 nM, about 300 pM to about 40 nM, about 300 pM to about 35 nM, about 300 pM to about 30 nM, about 300 pM to about 25 nM, about 300 pM to about 20 nM, about 300 pM to about 15 nM, about 300 pM to about 10 nM, about 300 pM to about 5 nM, about 300 pM to about 2 nM, about 300 pM to about 1 nM, about 300 pM to about 950 pM, about 300 pM to about 900 pM, about 300 pM to about 850 pM, about 300 pM to about 800 pM, about 300 pM to about 750 pM, about 300 pM to about 700 pM, about 300 pM to about 650 pM, about 300 pM to about 600 pM, about 300 pM to about 550 pM, about 300 pM to about 500 pM, about 300 pM to about 450 pM, about 300 pM to about 400 pM, about 300 pM to about 350 pM, about 400 pM to about 100 μM, about 400 pM to about 95 μM, about 400 pM to about 90 μM, about 400 pM to about 85 μM, about 400 pM to about 80 μM, about 400 pM to about 75 μM, about 400 pM to about 70 μM, about 400 pM to about 65 μM, about 400 pM to about 60 μM, about 400 pM to about 55 μM, about 400 pM to about 50 μM, about 400 pM to about 45 μM, about 400 pM to about 40 μM, about 400 pM to about 45 μM, about 400 pM to about 40 μM, about 400 pM to about 35 μM, about 400 pM to about 30 μM, about 400 pM to about 25 μM, about 400 pM to about 20 μM, about 400 pM to about 15 μM, about 400 pM to about 10 μM, about 400 pM to about 5 μM, about 400 pM to about 2 μM, about 400 pM to about 1 μM, about 400 pM to about 950 nM, about 400 pM to about 900 nM, about 400 pM to about 850 nM, about 400 pM to about 800 nM, about 400 pM to about 750 nM, about 400 pM to about 700 nM, about 400 pM to about 650 nM, about 400 pM to about 600 nM, about 400 pM to about 550 nM, about 400 pM to about 500 nM, about 400 pM to about 450 nM, about 400 pM to about 400 nM, about 400 pM to about 350 nM, about 400 pM to about 300 nM, about 400 pM to about 250 nM, about 400 pM to about 200 nM, about 400 pM to about 150 nM, about 400 pM to about 100 nM, about 400 pM to about 95 nM, about 400 pM to about 90 nM, about 400 pM to about 85 nM, about 400 pM to about 80 nM, about 400 pM to about 75 nM, about 400 pM to about 70 nM, about 400 pM to about 75 nM, about 400 pM to about 70 nM, about 400 pM to about 65 nM, about 400 pM to about 60 nM, about 400 pM to about 55 nM, about 400 pM to about 50 nM, about 400 pM to about 45 nM, about 400 pM to about 40 nM, about 400 pM to about 35 nM, about 400 pM to about 30 nM, about 400 pM to about 25 nM, about 400 pM to about 20 nM, about 400 pM to about 15 nM, about 400 pM to about 10 nM, about 400 pM to about 5 nM, about 400 pM to about 2 nM, about 400 pM to about 1 nM, about 400 pM to about 950 pM, about 400 pM to about 900 pM, about 400 pM to about 850 pM, about 400 pM to about 800 pM, about 400 pM to about 750 pM, about 400 pM to about 700 pM, about 400 pM to about 650 pM, about 400 pM to about 600 pM, about 400 pM to about 550 pM, about 400 pM to about 500 pM, about 400 pM to about 450 pM, about 500 pM to about 100 μM, about 500 pM to about 95 μM, about 500 pM to about 90 μM, about 500 pM to about 85 μM, about 500 pM to about 80 μM, about 500 pM to about 75 μM, about 500 pM to about 70 μM, about 500 pM to about 65 μM, about 500 pM to about 60 μM, about 500 pM to about 55 μM, about 500 pM to about 50 μM, about 500 pM to about 45 μM, about 500 pM to about 40 μM, about 500 pM to about 45 μM, about 500 pM to about 40 μM, about 500 pM to about 35 μM, about 500 pM to about 30 μM, about 500 pM to about 25 μM, about 500 pM to about 20 μM, about 500 pM to about 15 μM, about 500 pM to about 10 μM, about 500 pM to about 5 μM, about 500 pM to about 2 μM, about 500 pM to about 1 μM, about 500 pM to about 950 nM, about 500 pM to about 900 nM, about 500 pM to about 850 nM, about 500 pM to about 800 nM, about 500 pM to about 750 nM, about 500 pM to about 700 nM, about 500 pM to about 650 nM, about 500 pM to about 600 nM, about 500 pM to about 550 nM, about 500 pM to about 500 nM, about 500 pM to about 450 nM, about 500 pM to about 400 nM, about 500 pM to about 350 nM, about 500 pM to about 300 nM, about 500 pM to about 250 nM, about 500 pM to about 200 nM, about 500 pM to about 150 nM, about 500 pM to about 100 nM, about 500 pM to about 95 nM, about 500 pM to about 90 nM, about 500 pM to about 85 nM, about 500 pM to about 80 nM, about 500 pM to about 75 nM, about 500 pM to about 70 nM, about 500 pM to about 75 nM, about 500 pM to about 70 nM, about 500 pM to about 65 nM, about 500 pM to about 60 nM, about 500 pM to about 55 nM, about 500 pM to about 50 nM, about 500 pM to about 45 nM, about 500 pM to about 40 nM, about 500 pM to about 35 nM, about 500 pM to about 30 nM, about 500 pM to about 25 nM, about 500 pM to about 20 nM, about 500 pM to about 15 nM, about 500 pM to about 10 nM, about 500 pM to about 5 nM, about 500 pM to about 2 nM, about 500 pM to about 1 nM, about 500 pM to about 950 pM, about 500 pM to about 900 pM, about 500 pM to about 850 pM, about 500 pM to about 800 pM, about 500 pM to about 750 pM, about 500 pM to about 700 pM, about 500 pM to about 650 pM, about 500 pM to about 600 pM, about 500 pM to about 550 pM, about 600 pM to about 100 μM, about 600 pM to about 95 μM, about 600 pM to about 90 μM, about 600 pM to about 85 μM, about 600 pM to about 80 μM, about 600 pM to about 75 μM, about 600 pM to about 70 μM, about 600 pM to about 65 μM, about 600 pM to about 60 μM, about 600 pM to about 55 μM, about 600 pM to about 50 μM, about 600 pM to about 45 μM, about 600 pM to about 40 μM, about 600 pM to about 45 μM, about 600 pM to about 40 μM, about 600 pM to about 35 μM, about 600 pM to about 30 μM, about 600 pM to about 25 μM, about 600 pM to about 20 μM, about 600 pM to about 15 μM, about 600 pM to about 10 μM, about 600 pM to about 5 μM, about 600 pM to about 2 μM, about 600 pM to about 1 μM, about 600 pM to about 950 nM, about 600 pM to about 900 nM, about 600 pM to about 850 nM, about 600 pM to about 800 nM, about 600 pM to about 750 nM, about 600 pM to about 700 nM, about 600 pM to about 650 nM, about 600 pM to about 600 nM, about 600 pM to about 550 nM, about 600 pM to about 500 nM, about 600 pM to about 450 nM, about 600 pM to about 400 nM, about 600 pM to about 350 nM, about 600 pM to about 300 nM, about 600 pM to about 250 nM, about 600 pM to about 200 nM, about 600 pM to about 150 nM, about 600 pM to about 100 nM, about 600 pM to about 95 nM, about 600 pM to about 90 nM, about 600 pM to about 85 nM, about 600 pM to about 80 nM, about 600 pM to about 75 nM, about 600 pM to about 70 nM, about 600 pM to about 75 nM, about 600 pM to about 70 nM, about 600 pM to about 65 nM, about 600 pM to about 60 nM, about 600 pM to about 55 nM, about 600 pM to about 50 nM, about 600 pM to about 45 nM, about 600 pM to about 40 nM, about 600 pM to about 35 nM, about 600 pM to about 30 nM, about 600 pM to about 25 nM, about 600 pM to about 20 nM, about 600 pM to about 15 nM, about 600 pM to about 10 nM, about 600 pM to about 5 nM, about 600 pM to about 2 nM, about 600 pM to about 1 nM, about 600 pM to about 950 pM, about 600 pM to about 900 pM, about 600 pM to about 850 pM, about 600 pM to about 800 pM, about 600 pM to about 750 pM, about 600 pM to about 700 pM, about 600 pM to about 650 pM, about 700 pM to about 100 μM, about 700 pM to about 95 μM, about 700 pM to about 90 μM, about 700 pM to about 85 μM, about 700 pM to about 80 μM, about 700 pM to about 75 μM, about 700 pM to about 70 μM, about 700 pM to about 65 μM, about 700 pM to about 60 μM, about 700 pM to about 55 μM, about 700 pM to about 50 μM, about 700 pM to about 45 μM, about 700 pM to about 40 μM, about 700 pM to about 45 μM, about 700 pM to about 40 pM, about 700 pM to about 35 pM, about 700 pM to about 30 μM, about 700 pM to about 25 pM, about 700 pM to about 20 pM, about 700 pM to about 15 μM, about 700 pM to about 10 pM, about 700 pM to about 5 μM, about 700 pM to about 2 μM, about 700 pM to about 1 μM, about 700 pM to about 950 nM, about 700 pM to about 900 nM, about 700 pM to about 850 nM, about 700 pM to about 800 nM, about 700 pM to about 750 nM, about 700 pM to about 700 nM, about 700 pM to about 650 nM, about 700 pM to about 600 nM, about 700 pM to about 550 nM, about 700 pM to about 500 nM, about 700 pM to about 450 nM, about 700 pM to about 400 nM, about 700 pM to about 350 nM, about 700 pM to about 300 nM, about 700 pM to about 250 nM, about 700 pM to about 200 nM, about 700 pM to about 150 nM, about 700 pM to about 100 nM, about 700 pM to about 95 nM, about 700 pM to about 90 nM, about 700 pM to about 85 nM, about 700 pM to about 80 nM, about 700 pM to about 75 nM, about 700 pM to about 70 nM, about 700 pM to about 75 nM, about 700 pM to about 70 nM, about 700 pM to about 65 nM, about 700 pM to about 60 nM, about 700 pM to about 55 nM, about 700 pM to about 50 nM, about 700 pM to about 45 nM, about 700 pM to about 40 nM, about 700 pM to about 35 nM, about 700 pM to about 30 nM, about 700 pM to about 25 nM, about 700 pM to about 20 nM, about 700 pM to about 15 nM, about 700 pM to about 10 nM, about 700 pM to about 5 nM, about 700 pM to about 2 nM, about 700 pM to about 1 nM, about 700 pM to about 950 pM, about 700 pM to about 900 pM, about 700 pM to about 850 pM, about 700 pM to about 800 pM, about 700 pM to about 750 pM, about 800 pM to about 100 μM, about 800 pM to about 95 μM, about 800 pM to about 90 μM, about 800 pM to about 85 μM, about 800 pM to about 80 μM, about 800 pM to about 75 μM, about 800 pM to about 70 μM, about 800 pM to about 65 μM, about 800 pM to about 60 μM, about 800 pM to about 55 μM, about 800 pM to about 50 μM, about 800 pM to about 45 μM, about 800 pM to about 40 μM, about 800 pM to about 45 μM, about 800 pM to about 40 μM, about 800 pM to about 35 μM, about 800 pM to about 30 μM, about 800 pM to about 25 μM, about 800 pM to about 20 μM, about 800 pM to about 15 μM, about 800 pM to about 10 μM, about 800 pM to about 5 μM, about 800 pM to about 2 μM, about 800 pM to about 1 μM, about 800 pM to about 950 nM, about 800 pM to about 900 nM, about 800 pM to about 850 nM, about 800 pM to about 800 nM, about 800 pM to about 750 nM, about 800 pM to about 700 nM, about 800 pM to about 650 nM, about 800 pM to about 600 nM, about 800 pM to about 550 nM, about 800 pM to about 500 nM, about 800 pM to about 450 nM, about 800 pM to about 400 nM, about 800 pM to about 350 nM, about 800 pM to about 300 nM, about 800 pM to about 250 nM, about 800 pM to about 200 nM, about 800 pM to about 150 nM, about 800 pM to about 100 nM, about 800 pM to about 95 nM, about 800 pM to about 90 nM, about 800 pM to about 85 nM, about 800 pM to about 80 nM, about 800 pM to about 75 nM, about 800 pM to about 70 nM, about 800 pM to about 75 nM, about 800 pM to about 70 nM, about 800 pM to about 65 nM, about 800 pM to about 60 nM, about 800 pM to about 55 nM, about 800 pM to about 50 nM, about 800 pM to about 45 nM, about 800 pM to about 40 nM, about 800 pM to about 35 nM, about 800 pM to about 30 nM, about 800 pM to about 25 nM, about 800 pM to about 20 nM, about 800 pM to about 15 nM, about 800 pM to about 10 nM, about 800 pM to about 5 nM, about 800 pM to about 2 nM, about 800 pM to about 1 nM, about 800 pM to about 950 pM, about 800 pM to about 900 pM, about 800 pM to about 850 pM, about 900 pM to about 100 μM, about 900 pM to about 95 μM, about 900 pM to about 90 μM, about 900 pM to about 85 μM, about 900 pM to about 80 μM, about 900 pM to about 75 μM, about 900 pM to about 70 μM, about 900 pM to about 65 μM, about 900 pM to about 60 μM, about 900 pM to about 55 μM, about 900 pM to about 50 μM, about 900 pM to about 45 μM, about 900 pM to about 40 μM, about 900 pM to about 45 μM, about 900 pM to about 40 μM, about 900 pM to about 35 μM, about 900 pM to about 30 μM, about 900 pM to about 25 μM, about 900 pM to about 20 μM, about 900 pM to about 15 μM, about 900 pM to about 10 μM, about 900 pM to about 5 μM, about 900 pM to about 2 μM, about 900 pM to about 1 μM, about 900 pM to about 950 nM, about 900 pM to about 900 nM, about 900 pM to about 850 nM, about 900 pM to about 800 nM, about 900 pM to about 750 nM, about 900 pM to about 700 nM, about 900 pM to about 650 nM, about 900 pM to about 600 nM, about 900 pM to about 550 nM, about 900 pM to about 500 nM, about 900 pM to about 450 nM, about 900 pM to about 400 nM, about 900 pM to about 350 nM, about 900 pM to about 300 nM, about 900 pM to about 250 nM, about 900 pM to about 200 nM, about 900 pM to about 150 nM, about 900 pM to about 100 nM, about 900 pM to about 95 nM, about 900 pM to about 90 nM, about 900 pM to about 85 nM, about 900 pM to about 80 nM, about 900 pM to about 75 nM, about 900 pM to about 70 nM, about 900 pM to about 75 nM, about 900 pM to about 70 nM, about 900 pM to about 65 nM, about 900 pM to about 60 nM, about 900 pM to about 55 nM, about 900 pM to about 50 nM, about 900 pM to about 45 nM, about 900 pM to about 40 nM, about 900 pM to about 35 nM, about 900 pM to about 30 nM, about 900 pM to about 25 nM, about 900 pM to about 20 nM, about 900 pM to about 15 nM, about 900 pM to about 10 nM, about 900 pM to about 5 nM, about 900 pM to about 2 nM, about 900 pM to about 1 nM, about 900 pM to about 950 pM, about 1 nM to about 100 μM, about 1 nM to about 95 μM, about 1 nM to about 90 μM, about 1 nM to about 85 μM, about 1 nM to about 80 μM, about 1 nM to about 75 μM, about 1 nM to about 70 μM, about 1 nM to about 65 μM, about 1 nM to about 60 μM, about 1 nM to about 55 μM, about 1 nM to about 50 μM, about 1 nM to about 45 μM, about 1 nM to about 40 μM, about 1 nM to about 45 μM, about 1 nM to about 40 μM, about 1 nM to about 35 μM, about 1 nM to about 30 μM, about 1 nM to about 25 μM, about 1 nM to about 20 μM, about 1 nM to about 15 μM, about 1 nM to about 10 μM, about 1 nM to about 5 μM, about 1 nM to about 2 μM, about 1 nM to about 1 μM, about 1 nM to about 950 nM, about 1 nM to about 900 nM, about 1 nM to about 850 nM, about 1 nM to about 800 nM, about 1 nM to about 750 nM, about 1 nM to about 700 nM, about 1 nM to about 650 nM, about 1 nM to about 600 nM, about 1 nM to about 550 nM, about 1 nM to about 500 nM, about 1 nM to about 450 nM, about 1 nM to about 400 nM, about 1 nM to about 350 nM, about 1 nM to about 300 nM, about 1 nM to about 250 nM, about 1 nM to about 200 nM, about 1 nM to about 150 nM, about 1 nM to about 100 nM, about 1 nM to about 95 nM, about 1 nM to about 90 nM, about 1 nM to about 85 nM, about 1 nM to about 80 nM, about 1 nM to about 75 nM, about 1 nM to about 70 nM, about 1 nM to about 75 nM, about 1 nM to about 70 nM, about 1 nM to about 65 nM, about 1 nM to about 60 nM, about 1 nM to about 55 nM, about 1 nM to about 50 nM, about 1 nM to about 45 nM, about 1 nM to about 40 nM, about 1 nM to about 35 nM, about 1 nM to about 30 nM, about 1 nM to about 25 nM, about 1 nM to about 20 nM, about 1 nM to about 15 nM, about 1 nM to about 10 nM, about 1 nM to about 5 nM, about 1 nM to about 2 nM, about 2 nM to about 100 μM, about 2 nM to about 95 μM, about 2 nM to about 90 μM, about 2 nM to about 85 μM, about 2 nM to about 80 μM, about 2 nM to about 75 μM, about 2 nM to about 70 μM, about 2 nM to about 65 μM, about 2 nM to about 60 μM, about 2 nM to about 55 μM, about 2 nM to about 50 μM, about 2 nM to about 45 μM, about 2 nM to about 40 μM, about 2 nM to about 45 μM, about 2 nM to about 40 μM, about 2 nM to about 35 μM, about 2 nM to about 30 μM, about 2 nM to about 25 μM, about 2 nM to about 20 μM, about 2 nM to about 15 μM, about 2 nM to about 10 μM, about 2 nM to about 5 μM, about 2 nM to about 2 μM, about 2 nM to about 1 μM, about 2 nM to about 950 nM, about 2 nM to about 900 nM, about 2 nM to about 850 nM, about 2 nM to about 800 nM, about 2 nM to about 750 nM, about 2 nM to about 700 nM, about 2 nM to about 650 nM, about 2 nM to about 600 nM, about 2 nM to about 550 nM, about 2 nM to about 500 nM, about 2 nM to about 450 nM, about 2 nM to about 400 nM, about 2 nM to about 350 nM, about 2 nM to about 300 nM, about 2 nM to about 250 nM, about 2 nM to about 200 nM, about 2 nM to about 150 nM, about 2 nM to about 100 nM, about 2 nM to about 95 nM, about 2 nM to about 90 nM, about 2 nM to about 85 nM, about 2 nM to about 80 nM, about 2 nM to about 75 nM, about 2 nM to about 70 nM, about 2 nM to about 75 nM, about 2 nM to about 70 nM, about 2 nM to about 65 nM, about 2 nM to about 60 nM, about 2 nM to about 55 nM, about 2 nM to about 50 nM, about 2 nM to about 45 nM, about 2 nM to about 40 nM, about 2 nM to about 35 nM, about 2 nM to about 30 nM, about 2 nM to about 25 nM, about 2 nM to about 20 nM, about 2 nM to about 15 nM, about 2 nM to about 10 nM, about 2 nM to about 5 nM, about 5 nM to about 100 μM, about 5 nM to about 95 μM, about 5 nM to about 90 μM, about 5 nM to about 85 μM, about 5 nM to about 80 μM, about 5 nM to about 75 μM, about 5 nM to about 70 μM, about 5 nM to about 65 μM, about 5 nM to about 60 μM, about 5 nM to about 55 μM, about 5 nM to about 50 μM, about 5 nM to about 45 μM, about 5 nM to about 40 μM, about 5 nM to about 45 μM, about 5 nM to about 40 μM, about 5 nM to about 35 μM, about 5 nM to about 30 μM, about 5 nM to about 25 μM, about 5 nM to about 20 μM, about 5 nM to about 15 μM, about 5 nM to about 10 μM, about 5 nM to about 5 μM, about 5 nM to about 2 μM, about 5 nM to about 1 μM, about 5 nM to about 950 nM, about 5 nM to about 900 nM, about 5 nM to about 850 nM, about 5 nM to about 800 nM, about 5 nM to about 750 nM, about 5 nM to about 700 nM, about 5 nM to about 650 nM, about 5 nM to about 600 nM, about 5 nM to about 550 nM, about 5 nM to about 500 nM, about 5 nM to about 450 nM, about 5 nM to about 400 nM, about 5 nM to about 350 nM, about 5 nM to about 300 nM, about 5 nM to about 250 nM, about 5 nM to about 200 nM, about 5 nM to about 150 nM, about 5 nM to about 100 nM, about 5 nM to about 95 nM, about 5 nM to about 90 nM, about 5 nM to about 85 nM, about 5 nM to about 80 nM, about 5 nM to about 75 nM, about 5 nM to about 70 nM, about 5 nM to about 75 nM, about 5 nM to about 70 nM, about 5 nM to about 65 nM, about 5 nM to about 60 nM, about 5 nM to about 55 nM, about 5 nM to about 50 nM, about 5 nM to about 45 nM, about 5 nM to about 40 nM, about 5 nM to about 35 nM, about 5 nM to about 30 nM, about 5 nM to about 25 nM, about 5 nM to about 20 nM, about 5 nM to about 15 nM, about 5 nM to about 10 nM, about 10 nM to about 100 μM, about 10 nM to about 95 μM, about 10 nM to about 90 μM, about 10 nM to about 85 μM, about 10 nM to about 80 μM, about 10 nM to about 75 μM, about 10 nM to about 70 μM, about 10 nM to about 65 μM, about 10 nM to about 60 μM, about 10 nM to about 55 μM, about 10 nM to about 50 μM, about 10 nM to about 45 μM, about 10 nM to about 40 μM, about 10 nM to about 45 μM, about 10 nM to about 40 μM, about 10 nM to about 35 μM, about 10 nM to about 30 μM, about 10 nM to about 25 μM, about 10 nM to about 20 μM, about 10 nM to about 15 μM, about 10 nM to about 10 μM, about 10 nM to about 5 μM, about 10 nM to about 2 μM, about 10 nM to about 1 μM, about 10 nM to about 950 nM, about 10 nM to about 900 nM, about 10 nM to about 850 nM, about 10 nM to about 800 nM, about 10 nM to about 750 nM, about 10 nM to about 700 nM, about 10 nM to about 650 nM, about 10 nM to about 600 nM, about 10 nM to about 550 nM, about 10 nM to about 500 nM, about 10 nM to about 450 nM, about 10 nM to about 400 nM, about 10 nM to about 350 nM, about 10 nM to about 300 nM, about 10 nM to about 250 nM, about 10 nM to about 200 nM, about 10 nM to about 150 nM, about 10 nM to about 100 nM, about 10 nM to about 95 nM, about 10 nM to about 90 nM, about 10 nM to about 85 nM, about 10 nM to about 80 nM, about 10 nM to about 75 nM, about 10 nM to about 70 nM, about 10 nM to about 75 nM, about 10 nM to about 70 nM, about 10 nM to about 65 nM, about 10 nM to about 60 nM, about 10 nM to about 55 nM, about 10 nM to about 50 nM, about 10 nM to about 45 nM, about 10 nM to about 40 nM, about 10 nM to about 35 nM, about 10 nM to about 30 nM, about 10 nM to about 25 nM, about 10 nM to about 20 nM, about 10 nM to about 15 nM, about 20 nM to about 100 μM, about 20 nM to about 95 μM, about 20 nM to about 90 μM, about 20 nM to about 85 μM, about 20 nM to about 80 μM, about 20 nM to about 75 μM, about 20 nM to about 70 μM, about 20 nM to about 65 μM, about 20 nM to about 60 μM, about 20 nM to about 55 μM, about 20 nM to about 50 μM, about 20 nM to about 45 μM, about 20 nM to about 40 μM, about 20 nM to about 45 μM, about 20 nM to about 40 μM, about 20 nM to about 35 μM, about 20 nM to about 30 μM, about 20 nM to about 25 μM, about 20 nM to about 20 μM, about 20 nM to about 15 μM, about 20 nM to about 10 μM, about 20 nM to about 5 μM, about 20 nM to about 2 μM, about 20 nM to about 1 μM, about 20 nM to about 950 nM, about 20 nM to about 900 nM, about 20 nM to about 850 nM, about 20 nM to about 800 nM, about 20 nM to about 750 nM, about 20 nM to about 700 nM, about 20 nM to about 650 nM, about 20 nM to about 600 nM, about 20 nM to about 550 nM, about 20 nM to about 500 nM, about 20 nM to about 450 nM, about 20 nM to about 400 nM, about 20 nM to about 350 nM, about 20 nM to about 300 nM, about 20 nM to about 250 nM, about 20 nM to about 200 nM, about 20 nM to about 150 nM, about 20 nM to about 100 nM, about 20 nM to about 95 nM, about 20 nM to about 90 nM, about 20 nM to about 85 nM, about 20 nM to about 80 nM, about 20 nM to about 75 nM, about 20 nM to about 70 nM, about 20 nM to about 75 nM, about 20 nM to about 70 nM, about 20 nM to about 65 nM, about 20 nM to about 60 nM, about 20 nM to about 55 nM, about 20 nM to about 50 nM, about 20 nM to about 45 nM, about 20 nM to about 40 nM, about 20 nM to about 35 nM, about 20 nM to about 30 nM, about 20 nM to about 25 nM, about 50 nM to about 100 μM, about 50 nM to about 95 μM, about 50 nM to about 90 μM, about 50 nM to about 85 μM, about 50 nM to about 80 μM, about 50 nM to about 75 μM, about 50 nM to about 70 μM, about 50 nM to about 65 μM, about 50 nM to about 60 μM, about 50 nM to about 55 μM, about 50 nM to about 50 μM, about 50 nM to about 45 μM, about 50 nM to about 40 μM, about 50 nM to about 45 μM, about 50 nM to about 40 μM, about 50 nM to about 35 μM, about 50 nM to about 30 μM, about 50 nM to about 25 μM, about 50 nM to about 20 μM, about 50 nM to about 15 μM, about 50 nM to about 10 μM, about 50 nM to about 5 μM, about 50 nM to about 2 μM, about 50 nM to about 1 μM, about 50 nM to about 950 nM, about 50 nM to about 900 nM, about 50 nM to about 850 nM, about 50 nM to about 800 nM, about 50 nM to about 750 nM, about 50 nM to about 700 nM, about 50 nM to about 650 nM, about 50 nM to about 600 nM, about 50 nM to about 550 nM, about 50 nM to about 500 nM, about 50 nM to about 450 nM, about 50 nM to about 400 nM, about 50 nM to about 350 nM, about 50 nM to about 300 nM, about 50 nM to about 250 nM, about 50 nM to about 200 nM, about 50 nM to about 150 nM, about 50 nM to about 100 nM, about 50 nM to about 95 nM, about 50 nM to about 90 nM, about 50 nM to about 85 nM, about 50 nM to about 80 nM, about 50 nM to about 75 nM, about 50 nM to about 70 nM, about 50 nM to about 75 nM, about 50 nM to about 70 nM, about 50 nM to about 65 nM, about 50 nM to about 60 nM, about 50 nM to about 55 nM, about 100 nM to about 100 μM, about 100 nM to about 95 μM, about 100 nM to about 90 μM, about 100 nM to about 85 μM, about 100 nM to about 80 μM, about 100 nM to about 75 μM, about 100 nM to about 70 μM, about 100 nM to about 65 μM, about 100 nM to about 60 μM, about 100 nM to about 55 μM, about 100 nM to about 50 μM, about 100 nM to about 45 μM, about 100 nM to about 40 μM, about 100 nM to about 45 μM, about 100 nM to about 40 μM, about 100 nM to about 35 μM, about 100 nM to about 30 μM, about 100 nM to about 25 μM, about 100 nM to about 20 μM, about 100 nM to about 15 μM, about 100 nM to about 10 μM, about 100 nM to about 5 μM, about 100 nM to about 2 μM, about 100 nM to about 1 μM, about 100 nM to about 950 nM, about 100 nM to about 900 nM, about 100 nM to about 850 nM, about 100 nM to about 800 nM, about 100 nM to about 750 nM, about 100 nM to about 700 nM, about 100 nM to about 650 nM, about 100 nM to about 600 nM, about 100 nM to about 550 nM, about 100 nM to about 500 nM, about 100 nM to about 450 nM, about 100 nM to about 400 nM, about 100 nM to about 350 nM, about 100 nM to about 300 nM, about 100 nM to about 250 nM, about 100 nM to about 200 nM, about 100 nM to about 150 nM, about 200 nM to about 100 μM, about 200 nM to about 95 μM, about 200 nM to about 90 μM, about 200 nM to about 85 μM, about 200 nM to about 80 μM, about 200 nM to about 75 μM, about 200 nM to about 70 μM, about 200 nM to about 65 μM, about 200 nM to about 60 μM, about 200 nM to about 55 μM, about 200 nM to about 50 μM, about 200 nM to about 45 μM, about 200 nM to about 40 μM, about 200 nM to about 45 μM, about 200 nM to about 40 μM, about 200 nM to about 35 μM, about 200 nM to about 30 μM, about 200 nM to about 25 μM, about 200 nM to about 20 μM, about 200 nM to about 15 μM, about 200 nM to about 10 μM, about 200 nM to about 5 μM, about 200 nM to about 2 μM, about 200 nM to about 1 μM, about 200 nM to about 950 nM, about 200 nM to about 900 nM, about 200 nM to about 850 nM, about 200 nM to about 800 nM, about 200 nM to about 750 nM, about 200 nM to about 700 nM, about 200 nM to about 650 nM, about 200 nM to about 600 nM, about 200 nM to about 550 nM, about 200 nM to about 500 nM, about 200 nM to about 450 nM, about 200 nM to about 400 nM, about 200 nM to about 350 nM, about 200 nM to about 300 nM, about 200 nM to about 250 nM, about 300 nM to about 100 μM, about 300 nM to about 95 μM, about 300 nM to about 90 μM, about 300 nM to about 85 μM, about 300 nM to about 80 μM, about 300 nM to about 75 μM, about 300 nM to about 70 μM, about 300 nM to about 65 μM, about 300 nM to about 60 μM, about 300 nM to about 55 μM, about 300 nM to about 50 μM, about 300 nM to about 45 μM, about 300 nM to about 40 μM, about 300 nM to about 45 μM, about 300 nM to about 40 μM, about 300 nM to about 35 μM, about 300 nM to about 30 μM, about 300 nM to about 25 μM, about 300 nM to about 20 μM, about 300 nM to about 15 μM, about 300 nM to about 10 μM, about 300 nM to about 5 μM, about 300 nM to about 2 μM, about 300 nM to about 1 μM, about 300 nM to about 950 nM, about 300 nM to about 900 nM, about 300 nM to about 850 nM, about 300 nM to about 800 nM, about 300 nM to about 750 nM, about 300 nM to about 700 nM, about 300 nM to about 650 nM, about 300 nM to about 600 nM, about 300 nM to about 550 nM, about 300 nM to about 500 nM, about 300 nM to about 450 nM, about 300 nM to about 400 nM, about 300 nM to about 350 nM, about 400 nM to about 100 μM, about 400 nM to about 95 μM, about 400 nM to about 90 μM, about 400 nM to about 85 μM, about 400 nM to about 80 μM, about 400 nM to about 75 μM, about 400 nM to about 70 μM, about 400 nM to about 65 μM, about 400 nM to about 60 μM, about 400 nM to about 55 μM, about 400 nM to about 50 μM, about 400 nM to about 45 μM, about 400 nM to about 40 μM, about 400 nM to about 45 μM, about 400 nM to about 40 μM, about 400 nM to about 35 μM, about 400 nM to about 30 μM, about 400 nM to about 25 μM, about 400 nM to about 20 μM, about 400 nM to about 15 μM, about 400 nM to about 10 μM, about 400 nM to about 5 μM, about 400 nM to about 2 μM, about 400 nM to about 1 μM, about 400 nM to about 950 nM, about 400 nM to about 900 nM, about 400 nM to about 850 nM, about 400 nM to about 800 nM, about 400 nM to about 750 nM, about 400 nM to about 700 nM, about 400 nM to about 650 nM, about 400 nM to about 600 nM, about 400 nM to about 550 nM, about 400 nM to about 500 nM, about 400 nM to about 450 nM, about 500 nM to about 100 μM, about 500 nM to about 95 μM, about 500 nM to about 90 μM, about 500 nM to about 85 μM, about 500 nM to about 80 μM, about 500 nM to about 75 μM, about 500 nM to about 70 μM, about 500 nM to about 65 μM, about 500 nM to about 60 μM, about 500 nM to about 55 μM, about 500 nM to about 50 μM, about 500 nM to about 45 μM, about 500 nM to about 40 μM, about 500 nM to about 45 μM, about 500 nM to about 40 μM, about 500 nM to about 35 μM, about 500 nM to about 30 μM, about 500 nM to about 25 μM, about 500 nM to about 20 μM, about 500 nM to about 15 μM, about 500 nM to about 10 μM, about 500 nM to about 5 μM, about 500 nM to about 2 μM, about 500 nM to about 1 μM, about 500 nM to about 950 nM, about 500 nM to about 900 nM, about 500 nM to about 850 nM, about 500 nM to about 800 nM, about 500 nM to about 750 nM, about 500 nM to about 700 nM, about 500 nM to about 650 nM, about 500 nM to about 600 nM, about 500 nM to about 550 nM, about 600 nM to about 100 μM, about 600 nM to about 95 μM, about 600 nM to about 90 μM, about 600 nM to about 85 μM, about 600 nM to about 80 μM, about 600 nM to about 75 μM, about 600 nM to about 70 μM, about 600 nM to about 65 μM, about 600 nM to about 60 μM, about 600 nM to about 55 μM, about 600 nM to about 50 μM, about 600 nM to about 45 μM, about 600 nM to about 40 μM, about 600 nM to about 45 μM, about 600 nM to about 40 μM, about 600 nM to about 35 μM, about 600 nM to about 30 μM, about 600 nM to about 25 μM, about 600 nM to about 20 μM, about 600 nM to about 15 μM, about 600 nM to about 10 μM, about 600 nM to about 5 μM, about 600 nM to about 2 μM, about 600 nM to about 1 μM, about 600 nM to about 950 nM, about 600 nM to about 900 nM, about 600 nM to about 850 nM, about 600 nM to about 800 nM, about 600 nM to about 750 nM, about 600 nM to about 700 nM, about 600 nM to about 650 nM, about 700 nM to about 100 μM, about 700 nM to about 95 μM, about 700 nM to about 90 μM, about 700 nM to about 85 μM, about 700 nM to about 80 μM, about 700 nM to about 75 μM, about 700 nM to about 70 μM, about 700 nM to about 65 μM, about 700 nM to about 60 μM, about 700 nM to about 55 μM, about 700 nM to about 50 μM, about 700 nM to about 45 μM, about 700 nM to about 40 μM, about 700 nM to about 45 μM, about 700 nM to about 40 μM, about 700 nM to about 35 μM, about 700 nM to about 30 μM, about 700 nM to about 25 μM, about 700 nM to about 20 μM, about 700 nM to about 15 μM, about 700 nM to about 10 μM, about 700 nM to about 5 μM, about 700 nM to about 2 μM, about 700 nM to about 1 μM, about 700 nM to about 950 nM, about 700 nM to about 900 nM, about 700 nM to about 850 nM, about 700 nM to about 800 nM, about 700 nM to about 750 nM, about 800 nM to about 100 μM, about 800 nM to about 95 μM, about 800 nM to about 90 μM, about 800 nM to about 85 μM, about 800 nM to about 80 μM, about 800 nM to about 75 μM, about 800 nM to about 70 μM, about 800 nM to about 65 μM, about 800 nM to about 60 μM, about 800 nM to about 55 μM, about 800 nM to about 50 μM, about 800 nM to about 45 μM, about 800 nM to about 40 μM, about 800 nM to about 45 μM, about 800 nM to about 40 μM, about 800 nM to about 35 μM, about 800 nM to about 30 μM, about 800 nM to about 25 μM, about 800 nM to about 20 μM, about 800 nM to about 15 μM, about 800 nM to about 10 μM, about 800 nM to about 5 μM, about 800 nM to about 2 μM, about 800 nM to about 1 μM, about 800 nM to about 950 nM, about 800 nM to about 900 nM, about 800 nM to about 850 nM, about 900 nM to about 100 μM, about 900 nM to about 95 μM, about 900 nM to about 90 μM, about 900 nM to about 85 μM, about 900 nM to about 80 μM, about 900 nM to about 75 μM, about 900 nM to about 70 μM, about 900 nM to about 65 μM, about 900 nM to about 60 μM, about 900 nM to about 55 μM, about 900 nM to about 50 μM, about 900 nM to about 45 μM, about 900 nM to about 40 μM, about 900 nM to about 45 μM, about 900 nM to about 40 μM, about 900 nM to about 35 μM, about 900 nM to about 30 μM, about 900 nM to about 25 μM, about 900 nM to about 20 μM, about 900 nM to about 15 μM, about 900 nM to about 10 μM, about 900 nM to about 5 μM, about 900 nM to about 2 μM, about 900 nM to about 1 μM, about 900 nM to about 950 nM, about 1 μM to about 100 μM, about 1 μM to about 95 μM, about 1 μM to about 90 μM, about 1 μM to about 85 μM, about 1 μM to about 80 μM, about 1 μM to about 75 μM, about 1 μM to about 70 μM, about 1 μM to about 65 μM, about 1 μM to about 60 μM, about 1 μM to about 55 μM, about 1 μM to about 50 μM, about 1 μM to about 45 μM, about 1 μM to about 40 μM, about 1 μM to about 45 μM, about 1 μM to about 40 μM, about 1 μM to about 35 μM, about 1 μM to about 30 μM, about 1 μM to about 25 μM, about 1 μM to about 20 μM, about 1 μM to about 15 μM, about 1 μM to about 10 μM, about 1 μM to about 5 μM, about 1 μM to about 2 μM, about 2 μM to about 100 μM, about 2 μM to about 95 μM, about 2 μM to about 90 μM, about 2 μM to about 85 μM, about 2 μM to about 80 μM, about 2 μM to about 75 μM, about 2 μM to about 70 μM, about 2 μM to about 65 μM, about 2 μM to about 60 μM, about 2 μM to about 55 μM, about 2 μM to about 50 μM, about 2 μM to about 45 μM, about 2 μM to about 40 μM, about 2 μM to about 45 μM, about 2 μM to about 40 μM, about 2 μM to about 35 μM, about 2 μM to about 30 μM, about 2 μM to about 25 μM, about 2 μM to about 20 μM, about 2 μM to about 15 μM, about 2 μM to about 10 μM, about 2 μM to about 5 μM, about 5 μM to about 100 μM, about 5 μM to about 95 μM, about 5 μM to about 90 μM, about 5 μM to about 85 μM, about 5 μM to about 80 μM, about 5 μM to about 75 μM, about 5 μM to about 70 μM, about 5 μM to about 65 μM, about 5 μM to about 60 μM, about 5 μM to about 55 μM, about 5 μM to about 50 μM, about 5 μM to about 45 μM, about 5 μM to about 40 μM, about 5 μM to about 45 μM, about 5 μM to about 40 μM, about 5 μM to about 35 μM, about 5 μM to about 30 μM, about 5 μM to about 25 μM, about 5 μM to about 20 μM, about 5 μM to about 15 μM, about 5 μM to about 10 μM, about 10 μM to about 100 μM, about 10 μM to about 95 μM, about 10 μM to about 90 μM, about 10 μM to about 85 μM, about 10 μM to about 80 μM, about 10 μM to about 75 μM, about 10 μM to about 70 μM, about 10 μM to about 65 μM, about 10 μM to about 60 μM, about 10 μM to about 55 μM, about 10 μM to about 50 μM, about 10 μM to about 45 μM, about 10 μM to about 40 μM, about 10 μM to about 45 μM, about 10 μM to about 40 μM, about 10 μM to about 35 μM, about 10 μM to about 30 μM, about 10 μM to about 25 μM, about 10 μM to about 20 μM, about 10 μM to about 15 μM, about 20 μM to about 100 μM, about 20 μM to about 95 μM, about 20 μM to about 90 μM, about 20 μM to about 85 μM, about 20 μM to about 80 μM, about 20 μM to about 75 μM, about 20 μM to about 70 μM, about 20 μM to about 65 μM, about 20 μM to about 60 μM, about 20 μM to about 55 μM, about 20 μM to about 50 μM, about 20 μM to about 45 μM, about 20 μM to about 40 μM, about 20 μM to about 45 μM, about 20 μM to about 40 μM, about 20 μM to about 35 μM, about 20 μM to about 30 μM, about 20 μM to about 25 μM, about 30 μM to about 100 μM, about 30 μM to about 95 μM, about 30 μM to about 90 μM, about 30 μM to about 85 μM, about 30 μM to about 80 μM, about 30 μM to about 75 μM, about 30 μM to about 70 μM, about 30 μM to about 65 μM, about 30 μM to about 60 μM, about 30 μM to about 55 μM, about 30 μM to about 50 μM, about 30 μM to about 45 μM, about 30 μM to about 40 μM, about 30 μM to about 45 μM, about 30 μM to about 40 μM, about 30 μM to about 35 μM, about 40 μM to about 100 μM, about 40 μM to about 95 μM, about 40 μM to about 90 μM, about 40 μM to about 85 μM, about 40 μM to about 80 μM, about 40 μM to about 75 μM, about 40 μM to about 70 μM, about 40 μM to about 65 μM, about 40 μM to about 60 μM, about 40 μM to about 55 μM, about 40 μM to about 50 μM, about 40 μM to about 45 μM, about 50 μM to about 100 μM, about 50 μM to about 95 μM, about 50 μM to about 90 μM, about 50 μM to about 85 μM, about 50 μM to about 80 μM, about 50 μM to about 75 μM, about 50 μM to about 70 μM, about 50 μM to about 65 μM, about 50 μM to about 60 μM, about 50 μM to about 55 μM, about 60 μM to about 100 μM, about 60 μM to about 95 μM, about 60 μM to about 90 μM, about 60 μM to about 85 μM, about 60 μM to about 80 μM, about 60 μM to about 75 μM, about 60 μM to about 70 μM, about 60 μM to about 65 μM, about 70 μM to about 100 μM, about 70 μM to about 95 μM, about 70 μM to about 90 μM, about 70 μM to about 85 μM, about 70 μM to about 80 μM, about 70 μM to about 75 μM, about 80 μM to about 100 μM, about 80 μM to about 95 μM, about 80 μM to about 90 μM, about 80 μM to about 85 μM, about 90 μM to about 100 μM, or about 90 μM to about 95 μM) (e.g., as measured using SPR in phosphate buffered saline). 
     In some embodiments, the chimeric polypeptides described herein can have a total length of about 20 amino acids to about 1400 amino acids, about 20 amino acids to about 1350 amino acids, about 20 amino acids to about 1300 amino acids, about 20 amino acids to about 1250 amino acids, about 20 amino acids to about 1200 amino acids, about 20 amino acids to about 1150 amino acids, about 20 amino acids to about 1100 amino acids, about 20 amino acid to about 1050 amino acids, about 20 amino acids to about 1000 amino acids, about 20 amino acids to about 950 amino acids, about 20 amino acids to about 900 amino acids, about 20 amino acids to about 850 amino acids, about 20 amino acids to about 800 amino acids, about 20 amino acids to about 750 amino acids, about 20 amino acids to about 700 amino acids, about 20 amino acids to about 650 amino acids, about 20 amino acids to about 600 amino acids, about 20 amino acids to about 550 amino acids, about 20 amino acids to about 500 amino acids, about 20 amino acids to about 450 amino acids, about 20 amino acids to about 400 amino acids, about 20 amino acids to about 350 amino acids, about 20 amino acids to about 300 amino acids, about 20 amino acids to about 250 amino acids, about 20 amino acids to about 200 amino acids, about 20 amino acids to about 150 amino acids, about 20 amino acids to about 100 amino acids, about 20 amino acids to about 90 amino acids, about 20 amino acids to about 80 amino acids, about 20 amino acids to about 70 amino acids, about 20 amino acids to about 60 amino acids, about 20 amino acids to about 50 amino acids, about 20 amino acids to about 45 amino acids, about 20 amino acids to about 40 amino acids, about 20 amino acids to about 35 amino acids, about 20 amino acids to about 30 amino acids, about 20 amino acids to about 25 amino acids, about 25 amino acids to about 1400 amino acids, about 25 amino acids to about 1350 amino acids, about 25 amino acids to about 1300 amino acids, about 25 amino acids to about 1250 amino acids, about 25 amino acids to about 1200 amino acids, about 25 amino acids to about 1150 amino acids, about 25 amino acids to about 1100 amino acids, about 25 amino acid to about 1050 amino acids, about 25 amino acids to about 1000 amino acids, about 25 amino acids to about 950 amino acids, about 25 amino acids to about 900 amino acids, about 25 amino acids to about 850 amino acids, about 25 amino acids to about 800 amino acids, about 25 amino acids to about 750 amino acids, about 25 amino acids to about 700 amino acids, about 25 amino acids to about 650 amino acids, about 25 amino acids to about 600 amino acids, about 25 amino acids to about 550 amino acids, about 25 amino acids to about 500 amino acids, about 25 amino acids to about 450 amino acids, about 25 amino acids to about 400 amino acids, about 25 amino acids to about 350 amino acids, about 25 amino acids to about 300 amino acids, about 25 amino acids to about 250 amino acids, about 25 amino acids to about 200 amino acids, about 25 amino acids to about 150 amino acids, about 25 amino acids to about 100 amino acids, about 25 amino acids to about 90 amino acids, about 25 amino acids to about 80 amino acids, about 25 amino acids to about 70 amino acids, about 25 amino acids to about 60 amino acids, about 25 amino acids to about 50 amino acids, about 25 amino acids to about 45 amino acids, about 25 amino acids to about 40 amino acids, about 25 amino acids to about 35 amino acids, about 25 amino acids to about 30 amino acids, about 30 amino acids to about 1400 amino acids, about 30 amino acids to about 1350 amino acids, about 30 amino acids to about 1300 amino acids, about 30 amino acids to about 1250 amino acids, about 30 amino acids to about 1200 amino acids, about 30 amino acids to about 1150 amino acids, about 30 amino acids to about 1100 amino acids, about 30 amino acid to about 1050 amino acids, about 30 amino acids to about 1000 amino acids, about 30 amino acids to about 950 amino acids, about 30 amino acids to about 900 amino acids, about 30 amino acids to about 850 amino acids, about 30 amino acids to about 800 amino acids, about 30 amino acids to about 750 amino acids, about 30 amino acids to about 700 amino acids, about 30 amino acids to about 650 amino acids, about 30 amino acids to about 600 amino acids, about 30 amino acids to about 550 amino acids, about 30 amino acids to about 500 amino acids, about 30 amino acids to about 450 amino acids, about 30 amino acids to about 400 amino acids, about 30 amino acids to about 350 amino acids, about 30 amino acids to about 300 amino acids, about 30 amino acids to about 250 amino acids, about 30 amino acids to about 200 amino acids, about 30 amino acids to about 150 amino acids, about 30 amino acids to about 100 amino acids, about 30 amino acids to about 90 amino acids, about 30 amino acids to about 80 amino acids, about 30 amino acids to about 70 amino acids, about 30 amino acids to about 60 amino acids, about 30 amino acids to about 50 amino acids, about 30 amino acids to about 45 amino acids, about 30 amino acids to about 40 amino acids, about 30 amino acids to about 35 amino acids, about 35 amino acids to about 1400 amino acids, about 35 amino acids to about 1350 amino acids, about 35 amino acids to about 1300 amino acids, about 35 amino acids to about 1250 amino acids, about 35 amino acids to about 1200 amino acids, about 35 amino acids to about 1150 amino acids, about 35 amino acids to about 1100 amino acids, about 35 amino acid to about 1050 amino acids, about 35 amino acids to about 1000 amino acids, about 35 amino acids to about 950 amino acids, about 35 amino acids to about 900 amino acids, about 35 amino acids to about 850 amino acids, about 35 amino acids to about 800 amino acids, about 35 amino acids to about 750 amino acids, about 35 amino acids to about 700 amino acids, about 35 amino acids to about 650 amino acids, about 35 amino acids to about 600 amino acids, about 35 amino acids to about 550 amino acids, about 35 amino acids to about 500 amino acids, about 35 amino acids to about 450 amino acids, about 35 amino acids to about 400 amino acids, about 35 amino acids to about 350 amino acids, about 35 amino acids to about 300 amino acids, about 35 amino acids to about 250 amino acids, about 35 amino acids to about 200 amino acids, about 35 amino acids to about 150 amino acids, about 35 amino acids to about 100 amino acids, about 35 amino acids to about 90 amino acids, about 35 amino acids to about 80 amino acids, about 35 amino acids to about 70 amino acids, about 35 amino acids to about 60 amino acids, about 35 amino acids to about 50 amino acids, about 35 amino acids to about 45 amino acids, about 35 amino acids to about 40 amino acids, about 40 amino acids to about 1400 amino acids, about 40 amino acids to about 1350 amino acids, about 40 amino acids to about 1300 amino acids, about 40 amino acids to about 1250 amino acids, about 40 amino acids to about 1200 amino acids, about 40 amino acids to about 1150 amino acids, about 40 amino acids to about 1100 amino acids, about 40 amino acid to about 1050 amino acids, about 40 amino acids to about 1000 amino acids, about 40 amino acids to about 950 amino acids, about 40 amino acids to about 900 amino acids, about 40 amino acids to about 850 amino acids, about 40 amino acids to about 800 amino acids, about 40 amino acids to about 750 amino acids, about 40 amino acids to about 700 amino acids, about 40 amino acids to about 650 amino acids, about 40 amino acids to about 600 amino acids, about 40 amino acids to about 550 amino acids, about 40 amino acids to about 500 amino acids, about 40 amino acids to about 450 amino acids, about 40 amino acids to about 400 amino acids, about 40 amino acids to about 350 amino acids, about 40 amino acids to about 300 amino acids, about 40 amino acids to about 250 amino acids, about 40 amino acids to about 200 amino acids, about 40 amino acids to about 150 amino acids, about 40 amino acids to about 100 amino acids, about 40 amino acids to about 90 amino acids, about 40 amino acids to about 80 amino acids, about 40 amino acids to about 70 amino acids, about 40 amino acids to about 60 amino acids, about 40 amino acids to about 50 amino acids, about 40 amino acids to about 45 amino acids, about 45 amino acids to about 1400 amino acids, about 45 amino acids to about 1350 amino acids, about 45 amino acids to about 1300 amino acids, about 45 amino acids to about 1250 amino acids, about 45 amino acids to about 1200 amino acids, about 45 amino acids to about 1150 amino acids, about 45 amino acids to about 1100 amino acids, about 45 amino acid to about 1050 amino acids, about 45 amino acids to about 1000 amino acids, about 45 amino acids to about 950 amino acids, about 45 amino acids to about 900 amino acids, about 45 amino acids to about 850 amino acids, about 45 amino acids to about 800 amino acids, about 45 amino acids to about 750 amino acids, about 45 amino acids to about 700 amino acids, about 45 amino acids to about 650 amino acids, about 45 amino acids to about 600 amino acids, about 45 amino acids to about 550 amino acids, about 45 amino acids to about 500 amino acids, about 45 amino acids to about 450 amino acids, about 45 amino acids to about 400 amino acids, about 45 amino acids to about 350 amino acids, about 45 amino acids to about 300 amino acids, about 45 amino acids to about 250 amino acids, about 45 amino acids to about 200 amino acids, about 45 amino acids to about 150 amino acids, about 45 amino acids to about 100 amino acids, about 45 amino acids to about 90 amino acids, about 45 amino acids to about 80 amino acids, about 45 amino acids to about 70 amino acids, about 45 amino acids to about 60 amino acids, about 45 amino acids to about 50 amino acids, about 50 amino acids to about 1400 amino acids, about 50 amino acids to about 1350 amino acids, about 50 amino acids to about 1300 amino acids, about 50 amino acids to about 1250 amino acids, about 50 amino acids to about 1200 amino acids, about 50 amino acids to about 1150 amino acids, about 50 amino acids to about 1100 amino acids, about 50 amino acid to about 1050 amino acids, about 50 amino acids to about 1000 amino acids, about 50 amino acids to about 950 amino acids, about 50 amino acids to about 900 amino acids, about 50 amino acids to about 850 amino acids, about 50 amino acids to about 800 amino acids, about 50 amino acids to about 750 amino acids, about 50 amino acids to about 700 amino acids, about 50 amino acids to about 650 amino acids, about 50 amino acids to about 600 amino acids, about 50 amino acids to about 550 amino acids, about 50 amino acids to about 500 amino acids, about 50 amino acids to about 450 amino acids, about 50 amino acids to about 400 amino acids, about 50 amino acids to about 350 amino acids, about 50 amino acids to about 300 amino acids, about 50 amino acids to about 250 amino acids, about 50 amino acids to about 200 amino acids, about 50 amino acids to about 150 amino acids, about 50 amino acids to about 100 amino acids, about 50 amino acids to about 90 amino acids, about 50 amino acids to about 80 amino acids, about 50 amino acids to about 70 amino acids, about 50 amino acids to about 60 amino acids, about 60 amino acids to about 1400 amino acids, about 60 amino acids to about 1350 amino acids, about 60 amino acids to about 1300 amino acids, about 60 amino acids to about 1250 amino acids, about 60 amino acids to about 1200 amino acids, about 60 amino acids to about 1150 amino acids, about 60 amino acids to about 1100 amino acids, about 60 amino acid to about 1050 amino acids, about 60 amino acids to about 1000 amino acids, about 60 amino acids to about 950 amino acids, about 60 amino acids to about 900 amino acids, about 60 amino acids to about 850 amino acids, about 60 amino acids to about 800 amino acids, about 60 amino acids to about 750 amino acids, about 60 amino acids to about 700 amino acids, about 60 amino acids to about 650 amino acids, about 60 amino acids to about 600 amino acids, about 60 amino acids to about 550 amino acids, about 60 amino acids to about 500 amino acids, about 60 amino acids to about 450 amino acids, about 60 amino acids to about 400 amino acids, about 60 amino acids to about 350 amino acids, about 60 amino acids to about 300 amino acids, about 60 amino acids to about 250 amino acids, about 60 amino acids to about 200 amino acids, about 60 amino acids to about 150 amino acids, about 60 amino acids to about 100 amino acids, about 60 amino acids to about 90 amino acids, about 60 amino acids to about 80 amino acids, about 60 amino acids to about 70 amino acids, about 70 amino acids to about 1400 amino acids, about 70 amino acids to about 1350 amino acids, about 70 amino acids to about 1300 amino acids, about 70 amino acids to about 1250 amino acids, about 70 amino acids to about 1200 amino acids, about 70 amino acids to about 1150 amino acids, about 70 amino acids to about 1100 amino acids, about 70 amino acid to about 1050 amino acids, about 70 amino acids to about 1000 amino acids, about 70 amino acids to about 950 amino acids, about 70 amino acids to about 900 amino acids, about 70 amino acids to about 850 amino acids, about 70 amino acids to about 800 amino acids, about 70 amino acids to about 750 amino acids, about 70 amino acids to about 700 amino acids, about 70 amino acids to about 650 amino acids, about 70 amino acids to about 600 amino acids, about 70 amino acids to about 550 amino acids, about 70 amino acids to about 500 amino acids, about 70 amino acids to about 450 amino acids, about 70 amino acids to about 400 amino acids, about 70 amino acids to about 350 amino acids, about 70 amino acids to about 300 amino acids, about 70 amino acids to about 250 amino acids, about 70 amino acids to about 200 amino acids, about 70 amino acids to about 150 amino acids, about 70 amino acids to about 100 amino acids, about 70 amino acids to about 90 amino acids, about 70 amino acids to about 80 amino acids, about 80 amino acids to about 1400 amino acids, about 80 amino acids to about 1350 amino acids, about 80 amino acids to about 1300 amino acids, about 80 amino acids to about 1250 amino acids, about 80 amino acids to about 1200 amino acids, about 80 amino acids to about 1150 amino acids, about 80 amino acids to about 1100 amino acids, about 80 amino acid to about 1050 amino acids, about 80 amino acids to about 1000 amino acids, about 80 amino acids to about 950 amino acids, about 80 amino acids to about 900 amino acids, about 80 amino acids to about 850 amino acids, about 80 amino acids to about 800 amino acids, about 80 amino acids to about 750 amino acids, about 80 amino acids to about 700 amino acids, about 80 amino acids to about 650 amino acids, about 80 amino acids to about 600 amino acids, about 80 amino acids to about 550 amino acids, about 80 amino acids to about 500 amino acids, about 80 amino acids to about 450 amino acids, about 80 amino acids to about 400 amino acids, about 80 amino acids to about 350 amino acids, about 80 amino acids to about 300 amino acids, about 80 amino acids to about 250 amino acids, about 80 amino acids to about 200 amino acids, about 80 amino acids to about 150 amino acids, about 80 amino acids to about 100 amino acids, about 80 amino acids to about 90 amino acids, about 90 amino acids to about 1400 amino acids, about 90 amino acids to about 1350 amino acids, about 90 amino acids to about 1300 amino acids, about 90 amino acids to about 1250 amino acids, about 90 amino acids to about 1200 amino acids, about 90 amino acids to about 1150 amino acids, about 90 amino acids to about 1100 amino acids, about 90 amino acid to about 1050 amino acids, about 90 amino acids to about 1000 amino acids, about 90 amino acids to about 950 amino acids, about 90 amino acids to about 900 amino acids, about 90 amino acids to about 850 amino acids, about 90 amino acids to about 800 amino acids, about 90 amino acids to about 750 amino acids, about 90 amino acids to about 700 amino acids, about 90 amino acids to about 650 amino acids, about 90 amino acids to about 600 amino acids, about 90 amino acids to about 550 amino acids, about 90 amino acids to about 500 amino acids, about 90 amino acids to about 450 amino acids, about 90 amino acids to about 400 amino acids, about 90 amino acids to about 350 amino acids, about 90 amino acids to about 300 amino acids, about 90 amino acids to about 250 amino acids, about 90 amino acids to about 200 amino acids, about 90 amino acids to about 150 amino acids, about 90 amino acids to about 100 amino acids, about 100 amino acids to about 1400 amino acids, about 100 amino acids to about 1350 amino acids, about 100 amino acids to about 1300 amino acids, about 100 amino acids to about 1250 amino acids, about 100 amino acids to about 1200 amino acids, about 100 amino acids to about 1150 amino acids, about 100 amino acids to about 1100 amino acids, about 100 amino acid to about 1050 amino acids, about 100 amino acids to about 1000 amino acids, about 100 amino acids to about 950 amino acids, about 100 amino acids to about 900 amino acids, about 100 amino acids to about 850 amino acids, about 100 amino acids to about 800 amino acids, about 100 amino acids to about 750 amino acids, about 100 amino acids to about 700 amino acids, about 100 amino acids to about 650 amino acids, about 100 amino acids to about 600 amino acids, about 100 amino acids to about 550 amino acids, about 100 amino acids to about 500 amino acids, about 100 amino acids to about 450 amino acids, about 100 amino acids to about 400 amino acids, about 100 amino acids to about 350 amino acids, about 100 amino acids to about 300 amino acids, about 100 amino acids to about 250 amino acids, about 100 amino acids to about 200 amino acids, about 100 amino acids to about 150 amino acids, about 150 amino acids to about 1400 amino acids, about 150 amino acids to about 1350 amino acids, about 150 amino acids to about 1300 amino acids, about 150 amino acids to about 1250 amino acids, about 150 amino acids to about 1200 amino acids, about 150 amino acids to about 1150 amino acids, about 150 amino acids to about 1100 amino acids, about 150 amino acid to about 1050 amino acids, about 150 amino acids to about 1000 amino acids, about 150 amino acids to about 950 amino acids, about 150 amino acids to about 900 amino acids, about 150 amino acids to about 850 amino acids, about 150 amino acids to about 800 amino acids, about 150 amino acids to about 750 amino acids, about 150 amino acids to about 700 amino acids, about 150 amino acids to about 650 amino acids, about 150 amino acids to about 600 amino acids, about 150 amino acids to about 550 amino acids, about 150 amino acids to about 500 amino acids, about 150 amino acids to about 450 amino acids, about 150 amino acids to about 400 amino acids, about 150 amino acids to about 350 amino acids, about 150 amino acids to about 300 amino acids, about 150 amino acids to about 250 amino acids, about 150 amino acids to about 200 amino acids, about 200 amino acids to about 1400 amino acids, about 200 amino acids to about 1350 amino acids, about 200 amino acids to about 1300 amino acids, about 200 amino acids to about 1250 amino acids, about 200 amino acids to about 1200 amino acids, about 200 amino acids to about 1150 amino acids, about 200 amino acids to about 1100 amino acids, about 200 amino acid to about 1050 amino acids, about 200 amino acids to about 1000 amino acids, about 200 amino acids to about 950 amino acids, about 200 amino acids to about 900 amino acids, about 200 amino acids to about 850 amino acids, about 200 amino acids to about 800 amino acids, about 200 amino acids to about 750 amino acids, about 200 amino acids to about 700 amino acids, about 200 amino acids to about 650 amino acids, about 200 amino acids to about 600 amino acids, about 200 amino acids to about 550 amino acids, about 200 amino acids to about 500 amino acids, about 200 amino acids to about 450 amino acids, about 200 amino acids to about 400 amino acids, about 200 amino acids to about 350 amino acids, about 200 amino acids to about 300 amino acids, about 200 amino acids to about 250 amino acids, about 250 amino acids to about 1400 amino acids, about 250 amino acids to about 1350 amino acids, about 250 amino acids to about 1300 amino acids, about 250 amino acids to about 1250 amino acids, about 250 amino acids to about 1200 amino acids, about 250 amino acids to about 1150 amino acids, about 250 amino acids to about 1100 amino acids, about 250 amino acid to about 1050 amino acids, about 250 amino acids to about 1000 amino acids, about 250 amino acids to about 950 amino acids, about 250 amino acids to about 900 amino acids, about 250 amino acids to about 850 amino acids, about 250 amino acids to about 800 amino acids, about 250 amino acids to about 750 amino acids, about 250 amino acids to about 700 amino acids, about 250 amino acids to about 650 amino acids, about 250 amino acids to about 600 amino acids, about 250 amino acids to about 550 amino acids, about 250 amino acids to about 500 amino acids, about 250 amino acids to about 450 amino acids, about 250 amino acids to about 400 amino acids, about 250 amino acids to about 350 amino acids, about 250 amino acids to about 300 amino acids, about 300 amino acids to about 1400 amino acids, about 300 amino acids to about 1350 amino acids, about 300 amino acids to about 1300 amino acids, about 300 amino acids to about 1250 amino acids, about 300 amino acids to about 1200 amino acids, about 300 amino acids to about 1150 amino acids, about 300 amino acids to about 1100 amino acids, about 300 amino acid to about 1050 amino acids, about 300 amino acids to about 1000 amino acids, about 300 amino acids to about 950 amino acids, about 300 amino acids to about 900 amino acids, about 300 amino acids to about 850 amino acids, about 300 amino acids to about 800 amino acids, about 300 amino acids to about 750 amino acids, about 300 amino acids to about 700 amino acids, about 300 amino acids to about 650 amino acids, about 300 amino acids to about 600 amino acids, about 300 amino acids to about 550 amino acids, about 300 amino acids to about 500 amino acids, about 300 amino acids to about 450 amino acids, about 300 amino acids to about 400 amino acids, about 300 amino acids to about 350 amino acids, about 350 amino acids to about 1400 amino acids, about 350 amino acids to about 1350 amino acids, about 350 amino acids to about 1300 amino acids, about 350 amino acids to about 1250 amino acids, about 350 amino acids to about 1200 amino acids, about 350 amino acids to about 1150 amino acids, about 350 amino acids to about 1100 amino acids, about 350 amino acid to about 1050 amino acids, about 350 amino acids to about 1000 amino acids, about 350 amino acids to about 950 amino acids, about 350 amino acids to about 900 amino acids, about 350 amino acids to about 850 amino acids, about 350 amino acids to about 800 amino acids, about 350 amino acids to about 750 amino acids, about 350 amino acids to about 700 amino acids, about 350 amino acids to about 650 amino acids, about 350 amino acids to about 600 amino acids, about 350 amino acids to about 550 amino acids, about 350 amino acids to about 500 amino acids, about 350 amino acids to about 450 amino acids, about 350 amino acids to about 400 amino acids, about 400 amino acids to about 1400 amino acids, about 400 amino acids to about 1350 amino acids, about 400 amino acids to about 1300 amino acids, about 400 amino acids to about 1250 amino acids, about 400 amino acids to about 1200 amino acids, about 400 amino acids to about 1150 amino acids, about 400 amino acids to about 1100 amino acids, about 400 amino acid to about 1050 amino acids, about 400 amino acids to about 1000 amino acids, about 400 amino acids to about 950 amino acids, about 400 amino acids to about 900 amino acids, about 400 amino acids to about 850 amino acids, about 400 amino acids to about 800 amino acids, about 400 amino acids to about 750 amino acids, about 400 amino acids to about 700 amino acids, about 400 amino acids to about 650 amino acids, about 400 amino acids to about 600 amino acids, about 400 amino acids to about 550 amino acids, about 400 amino acids to about 500 amino acids, about 400 amino acids to about 450 amino acids, about 450 amino acids to about 1400 amino acids, about 450 amino acids to about 1350 amino acids, about 450 amino acids to about 1300 amino acids, about 450 amino acids to about 1250 amino acids, about 450 amino acids to about 1200 amino acids, about 450 amino acids to about 1150 amino acids, about 450 amino acids to about 1100 amino acids, about 450 amino acid to about 1050 amino acids, about 450 amino acids to about 1000 amino acids, about 450 amino acids to about 950 amino acids, about 450 amino acids to about 900 amino acids, about 450 amino acids to about 850 amino acids, about 450 amino acids to about 800 amino acids, about 450 amino acids to about 750 amino acids, about 450 amino acids to about 700 amino acids, about 450 amino acids to about 650 amino acids, about 450 amino acids to about 600 amino acids, about 450 amino acids to about 550 amino acids, about 450 amino acids to about 500 amino acids, about 500 amino acids to about 1400 amino acids, about 500 amino acids to about 1350 amino acids, about 500 amino acids to about 1300 amino acids, about 500 amino acids to about 1250 amino acids, about 500 amino acids to about 1200 amino acids, about 500 amino acids to about 1150 amino acids, about 500 amino acids to about 1100 amino acids, about 500 amino acid to about 1050 amino acids, about 500 amino acids to about 1000 amino acids, about 500 amino acids to about 950 amino acids, about 500 amino acids to about 900 amino acids, about 500 amino acids to about 850 amino acids, about 500 amino acids to about 800 amino acids, about 500 amino acids to about 750 amino acids, about 500 amino acids to about 700 amino acids, about 500 amino acids to about 650 amino acids, about 500 amino acids to about 600 amino acids, about 500 amino acids to about 550 amino acids, about 550 amino acids to about 1400 amino acids, about 550 amino acids to about 1350 amino acids, about 550 amino acids to about 1300 amino acids, about 550 amino acids to about 1250 amino acids, about 550 amino acids to about 1200 amino acids, about 550 amino acids to about 1150 amino acids, about 550 amino acids to about 1100 amino acids, about 550 amino acid to about 1050 amino acids, about 550 amino acids to about 1000 amino acids, about 550 amino acids to about 950 amino acids, about 550 amino acids to about 900 amino acids, about 550 amino acids to about 850 amino acids, about 550 amino acids to about 800 amino acids, about 550 amino acids to about 750 amino acids, about 550 amino acids to about 700 amino acids, about 550 amino acids to about 650 amino acids, about 550 amino acids to about 600 amino acids, about 600 amino acids to about 1400 amino acids, about 600 amino acids to about 1350 amino acids, about 600 amino acids to about 1300 amino acids, about 600 amino acids to about 1250 amino acids, about 600 amino acids to about 1200 amino acids, about 600 amino acids to about 1150 amino acids, about 600 amino acids to about 1100 amino acids, about 600 amino acid to about 1050 amino acids, about 600 amino acids to about 1000 amino acids, about 600 amino acids to about 950 amino acids, about 600 amino acids to about 900 amino acids, about 600 amino acids to about 850 amino acids, about 600 amino acids to about 800 amino acids, about 600 amino acids to about 750 amino acids, about 600 amino acids to about 700 amino acids, about 600 amino acids to about 650 amino acids, about 650 amino acids to about 1400 amino acids, about 650 amino acids to about 1350 amino acids, about 650 amino acids to about 1300 amino acids, about 650 amino acids to about 1250 amino acids, about 650 amino acids to about 1200 amino acids, about 650 amino acids to about 1150 amino acids, about 650 amino acids to about 1100 amino acids, about 650 amino acid to about 1050 amino acids, about 650 amino acids to about 1000 amino acids, about 650 amino acids to about 950 amino acids, about 650 amino acids to about 900 amino acids, about 650 amino acids to about 850 amino acids, about 650 amino acids to about 800 amino acids, about 650 amino acids to about 750 amino acids, about 650 amino acids to about 700 amino acids, about 700 amino acids to about 1400 amino acids, about 700 amino acids to about 1350 amino acids, about 700 amino acids to about 1300 amino acids, about 700 amino acids to about 1250 amino acids, about 700 amino acids to about 1200 amino acids, about 700 amino acids to about 1150 amino acids, about 700 amino acids to about 1100 amino acids, about 700 amino acid to about 1050 amino acids, about 700 amino acids to about 1000 amino acids, about 700 amino acids to about 950 amino acids, about 700 amino acids to about 900 amino acids, about 700 amino acids to about 850 amino acids, about 700 amino acids to about 800 amino acids, about 700 amino acids to about 750 amino acids, about 750 amino acids to about 1400 amino acids, about 750 amino acids to about 1350 amino acids, about 750 amino acids to about 1300 amino acids, about 750 amino acids to about 1250 amino acids, about 750 amino acids to about 1200 amino acids, about 750 amino acids to about 1150 amino acids, about 750 amino acids to about 1100 amino acids, about 750 amino acid to about 1050 amino acids, about 750 amino acids to about 1000 amino acids, about 750 amino acids to about 950 amino acids, about 750 amino acids to about 900 amino acids, about 750 amino acids to about 850 amino acids, about 750 amino acids to about 800 amino acids, about 800 amino acids to about 1400 amino acids, about 800 amino acids to about 1350 amino acids, about 800 amino acids to about 1300 amino acids, about 800 amino acids to about 1250 amino acids, about 800 amino acids to about 1200 amino acids, about 800 amino acids to about 1150 amino acids, about 800 amino acids to about 1100 amino acids, about 800 amino acid to about 1050 amino acids, about 800 amino acids to about 1000 amino acids, about 800 amino acids to about 950 amino acids, about 800 amino acids to about 900 amino acids, about 800 amino acids to about 850 amino acids, about 850 amino acids to about 1400 amino acids, about 850 amino acids to about 1350 amino acids, about 850 amino acids to about 1300 amino acids, about 850 amino acids to about 1250 amino acids, about 850 amino acids to about 1200 amino acids, about 850 amino acids to about 1150 amino acids, about 850 amino acids to about 1100 amino acids, about 850 amino acid to about 1050 amino acids, about 850 amino acids to about 1000 amino acids, about 850 amino acids to about 950 amino acids, about 850 amino acids to about 900 amino acids, about 900 amino acids to about 1400 amino acids, about 900 amino acids to about 1350 amino acids, about 900 amino acids to about 1300 amino acids, about 900 amino acids to about 1250 amino acids, about 900 amino acids to about 1200 amino acids, about 900 amino acids to about 1150 amino acids, about 900 amino acids to about 1100 amino acids, about 900 amino acid to about 1050 amino acids, about 900 amino acids to about 1000 amino acids, about 900 amino acids to about 950 amino acids, about 950 amino acids to about 1400 amino acids, about 950 amino acids to about 1350 amino acids, about 950 amino acids to about 1300 amino acids, about 950 amino acids to about 1250 amino acids, about 950 amino acids to about 1200 amino acids, about 950 amino acids to about 1150 amino acids, about 950 amino acids to about 1100 amino acids, about 950 amino acid to about 1050 amino acids, about 950 amino acids to about 1000 amino acids, about 1000 amino acids to about 1400 amino acids, about 1000 amino acids to about 1350 amino acids, about 1000 amino acids to about 1300 amino acids, about 1000 amino acids to about 1250 amino acids, about 1000 amino acids to about 1200 amino acids, about 1000 amino acids to about 1150 amino acids, about 1000 amino acids to about 1100 amino acids, about 1000 amino acid to about 1050 amino acids, about 1050 amino acids to about 1400 amino acids, about 1050 amino acids to about 1350 amino acids, about 1050 amino acids to about 1300 amino acids, about 1050 amino acids to about 1250 amino acids, about 1050 amino acids to about 1200 amino acids, about 1050 amino acids to about 1150 amino acids, about 1050 amino acids to about 1100 amino acids, about 1100 amino acids to about 1400 amino acids, about 1100 amino acids to about 1350 amino acids, about 1100 amino acids to about 1300 amino acids, about 1100 amino acids to about 1250 amino acids, about 1100 amino acids to about 1200 amino acids, about 1100 amino acids to about 1150 amino acids, about 1150 amino acids to about 1400 amino acids, about 1150 amino acids to about 1350 amino acids, about 1150 amino acids to about 1300 amino acids, about 1150 amino acids to about 1250 amino acids, about 1150 amino acids to about 1200 amino acids, about 1200 amino acids to about 1400 amino acids, about 1200 amino acids to about 1350 amino acids, about 1200 amino acids to about 1300 amino acids, about 1200 amino acids to about 1250 amino acids, about 1250 amino acids to about 1400 amino acids, about 1250 amino acids to about 1350 amino acids, about 1250 amino acids to about 1300 amino acids, about 1300 amino acids to about 1400 amino acids, about 1300 amino acids to about 1350 amino acids, or about 1350 amino acids to about 1400 amino acids. 
     For example, the chimeric polypeptide may include: LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFTGLGDTTHERPWGILAESTHHKPWT A TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 44). In some instances the chimeric polypeptide includes a β-TCP binding sequence and a linker that has an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%) sequence identity to SEQ ID NO: 44. 
     For example, the chimeric polypeptide may include: LLADTTHERPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLLADTTHHR PWT TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 45. In some instances the chimeric polypeptide includes a β-TCP binding sequence and a linker that has an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%) sequence identity to SEQ ID NO: 45. 
     A variety of different methods known in the art can be used to determine the K D  values of any of the chimeric polypeptides described herein for binding to β-TCP (e.g., any of the types of β-TCP described herein) (e.g., an electrophoretic mobility shift assay, a filter binding assay, surface plasmon resonance, and a biomolecular binding kinetics assay, etc.) 
     The chimeric polypeptides provided herein are useful orthopedic materials, and can be used as bone void fillers and for bone reconstructions. The chimeric polypeptides described herein are osteo-conductive and easily resorbed. 
     Linkers 
     In some instances, a neighboring pair (or each neighboring pair) of two β-TCP binding sequences directly abut each other. In other instances, a neighboring pair (or each neighboring pair) of two β-TCP binding sequences are separated by a linker sequence. For example, a linker sequence can be 1 amino acid to about 100 amino acids, 1 amino acid to about 95 amino acids, 1 amino acid to about 90 amino acids, 1 amino acid to about 85 amino acids, 1 amino acid to about 80 amino acids, 1 amino acid to about 75 amino acids, 1 amino acid to about 70 amino acids, 1 amino acid to about 65 amino acids, 1 amino acid to about 60 amino acids, 1 amino acid to about 55 amino acids, 1 amino acid to about 50 amino acids, 1 amino acid to about 45 amino acids, 1 amino acid to about 40 amino acids, 1 amino acid to about 38 amino acids, 1 amino acid to about 36 amino acids, 1 amino acid to about 34 amino acids, 1 amino acid to about 32 amino acids, 1 amino acid to about 30 amino acids, 1 amino acid to about 28 amino acids, 1 amino acid to about 26 amino acids, 1 amino acid to about 24 amino acids, 1 amino acid to about 22 amino acids, 1 amino acid to about 20 amino acids, 1 amino acid to about 18 amino acids, 1 amino acid to about 16 amino acids, 1 amino acid to about 14 amino acids, 1 amino acid to about 12 amino acids, 1 amino acid to about 10 amino acids, 1 amino acid to about 8 amino acids, 1 amino acid to about 6 amino acids, 1 amino acid to about 4 amino acids, about 2 amino acids to about 100 amino acids, about 2 amino acids to about 95 amino acids, about 2 amino acids to about 90 amino acids, about 2 amino acids to about 85 amino acids, about 2 amino acids to about 80 amino acids, about 2 amino acids to about 75 amino acids, about 2 amino acids to about 70 amino acids, about 2 amino acids to about 65 amino acids, about 2 amino acids to about 60 amino acids, about 2 amino acids to about 55 amino acids, about 2 amino acids to about 50 amino acids, about 2 amino acids to about 45 amino acids, about 2 amino acids to about 40 amino acids, about 2 amino acids to about 38 amino acids, about 2 amino acids to about 36 amino acids, about 2 amino acids to about 34 amino acids, about 2 amino acids to about 32 amino acids, about 2 amino acids to about 30 amino acids, about 2 amino acids to about 28 amino acids, about 2 amino acids to about 26 amino acids, about 2 amino acids to about 24 amino acids, about 2 amino acids to about 22 amino acids, about 2 amino acids to about 20 amino acids, about 2 amino acids to about 18 amino acids, about 2 amino acids to about 16 amino acids, about 2 amino acids to about 14 amino acids, about 2 amino acids to about 12 amino acids, about 2 amino acids to about 10 amino acids, about 2 amino acids to about 8 amino acids, about 2 amino acids to about 6 amino acids, about 2 amino acids to about 4 amino acids, about 4 amino acids to about 100 amino acids, about 4 amino acids to about 95 amino acids, about 4 amino acids to about 90 amino acids, about 4 amino acids to about 85 amino acids, about 4 amino acids to about 80 amino acids, about 4 amino acids to about 75 amino acids, about 4 amino acids to about 70 amino acids, about 4 amino acids to about 65 amino acids, about 4 amino acids to about 60 amino acids, about 4 amino acids to about 55 amino acids, about 4 amino acids to about 50 amino acids, about 4 amino acids to about 45 amino acids, about 4 amino acids to about 40 amino acids, about 4 amino acids to about 38 amino acids, about 4 amino acids to about 36 amino acids, about 4 amino acids to about 34 amino acids, about 4 amino acids to about 32 amino acids, about 4 amino acids to about 30 amino acids, about 4 amino acids to about 28 amino acids, about 4 amino acids to about 26 amino acids, about 4 amino acids to about 24 amino acids, about 4 amino acids to about 22 amino acids, about 4 amino acids to about 20 amino acids, about 4 amino acids to about 18 amino acids, about 4 amino acids to about 16 amino acids, about 4 amino acids to about 14 amino acids, about 4 amino acids to about 12 amino acids, about 4 amino acids to about 10 amino acids, about 4 amino acids to about 8 amino acids, about 4 amino acids to about 6 amino acids, about 6 amino acids to about 100 amino acids, about 6 amino acids to about 95 amino acids, about 6 amino acids to about 90 amino acids, about 6 amino acids to about 85 amino acids, about 6 amino acids to about 80 amino acids, about 6 amino acids to about 75 amino acids, about 6 amino acids to about 70 amino acids, about 6 amino acids to about 65 amino acids, about 6 amino acids to about 60 amino acids, about 6 amino acids to about 55 amino acids, about 6 amino acids to about 50 amino acids, about 6 amino acids to about 45 amino acids, about 6 amino acids to about 40 amino acids, about 6 amino acids to about 38 amino acids, about 6 amino acids to about 36 amino acids, about 6 amino acids to about 34 amino acids, about 6 amino acids to about 32 amino acids, about 6 amino acids to about 30 amino acids, about 6 amino acids to about 28 amino acids, about 6 amino acids to about 26 amino acids, about 6 amino acids to about 24 amino acids, about 6 amino acids to about 22 amino acids, about 6 amino acids to about 20 amino acids, about 6 amino acids to about 18 amino acids, about 6 amino acids to about 16 amino acids, about 6 amino acids to about 14 amino acids, about 6 amino acids to about 12 amino acids, about 6 amino acids to about 10 amino acids, about 6 amino acids to about 8 amino acids, about 8 amino acids to about 100 amino acids, about 8 amino acids to about 95 amino acids, about 8 amino acids to about 90 amino acids, about 8 amino acids to about 85 amino acids, about 8 amino acids to about 80 amino acids, about 8 amino acids to about 75 amino acids, about 8 amino acids to about 70 amino acids, about 8 amino acids to about 65 amino acids, about 8 amino acids to about 60 amino acids, about 8 amino acids to about 55 amino acids, about 8 amino acids to about 50 amino acids, about 8 amino acids to about 45 amino acids, about 8 amino acids to about 40 amino acids, about 8 amino acids to about 38 amino acids, about 8 amino acids to about 36 amino acids, about 8 amino acids to about 34 amino acids, about 8 amino acids to about 32 amino acids, about 8 amino acids to about 30 amino acids, about 8 amino acids to about 28 amino acids, about 8 amino acids to about 26 amino acids, about 8 amino acids to about 24 amino acids, about 8 amino acids to about 22 amino acids, about 8 amino acids to about 20 amino acids, about 8 amino acids to about 18 amino acids, about 8 amino acids to about 16 amino acids, about 8 amino acids to about 14 amino acids, about 8 amino acids to about 12 amino acids, about 8 amino acids to about 10 amino acids, about 10 amino acids to about 100 amino acids, about 10 amino acids to about 95 amino acids, about 10 amino acids to about 90 amino acids, about 10 amino acids to about 85 amino acids, about 10 amino acids to about 80 amino acids, about 10 amino acids to about 75 amino acids, about 10 amino acids to about 70 amino acids, about 10 amino acids to about 65 amino acids, about 10 amino acids to about 60 amino acids, about 10 amino acids to about 55 amino acids, about 10 amino acids to about 50 amino acids, about 10 amino acids to about 45 amino acids, about 10 amino acids to about 40 amino acids, about 10 amino acids to about 38 amino acids, about 10 amino acids to about 36 amino acids, about 10 amino acids to about 34 amino acids, about 10 amino acids to about 32 amino acids, about 10 amino acids to about 30 amino acids, about 10 amino acids to about 28 amino acids, about 10 amino acids to about 26 amino acids, about 10 amino acids to about 24 amino acids, about 10 amino acids to about 22 amino acids, about 10 amino acids to about 20 amino acids, about 10 amino acids to about 18 amino acids, about 10 amino acids to about 16 amino acids, about 10 amino acids to about 14 amino acids, about 10 amino acids to about 12 amino acids, about 12 amino acids to about 100 amino acids, about 12 amino acids to about 95 amino acids, about 12 amino acids to about 90 amino acids, about 12 amino acids to about 85 amino acids, about 12 amino acids to about 80 amino acids, about 12 amino acids to about 75 amino acids, about 12 amino acids to about 70 amino acids, about 12 amino acids to about 65 amino acids, about 12 amino acids to about 60 amino acids, about 12 amino acids to about 55 amino acids, about 12 amino acids to about 50 amino acids, about 12 amino acids to about 45 amino acids, about 12 amino acids to about 40 amino acids, about 12 amino acids to about 38 amino acids, about 12 amino acids to about 36 amino acids, about 12 amino acids to about 34 amino acids, about 12 amino acids to about 32 amino acids, about 12 amino acids to about 30 amino acids, about 12 amino acids to about 28 amino acids, about 12 amino acids to about 26 amino acids, about 12 amino acids to about 24 amino acids, about 12 amino acids to about 22 amino acids, about 12 amino acids to about 20 amino acids, about 12 amino acids to about 18 amino acids, about 12 amino acids to about 16 amino acids, about 12 amino acids to about 14 amino acids, about 14 amino acids to about 100 amino acids, about 14 amino acids to about 95 amino acids, about 14 amino acids to about 90 amino acids, about 14 amino acids to about 85 amino acids, about 14 amino acids to about 80 amino acids, about 14 amino acids to about 75 amino acids, about 14 amino acids to about 70 amino acids, about 14 amino acids to about 65 amino acids, about 14 amino acids to about 60 amino acids, about 14 amino acids to about 55 amino acids, about 14 amino acids to about 50 amino acids, about 14 amino acids to about 45 amino acids, about 14 amino acids to about 40 amino acids, about 14 amino acids to about 38 amino acids, about 14 amino acids to about 36 amino acids, about 14 amino acids to about 34 amino acids, about 14 amino acids to about 32 amino acids, about 14 amino acids to about 30 amino acids, about 14 amino acids to about 28 amino acids, about 14 amino acids to about 26 amino acids, about 14 amino acids to about 24 amino acids, about 14 amino acids to about 22 amino acids, about 14 amino acids to about 20 amino acids, about 14 amino acids to about 18 amino acids, about 14 amino acids to about 16 amino acids, about 16 amino acids to about 100 amino acids, about 16 amino acids to about 95 amino acids, about 16 amino acids to about 90 amino acids, about 16 amino acids to about 85 amino acids, about 16 amino acids to about 80 amino acids, about 16 amino acids to about 75 amino acids, about 16 amino acids to about 70 amino acids, about 16 amino acids to about 65 amino acids, about 16 amino acids to about 60 amino acids, about 16 amino acids to about 55 amino acids, about 16 amino acids to about 50 amino acids, about 16 amino acids to about 45 amino acids, about 16 amino acids to about 40 amino acids, about 16 amino acids to about 38 amino acids, about 16 amino acids to about 36 amino acids, about 16 amino acids to about 34 amino acids, about 16 amino acids to about 32 amino acids, about 16 amino acids to about 30 amino acids, about 16 amino acids to about 28 amino acids, about 16 amino acids to about 26 amino acids, about 16 amino acids to about 24 amino acids, about 16 amino acids to about 22 amino acids, about 16 amino acids to about 20 amino acids, about 16 amino acids to about 18 amino acids, about 18 amino acids to about 100 amino acids, about 18 amino acids to about 95 amino acids, about 18 amino acids to about 90 amino acids, about 18 amino acids to about 85 amino acids, about 18 amino acids to about 80 amino acids, about 18 amino acids to about 75 amino acids, about 18 amino acids to about 70 amino acids, about 18 amino acids to about 65 amino acids, about 18 amino acids to about 60 amino acids, about 18 amino acids to about 55 amino acids, about 18 amino acids to about 50 amino acids, about 18 amino acids to about 45 amino acids, about 18 amino acids to about 40 amino acids, about 18 amino acids to about 38 amino acids, about 18 amino acids to about 36 amino acids, about 18 amino acids to about 34 amino acids, about 18 amino acids to about 32 amino acids, about 18 amino acids to about 30 amino acids, about 18 amino acids to about 28 amino acids, about 18 amino acids to about 26 amino acids, about 18 amino acids to about 24 amino acids, about 18 amino acids to about 22 amino acids, about 18 amino acids to about 20 amino acids, about 20 amino acids to about 100 amino acids, about 20 amino acids to about 95 amino acids, about 20 amino acids to about 90 amino acids, about 20 amino acids to about 85 amino acids, about 20 amino acids to about 80 amino acids, about 20 amino acids to about 75 amino acids, about 20 amino acids to about 70 amino acids, about 20 amino acids to about 65 amino acids, about 20 amino acids to about 60 amino acids, about 20 amino acids to about 55 amino acids, about 20 amino acids to about 50 amino acids, about 20 amino acids to about 45 amino acids, about 20 amino acids to about 40 amino acids, about 20 amino acids to about 38 amino acids, about 20 amino acids to about 36 amino acids, about 20 amino acids to about 34 amino acids, about 20 amino acids to about 32 amino acids, about 20 amino acids to about 30 amino acids, about 20 amino acids to about 28 amino acids, about 20 amino acids to about 26 amino acids, about 20 amino acids to about 24 amino acids, about 20 amino acids to about 22 amino acids, about 22 amino acids to about 100 amino acids, about 22 amino acids to about 95 amino acids, about 22 amino acids to about 90 amino acids, about 22 amino acids to about 85 amino acids, about 22 amino acids to about 80 amino acids, about 22 amino acids to about 75 amino acids, about 22 amino acids to about 70 amino acids, about 22 amino acids to about 65 amino acids, about 22 amino acids to about 60 amino acids, about 22 amino acids to about 55 amino acids, about 22 amino acids to about 50 amino acids, about 22 amino acids to about 45 amino acids, about 22 amino acids to about 40 amino acids, about 22 amino acids to about 38 amino acids, about 22 amino acids to about 36 amino acids, about 22 amino acids to about 34 amino acids, about 22 amino acids to about 32 amino acids, about 22 amino acids to about 30 amino acids, about 22 amino acids to about 28 amino acids, about 22 amino acids to about 26 amino acids, about 22 amino acids to about 24 amino acids, about 24 amino acids to about 100 amino acids, about 24 amino acids to about 95 amino acids, about 24 amino acids to about 90 amino acids, about 24 amino acids to about 85 amino acids, about 24 amino acids to about 80 amino acids, about 24 amino acids to about 75 amino acids, about 24 amino acids to about 70 amino acids, about 24 amino acids to about 65 amino acids, about 24 amino acids to about 60 amino acids, about 24 amino acids to about 55 amino acids, about 24 amino acids to about 50 amino acids, about 24 amino acids to about 45 amino acids, about 24 amino acids to about 40 amino acids, about 24 amino acids to about 38 amino acids, about 24 amino acids to about 36 amino acids, about 24 amino acids to about 34 amino acids, about 24 amino acids to about 32 amino acids, about 24 amino acids to about 30 amino acids, about 24 amino acids to about 28 amino acids, about 24 amino acids to about 26 amino acids, about 26 amino acids to about 100 amino acids, about 26 amino acids to about 95 amino acids, about 26 amino acids to about 90 amino acids, about 26 amino acids to about 85 amino acids, about 26 amino acids to about 80 amino acids, about 26 amino acids to about 75 amino acids, about 26 amino acids to about 70 amino acids, about 26 amino acids to about 65 amino acids, about 26 amino acids to about 60 amino acids, about 26 amino acids to about 55 amino acids, about 26 amino acids to about 50 amino acids, about 26 amino acids to about 45 amino acids, about 26 amino acids to about 40 amino acids, about 26 amino acids to about 38 amino acids, about 26 amino acids to about 36 amino acids, about 26 amino acids to about 34 amino acids, about 26 amino acids to about 32 amino acids, about 26 amino acids to about 30 amino acids, about 26 amino acids to about 28 amino acids, about 28 amino acids to about 100 amino acids, about 28 amino acids to about 95 amino acids, about 28 amino acids to about 90 amino acids, about 28 amino acids to about 85 amino acids, about 28 amino acids to about 80 amino acids, about 28 amino acids to about 75 amino acids, about 28 amino acids to about 70 amino acids, about 28 amino acids to about 65 amino acids, about 28 amino acids to about 60 amino acids, about 28 amino acids to about 55 amino acids, about 28 amino acids to about 50 amino acids, about 28 amino acids to about 45 amino acids, about 28 amino acids to about 40 amino acids, about 28 amino acids to about 38 amino acids, about 28 amino acids to about 36 amino acids, about 28 amino acids to about 34 amino acids, about 28 amino acids to about 32 amino acids, about 28 amino acids to about 30 amino acids, about 30 amino acids to about 100 amino acids, about 30 amino acids to about 95 amino acids, about 30 amino acids to about 90 amino acids, about 30 amino acids to about 85 amino acids, about 30 amino acids to about 80 amino acids, about 30 amino acids to about 75 amino acids, about 30 amino acids to about 70 amino acids, about 30 amino acids to about 65 amino acids, about 30 amino acids to about 60 amino acids, about 30 amino acids to about 55 amino acids, about 30 amino acids to about 50 amino acids, about 30 amino acids to about 45 amino acids, about 30 amino acids to about 40 amino acids, about 30 amino acids to about 38 amino acids, about 30 amino acids to about 36 amino acids, about 30 amino acids to about 34 amino acids, about 30 amino acids to about 32 amino acids, about 32 amino acids to about 100 amino acids, about 32 amino acids to about 95 amino acids, about 32 amino acids to about 90 amino acids, about 32 amino acids to about 85 amino acids, about 32 amino acids to about 80 amino acids, about 32 amino acids to about 75 amino acids, about 32 amino acids to about 70 amino acids, about 32 amino acids to about 65 amino acids, about 32 amino acids to about 60 amino acids, about 32 amino acids to about 55 amino acids, about 32 amino acids to about 50 amino acids, about 32 amino acids to about 45 amino acids, about 32 amino acids to about 40 amino acids, about 32 amino acids to about 38 amino acids, about 32 amino acids to about 36 amino acids, about 32 amino acids to about 34 amino acids, about 34 amino acids to about 100 amino acids, about 34 amino acids to about 95 amino acids, about 34 amino acids to about 90 amino acids, about 34 amino acids to about 85 amino acids, about 34 amino acids to about 80 amino acids, about 34 amino acids to about 75 amino acids, about 34 amino acids to about 70 amino acids, about 34 amino acids to about 65 amino acids, about 34 amino acids to about 60 amino acids, about 34 amino acids to about 55 amino acids, about 34 amino acids to about 50 amino acids, about 34 amino acids to about 45 amino acids, about 34 amino acids to about 40 amino acids, about 34 amino acids to about 38 amino acids, about 34 amino acids to about 36 amino acids, about 36 amino acids to about 100 amino acids, about 36 amino acids to about 95 amino acids, about 36 amino acids to about 90 amino acids, about 36 amino acids to about 85 amino acids, about 36 amino acids to about 80 amino acids, about 36 amino acids to about 75 amino acids, about 36 amino acids to about 70 amino acids, about 36 amino acids to about 65 amino acids, about 36 amino acids to about 60 amino acids, about 36 amino acids to about 55 amino acids, about 36 amino acids to about 50 amino acids, about 36 amino acids to about 45 amino acids, about 36 amino acids to about 40 amino acids, about 36 amino acids to about 38 amino acids, about 38 amino acids to about 100 amino acids, about 38 amino acids to about 95 amino acids, about 38 amino acids to about 90 amino acids, about 38 amino acids to about 85 amino acids, about 38 amino acids to about 80 amino acids, about 38 amino acids to about 75 amino acids, about 38 amino acids to about 70 amino acids, about 38 amino acids to about 65 amino acids, about 38 amino acids to about 60 amino acids, about 38 amino acids to about 55 amino acids, about 38 amino acids to about 50 amino acids, about 38 amino acids to about 45 amino acids, about 38 amino acids to about 40 amino acids, about 40 amino acids to about 100 amino acids, about 40 amino acids to about 95 amino acids, about 40 amino acids to about 90 amino acids, about 40 amino acids to about 85 amino acids, about 40 amino acids to about 80 amino acids, about 40 amino acids to about 75 amino acids, about 40 amino acids to about 70 amino acids, about 40 amino acids to about 65 amino acids, about 40 amino acids to about 60 amino acids, about 40 amino acids to about 55 amino acids, about 40 amino acids to about 50 amino acids, about 40 amino acids to about 45 amino acids, about 45 amino acids to about 100 amino acids, about 45 amino acids to about 95 amino acids, about 45 amino acids to about 90 amino acids, about 45 amino acids to about 85 amino acids, about 45 amino acids to about 80 amino acids, about 45 amino acids to about 75 amino acids, about 45 amino acids to about 70 amino acids, about 45 amino acids to about 65 amino acids, about 45 amino acids to about 60 amino acids, about 45 amino acids to about 55 amino acids, about 45 amino acids to about 50 amino acids, about 50 amino acids to about 100 amino acids, about 50 amino acids to about 95 amino acids, about 50 amino acids to about 90 amino acids, about 50 amino acids to about 85 amino acids, about 50 amino acids to about 80 amino acids, about 50 amino acids to about 75 amino acids, about 50 amino acids to about 70 amino acids, about 50 amino acids to about 65 amino acids, about 50 amino acids to about 60 amino acids, about 50 amino acids to about 55 amino acids, about 55 amino acids to about 100 amino acids, about 55 amino acids to about 95 amino acids, about 55 amino acids to about 90 amino acids, about 55 amino acids to about 85 amino acids, about 55 amino acids to about 80 amino acids, about 55 amino acids to about 75 amino acids, about 55 amino acids to about 70 amino acids, about 55 amino acids to about 65 amino acids, about 55 amino acids to about 60 amino acids, about 60 amino acids to about 100 amino acids, about 60 amino acids to about 95 amino acids, about 60 amino acids to about 90 amino acids, about 60 amino acids to about 85 amino acids, about 60 amino acids to about 80 amino acids, about 60 amino acids to about 75 amino acids, about 60 amino acids to about 70 amino acids, about 60 amino acids to about 65 amino acids, about 65 amino acids to about 100 amino acids, about 65 amino acids to about 95 amino acids, about 65 amino acids to about 90 amino acids, about 65 amino acids to about 85 amino acids, about 65 amino acids to about 80 amino acids, about 65 amino acids to about 75 amino acids, about 65 amino acids to about 70 amino acids, about 70 amino acids to about 100 amino acids, about 70 amino acids to about 95 amino acids, about 70 amino acids to about 90 amino acids, about 70 amino acids to about 85 amino acids, about 70 amino acids to about 80 amino acids, about 70 amino acids to about 75 amino acids, about 75 amino acids to about 100 amino acids, about 75 amino acids to about 95 amino acids, about 75 amino acids to about 90 amino acids, about 75 amino acids to about 85 amino acids, about 75 amino acids to about 80 amino acids, about 80 amino acids to about 100 amino acids, about 80 amino acids to about 95 amino acids, about 80 amino acids to about 90 amino acids, about 80 amino acids to about 85 amino acids, about 85 amino acids to about 100 amino acids, about 85 amino acids to about 95 amino acids, about 85 amino acids to about 90 amino acids, about 90 amino acids to about 100 amino acids, about 90 amino acids to about 95 amino acids, or about 95 amino acids to about 100 amino acids. 
     For example, a linker sequence can comprise or consist of TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 33) or GSGATG (SEQ ID NO: 34). In some instances the chimeric polypeptide includes a linker that has an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%) sequence identity to SEQ ID NO: 33. For example, a linker sequence can comprise or consist of the sequences of 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 105) 
               
               
                   
                 GSGS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 106) 
               
               
                   
                 GSGSGS, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 107) 
               
               
                   
                 SGSG, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 108) 
               
               
                   
                 SGSGSG, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 109) 
               
               
                   
                 GSSG, 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 112) 
               
               
                   
                 SS, 
               
               
                   
                 or 
               
               
                   
                   
               
               
                   
                 (SEQ ID NO: 110) 
               
               
                   
                 GGGGS. 
               
            
           
         
       
     
     Growth Factors 
     A β-TCP-binding sequence as described herein can be tethered to a mammalian growth factor. In some instances, a linker sequence (e.g., any of the linker sequences described herein or known in the art) is disposed between the 0-TCP-binding sequence and the mammalian growth factor. 
     Mammalian growth factors can be osteoinductive molecules that are capable of initiating and enhancing the bone repair process. Bone morphogenetic proteins (BMP) represent a distinct subset of the transforming growth factor-0 family. A number of these BMP (BMP-2, BMP-7, and BMP-14) enhance the speed of bone healing in defects and non-unions. 
     Non-limiting examples of mammalian growth factors are described herein. In some instances, the mammalian growth factor is selected from the group of: epidermal growth factor (EGF), platelet derived growth factor (PDGF), insulin like growth factor (IGF-1), fibroblast growth factor (FGF), fibroblast growth factor 2 (FGF2), fibroblast growth factor 18 (FGF18), transforming growth factor alpha (TGF-α), transforming growth factor beta (TGF-β), transforming growth factor beta 1 (TGF-β1), transforming growth factor beta 3 (TGF-β3), osteogenic protein 1 (OP-1), osteogenic protein 2 (OP-2), osteogenic protein 3 (OP-3), bone morphogenetic protein 2 (BMP-2), bone morphogenetic protein 3 (BMP-3), bone morphogenetic protein 4 (BMP-4), bone morphogenetic protein 5 (BMP-5), bone morphogenetic protein 6 (BMP-6), bone morphogenetic protein 7 (BMP-7), bone morphogenetic protein (BMP-9), bone morphogenetic protein 10 (BMP-10), bone morphogenetic protein 11 (BMP-11), bone morphogenetic protein 12 (BMP-12), bone morphogenetic protein 13 (BMP-13), bone morphogenetic protein 15 (BMP-15), dentin phosphoprotein (DPP), vegetal related growth factor (Vgr), growth differentiation factor 1 (GDF-1), growth differentiation factor 3 (GDF-3), growth differentiation factor 5 (GDF-5), growth differentiation factor 6 (GDF-6), growth differentiation factor 7 (GDF-7), growth differentiation factor 8 (GDF8), growth differentiation factor 11 (GDF11), growth differentiation factor 15 (GDF15), vascular endothelial growth factor (VEGF), hyaluronic acid binding protein (HABP), and collagen binding protein (CBP), fibroblast growth factor 18 (FGF-18), keratinocyte growth factor (KGF), tumor necrosis factor alpha (TNFα), tumor necrosis factor (TNF)-related apoptosis inducing ligand (TRAIL), wnt family member 1 (WNT1), wnt family member 2 (WNT2), wnt family member 2B (WNT2B), wnt family member 3 (WNT3), wnt family member 3A (WNT3A), wnt family member 4 (WNT4), wnt family member 5A (WNT5A), wnt family member 5B (WNT5B), wnt family member 6 (WNT6), wnt family member 7A (WNT7A), wnt family member 7B (WNT7B), wnt family member 8A (WNT8A), wnt family member 8B (WNT8B), wnt family member 9A (WNT9A), wnt family member 9B (WNT9B), wnt family member 10A (WNT10A), wnt family member 10B (WNT10B), wnt family member 11 (WNT11), and wnt family member 16 (WNT16). 
     For example, the mammalian growth factor can be a human growth factor. Non-limiting examples of human growth factors are provided in Table B. 
     
       
         
           
               
             
               
                 TABLE B 
               
             
            
               
                   
               
               
                 Exemplary human growth factors 
               
            
           
           
               
               
               
            
               
                   
                   
                 SEQ ID 
               
               
                 Name 
                 Exemplary Human Protein Sequence 
                 NO: 
               
               
                   
               
            
           
           
               
               
               
            
               
                 EGF 
                 MLLTLIILLPVVSKFSFVSLSAPQHWSCPEGTLAGNGNSTCVG 
                 46 
               
               
                   
                 PAPFLIFSHGNSIFRIDTEGTNYEQLVVDAGVSVIMDFHYNEK 
                   
               
               
                   
                 RIYWVDLERQLLQRVFLNGSRQERVCNIEKNVSGMAINWIN 
                   
               
               
                   
                 EEVIWSNQQEGIITVTDMKGNNSHILLSALKYPANVAVDPVE 
                   
               
               
                   
                 RFIFWSSEVAGSLYRADLDGVGVKALLETSEKITAVSLDVLD 
                   
               
               
                   
                 KRLFWIQYNREGSNSLICSCDYDGGSVHISKHPTQHNLFAMS 
                   
               
               
                   
                 LFGDRIFYSTWKMKTIWIANKHTGKDMVRINLHSSFVPLGEL 
                   
               
               
                   
                 KVVHPLAQPKAEDDTWEPEQKLCKLRKGNCSSTVCGQDLQ 
                   
               
               
                   
                 SHLCMCAEGYALSRDRKYCEDVNECAFWNHGCTLGCKNTP 
                   
               
               
                   
                 GSYYCTCPVGFVLLPDGKRCHQLVSCPRNVSECSHDCVLTSE 
                   
               
               
                   
                 GPLCFCPEGSVLERDGKTCSGCSSPDNGGCSQLCVPLSPVSW 
                   
               
               
                   
                 ECDCFPGYDLQLDEKSCAASGPQPFLLFANSQDIRHMHFDGT 
                   
               
               
                   
                 DYGTLLSQQMGMVYALDHDPVENKIYFAHTALKWIERANM 
                   
               
               
                   
                 DGSQRERLIEEGVDVPEGLAVDWIGRRFYWTDRGKSLIGRSD 
                   
               
               
                   
                 LNGKRSKIITKENISQPRGIAVHPMAKRLFWTDTGINPRIESSS 
                   
               
               
                   
                 LQGLGRLVIASSDLIWPSGITIDFLTDKLYWCDAKQSVIEMA 
                   
               
               
                   
                 NLDGSKRRRLTQNDVGHPFAVAVFEDYVWFSDWAMPSVM 
                   
               
               
                   
                 RVNKRTGKDRVRLQGSMLKPSSLVVVHPLAKPGADPCLYQ 
                   
               
               
                   
                 NGGCEHICKKRLGTAWCSCREGFMKASDGKTCLALDGHQL 
                   
               
               
                   
                 LAGGEVDLKNQVTPLDILSKTRVSEDNITESQHMLVAEIMVS 
                   
               
               
                   
                 DQDDCAPVGCSMYARCISEGEDATCQCLKGFAGDGKLCSDI 
                   
               
               
                   
                 DECEMGVPVCPPASSKCINTEGGYVCRCSEGYQGDGIHCLDI 
                   
               
               
                   
                 DECQLGEHSCGENASCTNTEGGYTCMCAGRLSEPGLICPDST 
                   
               
               
                   
                 PPPHLREDDHHYSVRNSDSECPLSHDGYCLHDGVCMYIEAL 
                   
               
               
                   
                 DKYACNCVVGYIGERCQYRDLKWWELRHAGHGQQQKVIV 
                   
               
               
                   
                 VAVCVVVLVMLLLLSLWGAHYYRTQKLLSKNPKNPYEESS 
                   
               
               
                   
                 RDVRSRRPADTEDGMSSCPQPWFVVIKEHQDLKNGGQPVAG 
                   
               
               
                   
                 EDGQAADGSMQPTSWRQEPQLCGMGTEQGCWIPVSSDKGS 
                   
               
               
                   
                 CPQVMERSFHMPSYGTQTLEGGVEKPHSLLSANPLWQQRAL 
                   
               
               
                   
                 DPPHQMELTQ 
                   
               
               
                   
               
               
                 PDGF 
                 MRTLACLLLLGCGYLAHVLAEEAEIPREVIERLARSQIHSIRD 
                 47 
               
               
                   
                 LQRLLEIDSVGSEDSLDTSLRAHGVHATKHVPEKRPLPIRRKR 
                   
               
               
                   
                 SIEEAVPAVCKTRTVIYEIPRSQVDPTSANFLIWPPCVEVKRC 
                   
               
               
                   
                 TGCCNTSSVKCQPSRVHHRSVKVAKVEYVRKKPKLKEVQV 
                   
               
               
                   
                 RLEEHLECACATTSLNPDYREEDTGRPRESGKKRKRKRLKPT 
                   
               
               
                   
               
               
                 IGF-1 
                 MGKISSLPTQLFKCCFCDFLKVKMHTMSSSHLFYLALCLLTF 
                 48 
               
               
                   
                 TSSATAGPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSR 
                   
               
               
                   
                 RAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSARSVRAQR 
                   
               
               
                   
                 HTDMPKTQKYQPPSTNKNTKSQRRKGSTFEERK 
                   
               
               
                   
               
               
                 FGF 
                 MAEGEITTFTALTEKFNLPPGNYKKPKLLYCSNGGHFLRILPD 
                 49 
               
               
                   
                 GTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDT 
                   
               
               
                   
                 DGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVG 
                   
               
               
                   
                 LKKNGSCKRGPRTHYGQKAILFLPLPVSSD 
                   
               
               
                   
               
               
                 FGF2 
                 MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEA 
                 50 
               
               
                   
                 ALPRRRPRRHPSVNPRSRAAGSPRTRGRRTEERPSGSRLGDR 
                   
               
               
                   
                 GRGRALPGGRLGGRGRGRAPERVGGRGRGRGTAAPRAAPA 
                   
               
               
                   
                 ARGSRPGPAGTMAAGSITTLPALPEDGGSGAFPPGHFKDPKR 
                   
               
               
                   
                 LYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVS 
                   
               
               
                   
                 IKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNT 
                   
               
               
                   
                 YRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS 
                   
               
               
                   
               
               
                 FGF18 
                 MYSAPSACTCLCLHFLLLCFQVQVLVAEENVDFRIHVENQTR 
                 51 
               
               
                   
                 ARDDVSRKQLRLYQLYSRTSGKHIQVLGRRISARGEDGDKY 
                   
               
               
                   
                 AQLLVETDTFGSQVRIKGKETEFYLCMNRKGKLVGKPDGTS 
                   
               
               
                   
                 KECVFIEKVLENNYTALMSAKYSGWYVGFTKKGRPRKGPKT 
                   
               
               
                   
                 RENQQDVHFMKRYPKGQPELQKPFKYTTVTKRSRRIRPTHP 
                   
               
               
                   
                 A 
                   
               
               
                   
               
               
                 TGF-α 
                 MVPSAGQLALFALGIVLAACQALENSTSPLSADPPVAAAVVS 
                 52 
               
               
                   
                 HFNDCPDSHTQFCFHGTCRFLVQEDKPACVCHSGYVGARCE 
                   
               
               
                   
                 HADLLAVVAASQKKQAITALVVVSIVALAVLIITCVLIHCCQ 
                   
               
               
                   
                 VRKHCEWCRALICRHEKPSALLKGRTACCHSETVV 
                   
               
               
                   
               
               
                 TGF-β1 
                 MPPSGLRLLPLLLPLLWLLVLTPGRPAAGLSTCKTIDMELVK 
                 53 
               
               
                   
                 RKRIEAIRGQILSKLRLASPPSQGEVPPGPLPEAVLALYNSTRD 
                   
               
               
                   
                 RVAGESAEPEPEPEADYYAKEVTRVLMVETHNEIYDKFKQS 
                   
               
               
                   
                 THSIYMFFNTSELREAVPEPVLLSRAELRLLRLKLKVEQHVEL 
                   
               
               
                   
                 YQKYSNNSWRYLSNRLLAPSDSPEWLSFDVTGVVRQWLSR 
                   
               
               
                   
                 GGEIEGFRLSAHCSCDSRDNTLQVDINGFTTGRRGDLATIHG 
                   
               
               
                   
                 MNRPFLLLMATPLERAQHLQSSRHRRALDTNYCFSSTEKNC 
                   
               
               
                   
                 CVRQLYIDFRKDLGWKWIHEPKGYHANFCLGPCPYIWSLDT 
                   
               
               
                   
                 QYSKVLALYNQHNPGASAAPCCVPQALEPLPIVYYVGRKPK 
                   
               
               
                   
                 VEQLSNMIVRSCKCS 
                   
               
               
                   
               
               
                 TGF-β3 
                 MKMHLQRALVVLALLNFATVSLSLSTCTTLDFGHIKKKRVE 
                 54 
               
               
                   
                 AIRGQILSKLRLTSPPEPTVMTHVPYQVLALYNSTRELLEEM 
                   
               
               
                   
                 HGEREEGCTQENTESEYYAKEIHKFDMIQGLAEHNELAVCP 
                   
               
               
                   
                 KGITSKVFRFNVSSVEKNRTNLFRAEFRVLRVPNPSSKRNEQ 
                   
               
               
                   
                 RIELFQILRPDEHIAKQRYIGGKNLPTRGTAEWLSFDVTDTVR 
                   
               
               
                   
                 EWLLRRESNLGLEISIHCPCHTFQPNGDILENIHEVMEIKFKG 
                   
               
               
                   
                 VDNEDDHGRGDLGRLKKQKDHHNPHLILMMIPPHRLDNPG 
                   
               
               
                   
                 QGGQRKKRALDTNYCFRNLEENCCVRPLYIDFRQDLGWKW 
                   
               
               
                   
                 VHEPKGYYANFCSGPCPYLRSADTTHSTVLGLYNTLNPEASA 
                   
               
               
                   
                 SPCCVPQDLEPLTILYYVGRTPKVEQLSNMVVKSCKCS 
                   
               
               
                   
               
               
                 OP-2 
                 MTALPGPLWLLGLALCALGGGGPGLRPPPGCPQRRLGARER 
                 55 
               
               
                 (BMP-8) 
                 RDVQREILAVLGLPGRPRPRAPPAASRLPASAPLFMLDLYHA 
                   
               
               
                   
                 MAGDDDEDGAPAERRLGRADLVMSFVNMVERDRALGHQE 
                   
               
               
                   
                 PHWKEFRFDLTQIPAGEAVTAAEFRIYKVPSIHLLNRTLHVS 
                   
               
               
                   
                 MFQVVQEQSNRESDLEFLDLQTLRAGDEGWLVLDVTAASD 
                   
               
               
                   
                 CWLLKRHKDLGLRLYVETEDGHSVDPGLAGLLGQRAPRSQ 
                   
               
               
                   
                 QPFVVTFFRASPSPIRTPRAVRPLRRRQPKKSNELPQANRLPGI 
                   
               
               
                   
                 FDDVHGSHGRQVCRRHELYVSFQDLGWLDWVIAPQGYSAY 
                   
               
               
                   
                 YCEGECSFPLDSCMNATNHAILQSLVHLMMPDAVPKACCAP 
                   
               
               
                   
                 TKLSATSVLYYDSSNNVILRKHRNMVVKACGCH 
                   
               
               
                   
               
               
                 OP-3 
                 MAARPGLLWLLGLALCVLGGGHLSHPPHVFPQRRLGVREPR 
                 56 
               
               
                   
                 DMQREIREVLGLPGRPRSRAPVGAAQQPASAPLFMLDLYRA 
                   
               
               
                   
                 MTDDSGGGTPQPHLDRADLIMSFVNIVERDRTLGYQEPHWK 
                   
               
               
                   
                 EFHFDLTQIPAGEAVTAAEFRIYKEPSTHPLNTTLHISMFEVV 
                   
               
               
                   
                 QEHSNRESDLEFLDLQTLRSGDEGWLVLDITAASDRWLLNH 
                   
               
               
                   
                 HKDLGLRLYVETEDGHSIDPGLAGLLGRQAPRSRQPFMVGFF 
                   
               
               
                   
                 RANQSPVRAPRTARPLKKKQLNQINQLPHSNKHLGILDDGH 
                   
               
               
                   
                 GSHGREVCRRHELYVSFRDLGWLDSVIAPQGYSAYYCAGEC 
                   
               
               
                   
                 IYPLNSCMNSTNHATMQALVHLMKPDIIPKVCCVPTELSAISL 
                   
               
               
                   
                 LYYDRNNNVILRRERNMVVQACGCH 
                   
               
               
                   
               
               
                 BMP-2 
                 MVAGTRCLLALLLPQVLLGGAAGLVPELGRRKFAAASSGRP 
                 32 
               
               
                   
                 SSQPSDEVLSEFELRLLSMEGLKQRPTPSRDAVVPPYMLDLY 
                   
               
               
                   
                 RRHSGQPGSPAPDHRLERAASRANTVRSFHHEESLEELPETS 
                   
               
               
                   
                 GKTTRRFFFNLSSIPTEEFITSAELQVFREQMQDALGNNSSFH 
                   
               
               
                   
                 HRINIYEIIKPATANSKFPVTRLLDTRLVNQNASRWESEDVTP 
                   
               
               
                   
                 AVMRWTAQGHANHGFVVEVAHLEEKQGVSKRHVRISRSLH 
                   
               
               
                   
                 QDEHSWSQIRPLLVTFGHDGKGHPLHKREKRQAKHKQRKRL 
                   
               
               
                   
                 KSSCKRHPLYVDFSDVGWNDWIVAPPGYHAFYCHGECPFPL 
                   
               
               
                   
                 ADHLNSTNHAIVQTLVNSVNSKIPKACCVPTELSAISMLYLD 
                   
               
               
                   
                 ENEKVVLKNYQDMVVEGCGCR 
                   
               
               
                   
               
               
                 BMP-3 
                 MAGASRLLFLWLGCFCVSLAQGERPKPPFPELRKAVPGDRT 
                 57 
               
               
                   
                 AGGGPDSELQPQDKVSEHMLRLYDRYSTVQAARTPGSLEGG 
                   
               
               
                   
                 SQPWRPRLLREGNTVRSFRAAAAETLERKGLYIFNLTSLTKS 
                   
               
               
                   
                 ENILSATLYFCIGELGNISLSCPVSGGCSHHAQRKHIQIDLSA 
                   
               
               
                   
                 WTLKFSRNQSQLLGHLSVDMAKSHRDIMSWLSKDITQFLRK 
                   
               
               
                   
                 AKENEEFLIGFNITSKGRQLPKRRLPFPEPYILVYANDAAISEP 
                   
               
               
                   
                 ESVVSSLQGHRNFPTGTVPKWDSHIRAALSIERRKKRSTGVL 
                   
               
               
                   
                 LPLQNNELPGAEYQYKKDEVWEERKPYKTLQAQAPEKSKN 
                   
               
               
                   
                 KKKQRKGPHRKSQTLQFDEQTLKKARRKQWIEPRNCARRYL 
                   
               
               
                   
                 KVDFADIGWSEWIISPKSFDAYYCSGACQFPMPKSLKPSNHA 
                   
               
               
                   
                 TIQSIVRAVGVVPGIPEPCCVPEKMSSLSILFFDENKNVVLKV 
                   
               
               
                   
                 YPNMTVESCACR 
                   
               
               
                   
               
               
                 BMP-4 
                 MIPGNRMLMVVLLCQVLLGGASHASLIPETGKKKVAEIQGH 
                 58 
               
               
                   
                 AGGRRSGQSHELLRDFEATLLQMFGLRRRPQPSKSAVIPDYM 
                   
               
               
                   
                 RDLYRLQSGEEEEEQIHSTGLEYPERPASRANTVRSFHHEEHL 
                   
               
               
                   
                 ENIPGTSENSAFRFLFNLSSIPENEVISSAELRLFREQVDQGPD 
                   
               
               
                   
                 WERGEHRINIYEVMKPPAEVVPGHLITRLLDTRLVHENVTR 
                   
               
               
                   
                 WETFDVSPAVLRWTREKQPNYGLAIEVTHLHQTRTHQGQH 
                   
               
               
                   
                 VRISRSLPQGSGNWAQLRPLLVTFGHDGRGHALTRRRRAKR 
                   
               
               
                   
                 SPKHEISQRARKKNKNCRRHSLYVDFSDVGWNDWIVAPPGY 
                   
               
               
                   
                 QAFYCHGDCPFPLADHLNSTNHAIVQTLVNSVNSSIPKACCV 
                   
               
               
                   
                 PTELSAISMLYLDEYDKVVLKNYQEMVVEGCGCR 
                   
               
               
                   
               
               
                 BMP-5 
                 MHLTVFLLKGIVGFLWSCWVLVGYAKGGLGDNHVHSSFIYR 
                 59 
               
               
                   
                 RLRNHERREIQREILSILGLPHRPRPFSPGKQASSAPLFMLDLY 
                   
               
               
                   
                 NAMTNEENPEESEYSVRASLAEETRGARKGYPASPNGYPRRI 
                   
               
               
                   
                 QLSRTTPLTTQSPPLASLHDTNFLNDADMVMSFVNLVERDK 
                   
               
               
                   
                 DFSHQRRHYKEFRFDLTQIPHGEAVTAAEFRIYKDRSNNRFE 
                   
               
               
                   
                 NETIKISIYQIIKEYTNRDADLELLDTRKAQALDVGWLVEDIT 
                   
               
               
                   
                 VTSNHWVINPQNNLGLQLCAETGDGRSINVKSAGLVGRQGP 
                   
               
               
                   
                 QSKQPFMVAFFKASEVLLRSVRAANKRKNQNRNKSSSHQDS 
                   
               
               
                   
                 SRMSSVGDYNTSEQKQACKKHELYVSFRDLGWQDWIIAPEG 
                   
               
               
                   
                 YAAFYCDGECSFPLNAHMNATNHAIVQTLVHLMFPDHVPKP 
                   
               
               
                   
                 CCAPTKLNAISVLYFDDSSNVILKKYRNMVVRSCGCH 
                   
               
               
                   
               
               
                 BMP- 
                 MPGLGRRAQWLCWWWGLLCSCCGPPPLRPPLPAAAAAAAG 
                 60 
               
               
                 6/VGR 
                 GQLLGDGGSPGRTEQPPPSPQSSSGFLYRRLKTQEKREMQKE 
                   
               
               
                   
                 ILSVLGLPHRPRPLHGLQQPQPPALRQQEEQQQQQQLPRGEP 
                   
               
               
                   
                 PPGRLKSAPLFMLDLYNALSADNDEDGASEGERQQSWPHEA 
                   
               
               
                   
                 ASSSQRRQPPPGAAHPLNRKSLLAPGSGSGGASPLTSAQDSA 
                   
               
               
                   
                 FLNDADMVMSFVNLVEYDKEFSPRQRHHKEFKFNLSQIPEG 
                   
               
               
                   
                 EVVTAAEFRIYKDCVMGSFKNQTFLISIYQVLQEHQHRDSDL 
                   
               
               
                   
                 FLLDTRVVWASEEGWLEFDITATSNLWVVTPQHNMGLQLSV 
                   
               
               
                   
                 VTRDGVHVHPRAAGLVGRDGPYDKQPFMVAFFKVSEVHVR 
                   
               
               
                   
                 TTRSASSRRRQQSRNRSTQSQDVARVSSASDYNSSELKTACR 
                   
               
               
                   
                 KHELYVSFQDLGWQDWIIAPKGYAANYCDGECSFPLNAHM 
                   
               
               
                   
                 NATNHAIVQTLVHLMNPEYVPKPCCAPTKLNAISVLYFDDNS 
                   
               
               
                   
                 NVILKKYRNMVVRACGCH 
                   
               
               
                   
               
               
                 BMP- 
                 MHVRSLRAAAPHSFVALWAPLFLLRSALADFSLDNEVHSSFI 
                 61 
               
               
                 7/OP-1 
                 HRRLRSQERREMQREILSILGLPHRPRPHLQGKHNSAPMFML 
                   
               
               
                   
                 DLYNAMAVEEGGGPGGQGFSYPYKAVFSTQGPPLASLQDSH 
                   
               
               
                   
                 FLTDADMVMSFVNLVEHDKEFFHPRYHHREFRFDLSKIPEGE 
                   
               
               
                   
                 AVTAAEFRIYKDYIRERFDNETFRISVYQVLQEHLGRESDLFL 
                   
               
               
                   
                 LDSRTLWASEEGWLVFDITATSNHWVVNPRHNLGLQLSVET 
                   
               
               
                   
                 LDGQSINPKLAGLIGRHGPQNKQPFMVAFFKATEVHFRSIRST 
                   
               
               
                   
                 GSKQRSQNRSKTPKNQEALRMANVAENSSSDQRQACKKHE 
                   
               
               
                   
                 LYVSFRDLGWQDWIIAPEGYAAYYCEGECAFPLNSYMNATN 
                   
               
               
                   
                 HAIVQTLVHFINPETVPKPCCAPTQLNAISVLYFDDSSNVILK 
                   
               
               
                   
                 KYRNMVVRACGCH 
                   
               
               
                   
               
               
                 BMP-9 
                 MCPGALWVALPLLSLLAGSLQGKPLQSWGRGSAGGNAHSP 
                 62 
               
               
                   
                 LGVPGGGLPEHTFNLKMFLENVKVDFLRSLNLSGVPSQDKT 
                   
               
               
                   
                 RVEPPQYMIDLYNRYTSDKSTTPASNIVRSFSMEDAISITATE 
                   
               
               
                   
                 DFPFQKHILLFNISIPRHEQITRAELRLYVSCQNHVDPSHDLK 
                   
               
               
                   
                 GSVVIYDVLDGTDAWDSATETKTFLVSQDIQDEGWETLEVS 
                   
               
               
                   
                 SAVKRWVRSDSTKSKNKLEVTVESHRKGCDTLDISVPPGSR 
                   
               
               
                   
                 NLPFFVVFSNDHSSGTKETRLELREMISHEQESVLKKLSKDGS 
                   
               
               
                   
                 TEAGESSHEEDTDGHVAAGSTLARRKRSAGAGSHCQKTSLR 
                   
               
               
                   
                 VNFEDIGWDSWIIAPKEYEAYECKGGCFFPLADDVTPTKHAI 
                   
               
               
                   
                 VQTLVHLKFPTKVGKACCVPTKLSPISVLYKDDMGVPTLKY 
                   
               
               
                   
                 HYEGMSVAECGCR 
                   
               
               
                   
               
               
                 BMP-10 
                 MGSLVLTLCALFCLAAYLVSGSPIMNLEQSPLEEDMSLFGDV 
                 63 
               
               
                   
                 FSEQDGVDFNTLLQSMKDEFLKTLNLSDIPTQDSAKVDPPEY 
                   
               
               
                   
                 MLELYNKFATDRTSNIPSANIIRSEKNEDLFSQPVSFNGLRKYP 
                   
               
               
                   
                 LLFNVSIPHHEEVIMAELRLYTLVQRDRMIYDGVDRKITIFEV 
                   
               
               
                   
                 LESKGDNEGERNMLVLVSGEIYGTNSEWETFDVTDAIRRWQ 
                   
               
               
                   
                 KSGSSTHQLEVHIESKHDEAEDASSGRLEIDTSAQNKHNPLLI 
                   
               
               
                   
                 VFSDDQSSDKERKEELNEMISHEQLPELDNLGLDSFSSGPGEE 
                   
               
               
                   
                 ALLQMRSNIIYDSTARIRRNAKGNYCKRTPLYIDFKEIGWDS 
                   
               
               
                   
                 WIIAPPGYEAYECRGVCNYPLAEHLTPTKHAIIQALVHLKNS 
                   
               
               
                   
                 QKASKACCVPTKLEPISILYLDKGVVTYKFKYEGMAVSECG 
                   
               
               
                   
                 CR 
                   
               
               
                   
               
               
                 BMP- 
                 MVLAAPLLLGFLLLALELRPRGEAAEGPAAAAAAAAAAAA 
                 64 
               
               
                 11/GDF- 
                 AGVGGERSSRPAPSVAPEPDGCPVCVWRQHSRELRLESIKSQ 
                   
               
               
                 11 
                 ILSKLRLKEAPNISREVVKQLLPKAPPLQQILDLHDFQGDALQ 
                   
               
               
                   
                 PEDFLEEDEYHATTETVISMAQETDPAVQTDGSPLCCHFHFS 
                   
               
               
                   
                 PKVMFTKVLKAQLWVYLRPVPRPATVYLQILRLKPLTGEGT 
                   
               
               
                   
                 AGGGGGGRRHIRIRSLKIELHSRSGHWQSIDFKQVLHSWFRQ 
                   
               
               
                   
                 PQSNWGIEINAFDPSGTDLAVTSLGPGAEGLHPFMELRVLEN 
                   
               
               
                   
                 TKRSRRNLGLDCDEHSSESRCCRYPLTVDFEAFGWDWIIAPK 
                   
               
               
                   
                 RYKANYCSGQCEYMFMQKYPHTHLVQQANPRGSAGPCCTP 
                   
               
               
                   
                 TKMSPINMLYFNDKQQIIYGKIPGMVVDRCGCS 
                   
               
               
                   
               
               
                 BMP-12 
                 MDLSAAAALCLWLLSACRPRDGLEAAAVLRAAGAGPVRSP 
                 65 
               
               
                   
                 GGGGGGGGGGRTLAQAAGAAAVPAAAVPRARAARRAAGS 
                   
               
               
                   
                 GFRNGSVVPHHFMMSLYRSLAGRAPAGAAAVSASGHGRAD 
                   
               
               
                   
                 TITGFTDQATQDESAAETGQSFLFDVSSLNDADEVVGAELRV 
                   
               
               
                   
                 LRRGSPESGPGSWTSPPLLLLSTCPGAARAPRLLYSRAAEPLV 
                   
               
               
                   
                 GQRWEAFDVADAMRRHRREPRPPRAFCLLLRAVAGPVPSPL 
                   
               
               
                   
                 ALRRLGFGWPGGGGSAAEERAVLVVSSRTQRKESLFREIRA 
                   
               
               
                   
                 QARALGAALASEPLPDPGTGTASPRAVIGGRRRRRTALAGTR 
                   
               
               
                   
                 TAQGSGGGAGRGHGRRGRSRCSRKPLHVDFKELGWDDWII 
                   
               
               
                   
                 APLDYEAYHCEGLCDFPLRSHLEPTNHAIIQTLLNSMAPDAA 
                   
               
               
                   
                 PASCCVPARLSPISILYIDAANNVVYKQYEDMVVEACGCR 
                   
               
               
                   
               
               
                 BMP- 
                 MDTPRVLLSAVFLISFLWDLPGFQQASISSSSSSAELGSTKGM 
                 66 
               
               
                 13/GDF-6 
                 RSRKEGKMQRAPRDSDAGREGQEPQPRPQDEPRAQQPRAQE 
                   
               
               
                   
                 PPGRGPRVVPHEYMLSIYRTYSIAEKLGINASFFQSSKSANTIT 
                   
               
               
                   
                 SFVDRGLDDLSHTPLRRQKYLFDVSMLSDKEELVGAELRLFR 
                   
               
               
                   
                 QAPSAPWGPPAGPLHVQLFPCLSPLLLDARTLDPQGAPPAG 
                   
               
               
                   
                 WEVFDVWQGLRHQPWKQLCLELRAAWGELDAGEAEARAR 
                   
               
               
                   
                 GPQQPPPPDLRSLGFGRRVRPPQERALLVVFTRSQRKNLFAE 
                   
               
               
                   
                 MREQLGSAEAAGPGAGAEGSWPPPSGAPDARPWLPSPGRRR 
                   
               
               
                   
                 RRTAFASRHGKRHGKKSRLRCSKKPLHVNFKELGWDDWIIA 
                   
               
               
                   
                 PLEYEAYHCEGVCDFPLRSHLEPTNHAIIQTLMNSMDPGSTPP 
                   
               
               
                   
                 SCCVPTKLTPISILYIDAGNNVVYKQYEDMVVESCGCR 
                   
               
               
                   
               
               
                 BMP-15 
                 MVLLSILRILFLCELVLFMEHRAQMAEGGQSSIALLAEAPTLP 
                 67 
               
               
                   
                 LIEELLEESPGEQPRKPRLLGHSLRYMLELYRRSADSHGHPRE 
                   
               
               
                   
                 NRTIGATMVRLVKPLTNVARPHRGTWHIQILGFPLRPNRGLY 
                   
               
               
                   
                 QLVRATVVYRHHLQLTRFNLSCHVEPWVQKNPTNHFPSSEG 
                   
               
               
                   
                 DSSKPSLMSNAWKEMDITQLVQQRFWNNKGHRILRLRFMC 
                   
               
               
                   
                 QQQKDSGGLELWHGTSSLDIAFLLLYFNDTHKSIRKAKFLPR 
                   
               
               
                   
                 GMEEFMERESLLRRTRQADGISAEVTASSSKHSGPENNQCSL 
                   
               
               
                   
                 HPFQISFRQLGWDHWIIAPPFYTPNYCKGTCLRVLRDGLNSP 
                   
               
               
                   
                 NHAIIQNLINQLVDQSVPRPSCVPYKYVPISVLMIEANGSILY 
                   
               
               
                   
                 KEYEGMIAESCTCR 
                   
               
               
                   
               
               
                 DPP 
                 MKIITYFCIWAVAWAIPVPQSKPLERHVEKSMNLHLLARSNV 
                 68 
               
               
                   
                 SVQDELNASGTIKESGVLVHEGDRGRQENTQDGHKGEGNGS 
                   
               
               
                   
                 KWAEVGGKSFSTYSTLANEEGNIEGWNGDTGKAETYGHDGI 
                   
               
               
                   
                 HGKEENITANGIQGQVSIIDNAGATNRSNTNGNTDKNTQNG 
                   
               
               
                   
                 DVGDAGHNEDVAVVQEDGPQVAGSNNSTDNEDEIIENSCRN 
                   
               
               
                   
                 EGNTSEITPQINSKRNGTKEAEVTPGTGEDAGLDNSDGSPSG 
                   
               
               
                   
                 NGADEDEDEGSGDDEDEEAGNGKDSSNNSKGQEGQDHGKE 
                   
               
               
                   
                 DDHDSSIGQNSDSKEYYDPEGKEDPHNEVDGDKTSKSEENS 
                   
               
               
                   
                 AGIPEDNGSQRIEDTQKLNHRESKRVENRITKESETHAVGKS 
                   
               
               
                   
                 QDKGIEIKGPSSGNRNITKEVGKGNEGKEDKGQHGMILGKG 
                   
               
               
                   
                 NVKTQGEVVNIEGPGQKSEPGNKVGHSNTGSDSNSDGYDSY 
                   
               
               
                   
                 DFDDKSMQGDDPNSSDESNGNDDANSESDNNSSSRGDASYN 
                   
               
               
                   
                 SDESKDNGNGSDSKGAEDDDSDSTSDTNNSDSNGNGNNGN 
                   
               
               
                   
                 DDNDKSDSGKGKSDSSDSDSSDSSNSSDSSDSSDSDSSDSNSS 
                   
               
               
                   
                 SDSDSSDSDSSDSSDSDSSDSSNSSDSSDSSDSSDSSDSSDSSD 
                   
               
               
                   
                 SKSDSSKSESDSSDSDSKSDSSDSNSSDSSDNSDSSDSSNSSNS 
                   
               
               
                   
                 SDSSDSSDSSDSSSSSDSSNSSDSSDSSDSSNSSESSDSSDSSDS 
                   
               
               
                   
                 DSSDSSDSSNSNSSDSDSSNSSDSSDSSNSSDSSDSSDSSNSSD 
                   
               
               
                   
                 SSDSSDSSNSSDSSDSSDSSDSSDSSNSSDSNDSSNSSDSSDSS 
                   
               
               
                   
                 NSSDSSNSSDSSDSSDSSDSDSSNSSDSSNSSDSSDSSNSSDSS 
                   
               
               
                   
                 DSSDSSDGSDSDSSNRSDSSNSSDSSDSSDSSNSSDSSDSSDSN 
                   
               
               
                   
                 ESSNSSDSSDSSNSSDSDSSDSSNSSDSSDSSNSSDSSESSNSSD 
                   
               
               
                   
                 NSNSSDSSNSSDSSDSSDSSNSSDSSNSSDSSNSSDSSDSNSSD 
                   
               
               
                   
                 SSDSSNSSDSSDSSDSSDSSDSSDSSNSSDSSDSSDSSDSSNSSD 
                   
               
               
                   
                 SSNSSDSSNSSDSSDSSDSSDSSDSSDSSDSSDSSNSSDSSDSSD 
                   
               
               
                   
                 SSDSSDSSDSSDSSDSSESSDSSDSSNSSDSSDSSDSSDSSDSSD 
                   
               
               
                   
                 SSDSSDSSDSSNSSDSSDSSDSSDSSDSSNSSDSSDSSESSDSSD 
                   
               
               
                   
                 SSDSSDSSDSSDSSDSSDSSDSSNSSDSSDSSDSSDSSDSSDSSD 
                   
               
               
                   
                 SSDSSDSSDSSDSSDSSDSSDSSDSSDSSDSNESSDSSDSSDSSD 
                   
               
               
                   
                 SSNSSDSSDSSDSSDSTSDSNDESDSQSKSGNGNNNGSDSDSD 
                   
               
               
                   
                 SEGSDSNHSTSDD 
                   
               
               
                   
               
               
                 GDF-1 
                 MPPPQQGPCGHHLLLLLALLLPSLPLTRAPVPPGPAAALLQA 
                 69 
               
               
                   
                 LGLRDEPQGAPRLRPVPPVMWRLFRRRDPQETRSGSRRTSPG 
                   
               
               
                   
                 VTLQPCHVEELGVAGNIVRHIPDRGAPTRASEPASAAGHCPE 
                   
               
               
                   
                 WTVVFDLSAVEPAERPSRARLELRFAAAAAAAPEGGWELSV 
                   
               
               
                   
                 AQAGQGAGADPGPVLLRQLVPALGPPVRAELLGAAWARNA 
                   
               
               
                   
                 SWPRSLRLALALRPRAPAACARLAEASLLLVTLDPRLCHPLA 
                   
               
               
                   
                 RPRRDAEPVLGGGPGGACRARRLYVSFREVGWHRWVIAPR 
                   
               
               
                   
                 GFLANYCQGQCALPVALSGSGGPPALNHAVLRALMHAAAP 
                   
               
               
                   
                 GAADLPCCVPARLSPISVLFFDNSDNVVLRQYEDMVVDECG 
                   
               
               
                   
                 CR 
                   
               
               
                   
               
               
                 GDF-3 
                 MLRFLPDLAFSFLLILALGQAVQFQEYVFLQFLGLDKAPSPQ 
                 70 
               
               
                   
                 KFQPVPYILKKIFQDREAAATTGVSRDLCYVKELGVRGNVLR 
                   
               
               
                   
                 FLPDQGFFLYPKKISQASSCLQKLLYFNLSAIKEREQLTLAQL 
                   
               
               
                   
                 GLDLGPNSYYNLGPELELALFLVQEPHVWGQTTPKPGKMFV 
                   
               
               
                   
                 LRSVPWPQGAVHF&#39;NLLDVAKDWNDNPRKNFGLFLEILVKED 
                   
               
               
                   
                 RDSGVNFQPEDTCARLRCSLHASLLVVTLNPDQCHPSRKRR 
                   
               
               
                   
                 AAIPVPKLSCKNLCHRHQLFINFRDLGWHKWIIAPKGFMANY 
                   
               
               
                   
                 CHGECPFSLTISLNSSNYAFMQALMHAVDPEIPQAVCIPTKLS 
                   
               
               
                   
                 PISMLYQDNNDNVILRHYEDMVVDECGCG 
                   
               
               
                   
               
               
                 GDF-5 
                 MRLPKLLTELLWYLAWLDLEFICTVLGAPDLGQRPQGTRPG 
                 71 
               
               
                   
                 LAKAEAKERPPLARNVFRPGGHSYGGGATNANARAKGGTG 
                   
               
               
                   
                 QTGGLTQPKKDEPKKLPPRPGGPEPKPGHPPQTRQATARTVT 
                   
               
               
                   
                 PKGQLPGGKAPPKAGSVPSSELLKKAREPGPPREPKEPERPPPI 
                   
               
               
                   
                 TPHEYMLSLYRTLSDADRKGGNSSVKLEAGLANTITSFIDKG 
                   
               
               
                   
                 QDDRGPVVRKQRYVFDISALEKDGLLGAELRILRKKPSDTAK 
                   
               
               
                   
                 PAAPGGGRAAQLKLSSCPSGRQPAALLDVRSVPGLDGSGWE 
                   
               
               
                   
                 VEDIWKLERNEKNSAQLCLELEAWERGRAVDLRGLGEDRAA 
                   
               
               
                   
                 RQVHEKALELVEGRTKKRDLEENEIKARSGQDDKTVYEYLES 
                   
               
               
                   
                 QRRKRRAPLATRQGKRPSKNLKARCSRKALHVNFKDMGWD 
                   
               
               
                   
                 DWIIAPLEYEAFHCEGLCEFPLRSHLEPTNHAVIQTLMNSMD 
                   
               
               
                   
                 PESTPPTCCVPTRLSPISILFIDSANNVVYKQYEDMVVESCGC 
                   
               
               
                   
                 R 
                   
               
               
                   
               
               
                 GDF-7 
                 MDLSAAAALCLWLLSACRPRDGLEAAAVLRAAGAGPVRSP 
                 72 
               
               
                   
                 GGGGGGGGGGRTLAQAAGAAAVPAAAVPRARAARRAAGS 
                   
               
               
                   
                 GFRNGSVVPHHEMMSLYRSLAGRAPAGAAAVSASGHGRAD 
                   
               
               
                   
                 TITGETDQATQDESAAETGQSFLFDVSSLNDADEVVGAELRV 
                   
               
               
                   
                 LRRGSPESGPGSWTSPPLLLLSTCPGAARAPRLLYSRAAEPLV 
                   
               
               
                   
                 GQRWEAFDVADAMRRHRREPRPPRAFCLLLRAVAGPVPSPL 
                   
               
               
                   
                 ALRRLGFGWPGGGGSAAEERAVLVVSSRTQRKESLFREIRA 
                   
               
               
                   
                 QARALGAALASEPLPDPGTGTASPRAVIGGRRRRRTALAGTR 
                   
               
               
                   
                 TAQGSGGGAGRGHGRRGRSRCSRKPLHVDFKELGWDDWII 
                   
               
               
                   
                 APLDYEAYHCEGLCDFPLRSHLEPTNHAIIQTLLNSMAPDAA 
                   
               
               
                   
                 PASCCVPARLSPISILYIDAANNVVYKQYEDMVVEACGCR 
                   
               
               
                   
               
               
                 GDF8 
                 MQKLQLCVYIYLFMLIVAGPVDLNENSEQKENVEKEGLCNA 
                 73 
               
               
                   
                 CTWRQNTKSSRIEAIKIQILSKLRLETAPNISKDVIRQLLPKAP 
                   
               
               
                   
                 PLRELIDQYDVQRDDSSDGSLEDDDYHATTETIITMPTESDFL 
                   
               
               
                   
                 MQVDGKPKCCFFKFSSKIQYNKVVKAQLWIYLRPVETPTTV 
                   
               
               
                   
                 FVQILRLIKPMKDGTRYTGIRSLKLDMNPGTGIWQSIDVKTV 
                   
               
               
                   
                 LQNWLKQPESNLGIEIKALDENGHDLAVTFPGPGEDGLNPFL 
                   
               
               
                   
                 EVKVTDTPKRSRRDFGLDCDEHSTESRCCRYPLTVDFEAFG 
                   
               
               
                   
                 WDWIIAPKRYKANYCSGECEFVFLQKYPHTHLVHQANPRGS 
                   
               
               
                   
                 AGPCCTPTKMSPINMLYFNGKEQIIYGKIPAMVVDRCGCS 
                   
               
               
                   
               
               
                 GDF15 
                 MPGQELRTVNGSQMLLVLLVLSWLPHGGALSLAEASRASFP 
                 74 
               
               
                   
                 GPSELHSEDSRFRELRKRYEDLLTRLRANQSWEDSNTDLVPA 
                   
               
               
                   
                 PAVRILTPEVRLGSGGHLHLRISRAALPEGLPEASRLHRALFR 
                   
               
               
                   
                 LSPTASRSWDVTRPLRRQLSLARPQAPALHLRLSPPPSQSDQL 
                   
               
               
                   
                 LAESSSARPQLELHLRPQAARGRRRARARNGDHCPLGPGRC 
                   
               
               
                   
                 CRLHTVRASLEDLGWADWVLSPREVQVTMCIGACPSQFRAA 
                   
               
               
                   
                 NMHAQIKTSLHRLKPDTVPAPCCVPASYNPMVLIQKTDTGV 
                   
               
               
                   
                 SLQTYDDLLAKDCHCI 
                   
               
               
                   
               
               
                 VEGF 
                 MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGG 
                 75 
               
               
                   
                 VEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARS 
                   
               
               
                   
                 ASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEA 
                   
               
               
                   
                 AVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPS 
                   
               
               
                   
                 RRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWS 
                   
               
               
                   
                 QAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEY 
                   
               
               
                   
                 PDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMR 
                   
               
               
                   
                 IKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGK 
                   
               
               
                   
                 GQKRKRKKSRYKSWSVYVGARCCLMPWSLPGPHPCGPCSE 
                   
               
               
                   
                 RRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKP 
                   
               
               
                   
                 RR 
                   
               
               
                   
               
               
                 HABP 
                 MFARMSDLHVLLLMALVGKTACGFSLMSLLESLDPDWTPD 
                 76 
               
               
                   
                 QYDYSYEDYNQEENTSSTLTHAENPDWYYTEDQADPCQPNP 
                   
               
               
                   
                 CEHGGDCLVHGSTFTCSCLAPFSGNKCQKVQNTCKDNPCGR 
                   
               
               
                   
                 GQCLITQSPPYYRCVCKHPYTGPSCSQVVPVCRPNPCQNGAT 
                   
               
               
                   
                 CSRHKRRSKFTCACPDQFKGKFCEIGSDDCYVGDGYSYRGK 
                   
               
               
                   
                 MNRTVNQHACLYWNSHLLLQENYNMEMEDAETHGIGEHNF 
                   
               
               
                   
                 CRNPDADEKPWCFIKVTNDKVKWEYCDVSACSAQDVAYPE 
                   
               
               
                   
                 ESPTEPSTKLPGFDSCGKTEIAERKIKRIYGGEKSTAGKHPWQ 
                   
               
               
                   
                 ASLQSSLPLTISMPQGHFCGGALIHPCWVLTAAHCTDIKTRH 
                   
               
               
                   
                 LKVVLGDQDLKKEEFHEQSFRVEKIFKYSHYNERDEIPHNDI 
                   
               
               
                   
                 ALLKLKPVDGHCALESKYVKTVCLPDGSFPSGSECHISGWG 
                   
               
               
                   
                 VTETGKGSRQLLDAKVKLIANTLCNSRQLYDHMIDDSMICA 
                   
               
               
                   
                 GNLQKPGQDTCQGDSGGPLTCEKDGTYYVYGIVSWGLECG 
                   
               
               
                   
                 KRPGVYTQVTKFLNWIKATIKSESGF 
                   
               
               
                   
               
               
                 CBP 
                 MRSLLLLSAFCLLEAALAAEVKKPAAAAAPGTAEKLSPKAA 
                 77 
               
               
                   
                 TLAERSAGLAFSLYQAMAKDQAVENILVSPVVVASSLGLVS 
                   
               
               
                   
                 LGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLSNSTA 
                   
               
               
                   
                 RNVTWKLGSRLYGPSSVSFADDFVRSSKQHYNCEHSKINFR 
                   
               
               
                   
                 DKRSALQSINEWAAQTTDGKLPEVTKDVERTDGALLVNAM 
                   
               
               
                   
                 FFKPHWDEKEHHKMVDNRGEMVTRSYTVGVMMMHRTGLY 
                   
               
               
                   
                 NYYDDEKEKLQIVEMPLAHKLSSLIILMPHHVEPLERLEKLLT 
                   
               
               
                   
                 KEQLKIWMGKMQKKAVAISLPKGVVEVTHDLQKHLAGLGL 
                   
               
               
                   
                 TEAIDKNKADLSRMSGKKDLYLASVFHATAFELDTDGNPFD 
                   
               
               
                   
                 QDIYGREELRSPKLFYADHPFIFLVRDTQSGSLLFIGRLVRPK 
                   
               
               
                   
                 GDKMRDEL 
                   
               
               
                   
               
               
                 FGF-18 
                 MYSAPSACTCLCLHFLLLCFQVQVLVAEENVDFRIHVENQTR 
                 78 
               
               
                   
                 ARDDVSRKQLRLYQLYSRTSGKHIQVLGRRISARGEDGDKY 
                   
               
               
                   
                 AQLLVETDTFGSQVRIKGKETEFYLCMNRKGKLVGKPDGTS 
                   
               
               
                   
                 KECVFIEKVLENNYTALMSAKYSGWYVGFTKKGRPRKGPKT 
                   
               
               
                   
                 RENQQDVHFMKRYPKGQPELQKPFKYTTVTKRSRRIRPTHP 
                   
               
               
                   
                 A 
                   
               
               
                   
               
               
                 KGF 
                 MHKWILTWILPTLLYRSCFHIICLVGTISLACNDMTPEQMAT 
                 79 
               
               
                   
                 NVNCSSPERHTRSYDYMEGGDIRVRRLFCRTQWYLRIDKRG 
                   
               
               
                   
                 KVKGTQEMKNNYNIMEIRTVAVGIVAIKGVESEFYLAMNKE 
                   
               
               
                   
                 GKLYAKKECNEDCNFKELILENHYNTYASAKWTHNGGEMF 
                   
               
               
                   
                 VALNQKGIPVRGKKTKKEQKTAHFLPMAIT 
                   
               
               
                   
               
               
                 TNFα 
                 MSTESMIRDVELAEEALPKKTGGPQGSRRCLFLSLFSFLIVAG 
                 80 
               
               
                   
                 ATTLFCLLHFGVIGPQREEFPRDLSLISPLAQAVRSSSRTPSDK 
                   
               
               
                   
                 PVAHVVANPQAEGQLQWLNRRANALLANGVELRDNQLVVP 
                   
               
               
                   
                 SEGLYLIYSQVLFKGQGCPSTHVLLTHTISRIAVSYQTKVNLL 
                   
               
               
                   
                 SAIKSPCQRETPEGAEAKPWYEPIYLGGVFQLEKGDRLSAEIN 
                   
               
               
                   
                 RPDYLDFAESGQVYFGIIAL 
                   
               
               
                   
               
               
                 TRAIL 
                 MAMMEVQGGPSLGQTCVLIVIFTVLLQSLCVAVTYVYFTNE 
                 81 
               
               
                   
                 LKQMQDKYSKSGIACFLKEDDSYWDPNDEESMNSPCWQVK 
                   
               
               
                   
                 WQLRQLVRKMILRTSEETISTVQEKQQNISPLVRERGPQRVA 
                   
               
               
                   
                 AHITGTRGRSNTLSSPNSKNEKALGRKINSWESSRSGHSFLSN 
                   
               
               
                   
                 LHLRNGELVIHEKGFYYIYSQTYFRFQEEIKENTKNDKQMVQ 
                   
               
               
                   
                 YIYKYTSYPDPILLMKSARNSCWSKDAEYGLYSIYQGGIFEL 
                   
               
               
                   
                 KENDRIFVSVTNEHLIDMDHEASFFGAFLVG 
                   
               
               
                   
               
               
                 WNT1 
                 MGLWALLPGWVSATLLLALAALPAALAANSSGRWWGIVNV 
                 82 
               
               
                   
                 ASSTNLLTDSKSLQLVLEPSLQLLSRKQRRLIRQNPGILHSVS 
                   
               
               
                   
                 GGLQSAVRECKWQFRNRRWNCPTAPGPHLFGKIVNRGCRET 
                   
               
               
                   
                 AFIFAITSAGVTHSVARSCSEGSIESCTCDYRRRGPGGPDWH 
                   
               
               
                   
                 WGGCSDNIDFGRLFGREFVDSGEKGRDLRFLMNLHNNEAGR 
                   
               
               
                   
                 TTVFSEMRQECKCHGMSGSCTVRTCWMRLPTLRAVGDVLR 
                   
               
               
                   
                 DRFDGASRVLYGNRGSNRASRAELLRLEPEDPAHKPPSPHDL 
                   
               
               
                   
                 VYFEKSPNFCTYSGRLGTAGTAGRACNSSSPALDGCELLCCG 
                   
               
               
                   
                 RGHRTRTQRVTERCNCTFHWCCHVSCRNCTHTRVLHECL 
                   
               
               
                   
               
               
                 WNT2 
                 MNAPLGGIWLWLPLLLTWLTPEVNSSWWYMRATGGSSRV 
                 83 
               
               
                   
                 MCDNVPGLVSSQRQLCHRHPDVMRAISQGVAEWTAECQHQ 
                   
               
               
                   
                 FRQHRWNCNTLDRDHSLFGRVLLRSSRESAFVYAISSAGVVF 
                   
               
               
                   
                 AITRACSQGEVKSCSCDPKKMGSAKDSKGIFDWGGCSDNID 
                   
               
               
                   
                 YGIKFARAFVDAKERKGKDARALMNLHNNRAGRKAVKRFL 
                   
               
               
                   
                 KQECKCHGVSGSCTLRTCWLAMADFRKTGDYLWRKYNGAI 
                   
               
               
                   
                 QVVMNQDGTGFTVANERFKKPTKNDLVYFENSPDYCIRDRE 
                   
               
               
                   
                 AGSLGTAGRVCNLTSRGMDSCEVMCCGRGYDTSHVTRMTK 
                   
               
               
                   
                 CGCKFHWCCAVRCQDCLEALDVHTCKAPKNADWTTAT 
                   
               
               
                   
               
               
                 WNT2B 
                 MLRPGGAEEAAQLPLRRASAPVPVPSPAAPDGSRASARLGL 
                 84 
               
               
                   
                 ACLLLLLLLTLPARVDTSWWYIGALGARVICDNIPGLVSRQR 
                   
               
               
                   
                 QLCQRYPDIMRSVGEGAREWIRECQHQFRHHRWNCTTLDR 
                   
               
               
                   
                 DHTVFGRVMLRSSREAAFVYAISSAGVVHAITRACSQGELSV 
                   
               
               
                   
                 CSCDPYTRGRHHDQRGDFDWGGCSDNIHYGVRFAKAFVDA 
                   
               
               
                   
                 KEKRLKDARALMNLHNNRCGRTAVRRFLKLECKCHGVSGS 
                   
               
               
                   
                 CTLRTCWRALSDFRRTGDYLRRRYDGAVQVMATQDGANFT 
                   
               
               
                   
                 AARQGYRRATRTDLVYFDNSPDYCVLDKAAGSLGTAGRVC 
                   
               
               
                   
                 SKTSKGTDGCEEVICCGRGYDTTRVTRVTQCECKFHWCCAV 
                   
               
               
                   
                 RCKECRNTVDVHTCKAPKKAEWLDQT 
                   
               
               
                   
               
               
                 WNT3 
                 MEPHLLGLLLGLLLGGTRVLAGYPIWWSLALGQQYTSLGSQ 
                 85 
               
               
                   
                 PLLCGSIPGLVPKQLRFCRNYIEIMPSVAEGVKLGIQECQHQF 
                   
               
               
                   
                 RGRRWNCTTIDDSLAIFGPVLDKATRESAFVHAIASAGVAFA 
                   
               
               
                   
                 VTRSCAEGTSTICGCDSHHKGPPGEGWKWGGCSEDADFGVL 
                   
               
               
                   
                 VSREFADARENRPDARSAMNKHNNEAGRTTILDHMHLKCK 
                   
               
               
                   
                 CHGLSGSCEVKTCWWAQPDFRAIGDFLKDKYDSASEMVVE 
                   
               
               
                   
                 KHRESRGWVETLRAKYSLFKPPTERDLVYYENSPNFCEPNPE 
                   
               
               
                   
                 TGSFGTRDRTCNVTSHGIDGCDLLCCGRGHNTRTEKRKEKC 
                   
               
               
                   
                 HCIFHWCCYVSCQECIRIYDVHTCK 
                   
               
               
                   
               
               
                 WNT3A 
                 MAPLGYFLLLCSLKQALGSYPIWWSLAVGPQYSSLGSQPILC 
                 86 
               
               
                   
                 ASIPGLVPKQLRFCRNYVEIMPSVAEGIKIGIQECQHQFRGRR 
                   
               
               
                   
                 WNCTTVHDSLAIFGPVLDKATRESAFVHAIASAGVAFAVTRS 
                   
               
               
                   
                 CAEGTAAICGCSSRHQGSPGKGWKWGGCSEDIEFGGMVSRE 
                   
               
               
                   
                 FADARENRPDARSAMNRHNNEAGRQAIASHMHLKCKCHGL 
                   
               
               
                   
                 SGSCEVKTCWWSQPDFRAIGDFLKDKYDSASEMVVEKHRES 
                   
               
               
                   
                 RGWVETLRPRYTYFKVPTERDLVYYEASPNFCEPNPETGSFG 
                   
               
               
                   
                 TRDRTCNVSSHGIDGCDLLCCGRGHNARAERRREKCRCVFH 
                   
               
               
                   
                 WCCYVSCQECTRVYDVHTCK 
                   
               
               
                   
               
               
                 WNT4 
                 MSPRSCLRSLRLLVFAVFSAAASNWLYLAKLSSVGSISEEETC 
                 87 
               
               
                   
                 EKLKGLIQRQVQMCKRNLEVMDSVRRGAQLAIEECQYQFRN 
                   
               
               
                   
                 RRWNCSTLDSLPVFGKVVTQGTREAAFVYAISSAGVAFAVT 
                   
               
               
                   
                 RACSSGELEKCGCDRTVHGVSPQGFQWSGCSDNIAYGVAFS 
                   
               
               
                   
                 QSFVDVRERSKGASSSRALMNLHNNEAGRKAILTHMRVECK 
                   
               
               
                   
                 CHGVSGSCEVKTCWRAVPPFRQVGHALKEKFDGATEVEPRR 
                   
               
               
                   
                 VGSSRALVPRNAQFKPHTDEDLVYLEPSPDFCEQDMRSGVL 
                   
               
               
                   
                 GTRGRTCNKTSKAIDGCELLCCGRGFHTAQVELAERCSCKF 
                   
               
               
                   
                 HWCCFVKCRQCQRLVELHTCR 
                   
               
               
                   
               
               
                 WNT5A 
                 MKKSIGILSPGVALGMAGSAMSSKFFLVALAIFFSFAQVVIEA 
                 88 
               
               
                   
                 NSWWSLGMNNPVQMSEVYIIGAQPLCSQLAGLSQGQKKLC 
                   
               
               
                   
                 HLYQDHMQYIGEGAKTGIKECQYQFRHRRWNCSTVDNTSV 
                   
               
               
                   
                 FGRVMQIGSRETAFTYAVSAAGVVNAMSRACREGELSTCGC 
                   
               
               
                   
                 SRAARPKDLPRDWLWGGCGDNIDYGYRFAKEFVDARERERI 
                   
               
               
                   
                 HAKGSYESARILMNLHNNEAGRRTVYNLADVACKCHGVSG 
                   
               
               
                   
                 SCSLKTCWLQLADFRKVGDALKEKYDSAAAMRLNSRGKLV 
                   
               
               
                   
                 QVNSRFNSPTTQDLVYIDPSPDYCVRNESTGSLGTQGRLCNK 
                   
               
               
                   
                 TSEGMDGCELMCCGRGYDQFKTVQTERCHCKFHWCCYVK 
                   
               
               
                   
                 CKKCTEIVDQFVCK 
                   
               
               
                   
               
               
                 WNT5B 
                 MPSLLLLFTAALLSSWAQLLTDANSWWSLALNPVQRPEMFII 
                 89 
               
               
                   
                 GAQPVCSQLPGLSPGQRKLCQLYQEHMAYIGEGAKTGIKEC 
                   
               
               
                   
                 QHQFRQRRWNCSTADNASVFGRVMQIGSRETAFTHAVSAA 
                   
               
               
                   
                 GVVNAISRACREGELSTCGCSRTARPKDLPRDWLWGGCGDN 
                   
               
               
                   
                 VEYGYRFAKEFVDAREREKNFAKGSEEQGRVLMNLQNNEA 
                   
               
               
                   
                 GRRAVYKMADVACKCHGVSGSCSLKTCWLQLAEFRKVGD 
                   
               
               
                   
                 RLKEKYDSAAAMRVTRKGRLELVNSRFTQPTPEDLVYVDPS 
                   
               
               
                   
                 PDYCLRNESTGSLGTQGRLCNKTSEGMDGCELMCCGRGYN 
                   
               
               
                   
                 QFKSVQVERCHCKFHWCCFVRCKKCTEIVDQYICK 
                   
               
               
                   
               
               
                 WNT6 
                 MLPPLPSRLGLLLLLLLCPAHVGGLWWAVGSPLVMDPTSICR 
                 90 
               
               
                   
                 KARRLAGRQAELCQAEPEVVAELARGARLGVRECQFQFRFR 
                   
               
               
                   
                 RWNCSSHSKAFGRILQQDIRETAFVFAITAAGASHAVTQACS 
                   
               
               
                   
                 MGELLQCGCQAPRGRAPPRPSGLPGTPGPPGPAGSPEGSAA 
                   
               
               
                   
                 WEWGGCGDDVDFGDEKSRLFMDARHKRGRGDIRALVQLH 
                   
               
               
                   
                 NNEAGRLAVRSHTRTECKCHGLSGSCALRTCWQKLPPFREV 
                   
               
               
                   
                 GARLLERFHGASRVMGTNDGKALLPAVRTLKPPGRADLLYA 
                   
               
               
                   
                 ADSPDFCAPNRRTGSPGTRGRACNSSAPDLSGCDLLCCGRGH 
                   
               
               
                   
                 RQESVQLEENCLCRFHWCCVVQCHRCRVRKELSLCL 
                   
               
               
                   
               
               
                 WNT7A 
                 MNRKARRCLGHLFLSLGMVYLRIGGFSSVVALGASIICNKIP 
                 91 
               
               
                   
                 GLAPRQRAICQSRPDAIIVIGEGSQMGLDECQFQFRNGRWNC 
                   
               
               
                   
                 SALGERTVFGKELKVGSREAAFTYAIIAAGVAHAITAACTQG 
                   
               
               
                   
                 NLSDCGCDKEKQGQYHRDEGWKWGGCSADIRYGIGFAKVF 
                   
               
               
                   
                 VDAREIKQNARTLMNLHNNEAGRKILEENMKLECKCHGVS 
                   
               
               
                   
                 GSCTTKTCWTTLPQFRELGYVLKDKYNEAVHVEPVRASRNK 
                   
               
               
                   
                 RPTFLKIKKPLSYRKPMDTDLVYIEKSPNYCEEDPVTGSVGT 
                   
               
               
                   
                 QGRACNKTAPQASGCDLMCCGRGYNTHQYARVWQCNCKF 
                   
               
               
                   
                 HWCCYVKCNTCSERTEMYTCK 
                   
               
               
                   
               
               
                 WNT7B 
                 MHRNFRKWIFYVFLCFGVLYVKLGALSSVVALGANIICNKIP 
                 92 
               
               
                   
                 GLAPRQRAICQSRPDAIIVIGEGAQMGINECQYQFRFGRWNC 
                   
               
               
                   
                 SALGEKTVFGQELRVGSREAAFTYAITAAGVAHAVTAACSQ 
                   
               
               
                   
                 GNLSNCGCDREKQGYYNQAEGWKWGGCSADVRYGIDFSRR 
                   
               
               
                   
                 FVDAREIKKNARRLMNLHNNEAGRKVLEDRMQLECKCHGV 
                   
               
               
                   
                 SGSCTTKTCWTTLPKFREVGHLLKEKYNAAVQVEVVRASRL 
                   
               
               
                   
                 RQPTFLRIKQLRSYQKPMETDLVYIEKSPNYCEEDAATGSVG 
                   
               
               
                   
                 TQGRLCNRTSPGADGCDTMCCGRGYNTHQYTKVWQCNCK 
                   
               
               
                   
                 FHWCCFVKCNTCSERTEVFTCK 
                   
               
               
                   
               
               
                 WNT8A 
                 MLCCIQCLCLVSPFPTLTPCQGGPHCLIPIHLCLTFSLFGRSVN 
                 93 
               
               
                   
                 NFLITGPKAYLTYTTSVALGAQSGIEECKFQFAWERWNCPEN 
                   
               
               
                   
                 ALQLSTHNRLRSATRETSFIHAISSAGVMYIITKNCSMGDFEN 
                   
               
               
                   
                 CGCDGSNNGKTGGHGWIWGGCSDNVEFGERISKLFVDSLEK 
                   
               
               
                   
                 GKDARALMNLHNNRAGRLAVRATMKRTCKCHGISGSCSIQT 
                   
               
               
                   
                 CWLQLAEFREMGDYLKAKYDQALKIEMDKRQLRAGNSAEG 
                   
               
               
                   
                 HWVPAEAFLPSAEAELIFLEESPDYCTCNSSLGIYGTEGRECL 
                   
               
               
                   
                 QNSHNTSRWERRSCGRLCTECGLQVEERKTEVISSCNCKFQ 
                   
               
               
                   
                 WCCTVKCDQCRHVTMSNPAVLLGIRRIEAKNERVLFRLLKS 
                   
               
               
                   
                 SLWLQIYADK 
                   
               
               
                   
               
               
                 WNT8B 
                 MFLSKPSVYICLFTCVLQLSHSWSVNNFLMTGPKAYLIYSSS 
                 94 
               
               
                   
                 VAAGAQSGIEECKYQFAWDRWNCPERALQLSSHGGLRSAN 
                   
               
               
                   
                 RETAFVHAISSAGVMYTLTRNCSLGDFDNCGCDDSRNGQLG 
                   
               
               
                   
                 GQGWLWGGCSDNVGFGEAISKQFVDALETGQDARAAMNL 
                   
               
               
                   
                 HNNEAGRKAVKGTMKRTCKCHGVSGSCTTQTCWLQLPEFR 
                   
               
               
                   
                 EVGAHLKEKYHAALKVDLLQGAGNSAAGRGAIADTFRSIST 
                   
               
               
                   
                 RELVHLEDSPDYCLENKTLGLLGTEGRECLRRGRALGRWER 
                   
               
               
                   
                 RSCRRLCGDCGLAVEERRAETVSSCNCKFHWCCAVRCEQCR 
                   
               
               
                   
                 RRVTKYFCSRAERPRGGAAHKPGRKP 
                   
               
               
                   
               
               
                 WNT9A 
                 MLDGSPLARWLAAAFGLTLLLAALRPSAAYFGLTGSEPLTIL 
                 95 
               
               
                   
                 PLTLEPEAAAQAHYKACDRLKLERKQRRMCRRDPGVAETL 
                   
               
               
                   
                 VEAVSMSALECQFQFRFERWNCTLEGRYRASLLKRGFKETA 
                   
               
               
                   
                 FLYAISSAGLTHALAKACSAGRMERCTCDEAPDLENREAWQ 
                   
               
               
                   
                 WGGCGDNLKYSSKFVKEFLGRRSSKDLRARVDFHNNLVGV 
                   
               
               
                   
                 KVIKAGVETTCKCHGVSGSCTVRTCWRQLAPFHEVGKHLKH 
                   
               
               
                   
                 KYETALKVGSTTNEAAGEAGAISPPRGRASGAGGSDPLPRTP 
                   
               
               
                   
                 ELVHLDDSPSFCLAGRFSPGTAGRRCHREKNCESICCGRGHN 
                   
               
               
                   
                 TQSRVVTRPCQCQVRWCCYVECRQCTQREEVYTCKG 
                   
               
               
                   
               
               
                 WNT9B 
                 MRPPPALALAGLCLLALPAAAASYFGLTGREVLTPFPGLGTA 
                 96 
               
               
                   
                 AAPAQGGAHLKQCDLLKLSRRQKQLCRREPGLAETLRDAA 
                   
               
               
                   
                 HLGLLECQFQFRHERWNCSLEGRMGLLKRGFKETAFLYAVS 
                   
               
               
                   
                 SAALTHTLARACSAGRMERCTCDDSPGLESRQAWQWGVCG 
                   
               
               
                   
                 DNLKYSTKFLSNFLGSKRGNKDLRARADAHNTHVGIKAVKS 
                   
               
               
                   
                 GLRTTCKCHGVSGSCAVRTCWKQLSPFRETGQVLKLRYDSA 
                   
               
               
                   
                 VKVSSATNEALGRLELWAPARQGSLTKGLAPRSGDLVYME 
                   
               
               
                   
                 DSPSFCRPSKYSPGTAGRVCSREASCSSLCCGRGYDTQSRLV 
                   
               
               
                   
                 AFSCHCQVQWCCYVECQQCVQEELVYTCKH 
                   
               
               
                   
               
               
                 WNT10A 
                 MGSAHPRPWLRLRPQPQPRPALWVLLFFLLLLAAAMPRSAP 
                 97 
               
               
                   
                 NDILDLRLPPEPVLNANTVCLTLPGLSRRQMEVCVRHPDVAA 
                   
               
               
                   
                 SAIQGIQIAIHECQHQFRDQRWNCSSLETRNKIPYESPIFSRGF 
                   
               
               
                   
                 RESAFAYAIAAAGVVHAVSNACALGKLKACGCDASRRGDE 
                   
               
               
                   
                 EAFRRKLHRLQLDALQRGKGLSHGVPEHPALPTASPGLQDS 
                   
               
               
                   
                 WEWGGCSPDMGFGERFSKDFLDSREPHRDIHARMRLHNNR 
                   
               
               
                   
                 VGRQAVMENMRRKCKCHGTSGSCQLKTCWQVTPEFRTVGA 
                   
               
               
                   
                 LLRSRFHRATLIRPHNRNGGQLEPGPAGAPSPAPGAPGPRRR 
                   
               
               
                   
                 ASPADLVYFEKSPDFCEREPRLDSAGTVGRLCNKSSAGSDGC 
                   
               
               
                   
                 GSMCCGRGHNILRQTRSERCHCRFHWCCFVVCEECRITEWV 
                   
               
               
                   
                 SVCK 
                   
               
               
                   
               
               
                 WNT10B 
                 MLEEPRPRPPPSGLAGLLFLALCSRALSNEILGLKLPGEPPLTA 
                 98 
               
               
                   
                 NTVCLTLSGLSKRQLGLCLRNPDVTASALQGLHIAVHECQH 
                   
               
               
                   
                 QLRDQRWNCSALEGGGRLPHHSAILKRGFRESAFSFSMLAA 
                   
               
               
                   
                 GVMHAVATACSLGKLVSCGCGWKGSGEQDRLRAKLLQLQ 
                   
               
               
                   
                 ALSRGKSFPHSLPSPGPGSSPSPGPQDTWEWGGCNHDMDFG 
                   
               
               
                   
                 EKFSRDFLDSREAPRDIQARMRIHNNRVGRQVVTENLKRKC 
                   
               
               
                   
                 KCHGTSGSCQFKTCWRAAPEFRAVGAALRERLGRAIFIDTHN 
                   
               
               
                   
                 RNSGAFQPRLRPRRLSGELVYFEKSPDFCERDPTMGSPGTRG 
                   
               
               
                   
                 RACNKTSRLLDGCGSLCCGRGHNVLRQTRVERCHCRFHWC 
                   
               
               
                   
                 CYVLCDECKVTEWVNVCK 
                   
               
               
                   
               
               
                 WNT11 
                 MRARPQVCEALLFALALQTGVCYGIKWLALSKTPSALALNQ 
                 99 
               
               
                   
                 TQHCKQLEGLVSAQVQLCRSNLELMHTVVHAAREVMKACR 
                   
               
               
                   
                 RAFADMRWNCSSIELAPNYLLDLERGTRESAFVYALSAAAIS 
                   
               
               
                   
                 HAIARACTSGDLPGCSCGPVPGEPPGPGNRWGGCADNLSYG 
                   
               
               
                   
                 LLMGAKFSDAPMKVKKTGSQANKLMRLHNSEVGRQALRAS 
                   
               
               
                   
                 LEMKCKCHGVSGSCSIRTCWKGLQELQDVAADLKTRYLSAT 
                   
               
               
                   
                 KVVHRPMGTRKHLVPKDLDIRPVKDSELVYLQSSPDFCMKN 
                   
               
               
                   
                 EKVGSHGTQDRQCNKTSNGSDSCDLMCCGRGYNPYTDRVV 
                   
               
               
                   
                 ERCHCKYHWCCYVTCRRCERTVERYVCK 
                   
               
               
                   
               
               
                 WNT16 
                 MDRAALLGLARLCALWAALLVLFPYGAQGNWMWLGIASF 
                 100 
               
               
                   
                 GVPEKLGCANLPLNSRQKELCKRKPYLLPSIREGARLGIQEC 
                   
               
               
                   
                 GSQFRHERWNCMITAAATTAPMGASPLFGYELSSGTKETAFI 
                   
               
               
                   
                 YAVMAAGLVHSVTRSCSAGNMTECSCDTTLQNGGSASEGW 
                   
               
               
                   
                 HWGGCSDDVQYGMWFSRKFLDEPIGNTTGKENKVLLAMNL 
                   
               
               
                   
                 HNNEAGRQAVAKLMSVDCRCHGVSGSCAVKTCWKTMSSFE 
                   
               
               
                   
                 KIGHLLKDKYENSIQISDKTKRKMRRREKDQRKIPIHKDDLL 
                   
               
               
                   
                 YVNKSPNYCVEDKKLGIPGTQGRECNRTSEGADGCNLLCCG 
                   
               
               
                   
                 RGYNTHVVRHVERCECKFIWCCYVRCRRCESMTDVHTCK 
               
               
                   
               
            
           
         
       
     
     In some embodiments, the mammalian growth factor is a secreted human growth factor. In some embodiments, the mammalian growth factor is an active fragment (e.g., a fragment of a secreted human growth factor, e.g., any of the exemplary growth factors described herein) that has osteogenic activity). Non-limiting in vitro assays to determine whether a fragment of a secreted human growth factor, e.g., any of the exemplary growth factors described herein, has osteogenic activity are described in Kim et al.,  Amino Acids  42:1455-1465, 2012; Lee et al.,  ACS Med. Chem. Lett.  2(3):248-251, 2011; and Wang et al.,  Genetics Mol. Res.  13(2):4456-4465, 2014. 
     In some embodiments, a fragment of a secreted human growth factor having osteogenic activity can have 1 amino to about 40 amino acids (e.g., 1 amino acid to about 38 amino acids, 1 amino acid to about 36 amino acids, 1 amino acid to about 34 amino acids, 1 amino acid to about 32 amino acids, 1 amino acid to about 30 amino acids, 1 amino acid to about 28 amino acids, 1 amino acid to about 26 amino acid, 1 amino acid to about 24 amino acids, 1 amino acid to about 22 amino acids, 1 amino acid to about 20 amino acids, 1 amino acid to about 18 amino acids, 1 amino acid to about 16 amino acids, 1 amino acid to about 14 amino acids, 1 amino acid to about 12 amino acids, 1 amino acid to about 10 amino acids, 1 amino acid to about 8 amino acids, 1 amino acid to about 6 amino acids, 1 amino acid to about 4 amino acids, or about 1 amino acid to about 3 amino acids) removed from the N-terminus of the secreted human growth factor and/or 1 amino acid to about 20 amino acids (e.g., 1 amino acid to about 18 amino acids, 1 amino acid to about 16 amino acids, 1 amino acid to about 14 amino acids, 1 amino acid to about 12 amino acids, 1 amino acid to about 10 amino acids, 1 amino acid to about 8 amino acids, 1 amino acid to about 6 amino acids, 1 amino acid to about 4 amino acids, or about 1 amino acid to about 3 amino acids) removed from the C-terminus of the secreted human growth factor. 
     In some embodiments, the mammalian growth factor can have a sequence that is at least 70% identical (e.g., at least 75% identical, at least 80% identical, at least 85% identical, at least 90% identical, at least 95% identical, or at least 99% identical) to any of the sequences in Table B or any secreted human growth factor, and has osteogenic activity. As one skilled in the art can appreciate, the amino acids in a mammalian growth factor that are conserved between different species are likely important for osteogenic activity and should not be mutated, while amino acids in a mammalian growth factor that are not conserved between different species are not likely important for osteogenic activity and can be mutated. 
     β-TCP-Binding Polypeptides 
     Also provided herein are β-tricalcium phosphate (β-TCP)-binding polypeptides that include at least one (e.g., two, three, four, five, six, seven, eight, nine, ten, eleven, twelve, thirteen, fourteen, fifteen, sixteen, seventeen, eighteen, nineteen, or twenty) sequence selected from the group consisting of: VIGESTHHRPWS (SEQ ID NO: 2), LIADSTHHSPWT (SEQ ID NO: 3), ILAESTHHKPWT (SEQ ID NO: 4), ILAETTHHRPWS (SEQ ID NO: 5), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), VLGDTTHHKPWT (SEQ ID NO: 8), IVADSTHHRPWT (SEQ ID NO: 9); STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPST (SEQ ID NO: 14), VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT (SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18), and GGADTTHHRPGT (SEQ ID NO: 19). 
     Also provided herein are β-TCP-binding polypeptides that include an amino acid sequence of Formula I: 
     A 0 B 0 C 0 D 0 E 0 F 0 G 0 H 0 I 0 J 0 K 0 L 0  (Formula I) (SEQ ID NO: 35), where:
         A 0  is V, L, I, G, S, T, or A;   B 0  is I, L, V, Q, T, S, G, or A;   C 0  is G, A, V, or S;   D 0  is E, D, L, or G;   E 0  is S, T, PT, E, or D;   F 0  is T or S;   G 0  is H, T, or S;   H 0  is H or T;   I 0  is R, S, K, P, or H;   J 0  is P, S, R, or K;   K 0  is W, F, S, P, V, A, or G; and   L 0  is absent or is S, T, G, (or A);       

     wherein Formula I does not include LLADTTHHRPWT (SEQ ID NO: 1). 
     In some embodiments, any of the β-TCP-binding polypeptides described herein can include two or more (e.g., three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, ten or more, eleven or more, twelve or more, thirteen or more, fourteen or more, fifteen or more, sixteen or more, seventeen or more, eighteen or more, nineteen or more, or twenty or more; or 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, or 22) of any of SEQ ID NOs: 2-19 and a sequence of Formula I (not including SEQ ID NO: 1). In some embodiments, each neighboring pair of SEQ ID NOs: 2-19 and a sequence of Formula I (not including SEQ ID NO: 1) directly abut each other. In some embodiments, each neighboring pair of any of SEQ ID NOs: 2-19 and a sequence of Formula I (not including SEQ ID NO: 1) are separated by a linker sequence. 
     In some embodiments, the chimeric polypeptides can include at least two (e.g., at least three, at least four, at least five, at least six, at least seven, at least eight, at least nine, or at least ten; or 2, 3, 4, 5, 6, 7, 8, 9, or 10) different sequences selected from SEQ ID NOs: 2-19 and a sequence of Formula I (not including SEQ ID NO: 1). 
     In some embodiments, the β-TCP-binding polypeptide includes LLADTTHHRPWT (SEQ ID NO: 1) or GQVLPTTTPSSP (SEQ ID NO: 103). In some embodiments, the β-TCP-binding polypeptide includes LLADTTHHRPWT (SEQ ID NO: 1) and VIGESTHHRPWS (SEQ ID NO: 2). In some embodiments, the β-TCP-binding polypeptide includes the sequence of 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 20) 
               
               
                   
                 LLADTTHHRPWTVIGESTHHRPWS. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes LLADTTHHRPWT (SEQ ID NO: 1), VIGESTHHRPWS (SEQ ID NO: 2), and IIGESSHHKPFT (SEQ ID NO: 6). 
     In some embodiments, the β-TCP-binding polypeptide includes the sequence of 
     
       
         
           
               
               
            
               
                   
                 (SEQ ID NO: 21) 
               
               
                   
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFT. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes LLADTTHHRPWT (SEQ ID NO: 1), VIGESTHHRPWS (SEQ ID NO: 2), IIGESSHHKPFT (SEQ ID NO: 6), GLGDTTHHRPWG (SEQ ID NO: 7), and ILAESTHHKPWT (SEQ ID NO: 4). In some embodiments, the β-TCP-binding polypeptide includes the sequence of: 
     
       
         
           
               
            
               
                 (SEQ ID NO: 22) 
               
               
                 LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFTGLGDTTHHRPWGI 
               
               
                   
               
               
                 LAESTHHKPWT. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes LLADTTHHRPWT (SEQ ID NO: 1) and ILAESTHHKPWT (SEQ ID NO: 4). In some embodiments, the β-TCP-binding polypeptide includes at least one copy of the sequence LLADTTHHRPWTILAESTHHKPWT (SEQ ID NO: 23). In some embodiments, the β-TCP-binding polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 24) 
               
               
                 LLADTTHHRPWTILAESTHHKPWTLLADTTHHRPWTILAESTHHKPWTL 
               
               
                   
               
               
                 LADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes LLADTTHHRPWT (SEQ ID NO: 1) and GLGDTTHHRPWG (SEQ ID NO: 7). In some embodiments, the β-TCP-binding polypeptide includes at least one copy of the sequence of LLADTTHHRPWTGLGDTTHHRPWG (SEQ ID NO: 25). In some embodiments, the β-TCP-binding polypeptide includes the sequence of LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT (SEQ ID NO: 26). In some embodiments, the β-TCP-binding polypeptide includes the sequence of LLADTTHEIRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT (SEQ ID NO: 27). In some embodiments, the β-TCP-binding polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 28) 
               
               
                 LLADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLL 
               
               
                   
               
               
                 ADTTHHRPWTGLGDTTHHRPWGLLADTTHHRPWT. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes STADTSHHRPS (SEQ ID NO: 10), TSGGESTHHRPS (SEQ ID NO: 11), TSGGESSHHKPS (SEQ ID NO: 12), TGSGDSSHHRPS (SEQ ID NO: 13), and GSSGESTHHKPST (SEQ ID NO: 14). In some embodiments, the β-TCP-binding polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 29) 
               
               
                 STADTSHHRPSTSGGESTHHRPSTSGGESSHHKPSTGSGDSSHHRPSGSS 
               
               
                   
               
               
                 GESTHHKPST. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes VGADSTHHRPVT (SEQ ID NO: 15), GAADTTHHRPVT SEQ ID NO: 16), AGADTTHHRPVT (SEQ ID NO: 17), GGADTTHHRPAT (SEQ ID NO: 18) and GGADTTHHRPGT (SEQ ID NO: 19). In some embodiments, the β-TCP-binding polypeptide includes the sequence of 
     
       
         
           
               
            
               
                 (SEQ ID NO: 30) 
               
               
                 VGADSTHHRPVTGAADTTHHRPVTAGADTTHHRPVTGGADTTHHRPATGG 
               
               
                   
               
               
                 ADTTHHRPGT. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptide includes STADTSHHRPS (SEQ ID NO: 10), LLADTTHHRPWT (SEQ ID NO: 1), TSGGESTHHRPS (SEQ ID NO: 11), VGADSTHHRPVT (SEQ ID NO: 15), TSGGESSHHKPS (SEQ ID NO: 12), GAADTTHHRPVT (SEQ ID NO: 16), TGSGDSSHHRPS (SEQ ID NO: 13), GSSGESTHHKPS (SEQ ID NO: 101), and TGGADTTHHRPAT (SEQ ID NO: 102). In some embodiments, the β-TCP-binding polypeptide includes the sequence of: 
     
       
         
           
               
            
               
                 (SEQ ID NO: 31) 
               
               
                 STADTSHHRPSLLADTTHHRPWTTSGGESTHHRPSVGADSTHHRPVTTSG 
               
               
                   
               
               
                 GESSHHKPSGAADTTHHRPVTTGSGDSSHHRPSGSSGESTHHKPSTGGAD 
               
               
                   
               
               
                 TTHHRPAT. 
               
            
           
         
       
     
     In some embodiments, the β-TCP-binding polypeptides can include two or more (e.g., three or more, four or more, five or more, six or more, seven or more, eight or more, nine or more, ten or more, eleven or more, twelve or more, thirteen or more, fourteen or more, fifteen or more, sixteen or more, seventeen or more, eighteen or more, nineteen or more, or twenty or more; or 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20) copies of any one of SEQ ID NOs: 2-19 or a sequence of Formula I (excluding SEQ ID NO: 1). 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 1 (but excluding SEQ ID NO: 1). 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 2. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 3. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 4. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 5. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 6. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 7. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 8. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 9. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 10. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 11. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 12. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 13. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 14. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 15. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 16. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 17. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 18. 
     In some embodiments, the β-TCP-binding polypeptides can include an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%, or 100%) sequence identity to SEQ ID NO: 19. 
     In some embodiments, the β-TCP-binding polypeptide further comprises a linker sequence (e.g., any of the exemplary linker sequences described herein or known in the art) between a neighboring pair of any of SEQ ID NOs. 2-19 and a sequence of Formula I (excluding SEQ ID NO: 1). In some embodiments, the linker sequence can include the sequence of TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 33). In some embodiments, the linker sequence consists of TGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 33). In some embodiments, the linker sequence includes the sequence of GSGATG (SEQ ID NO: 34). In some embodiments, the linker sequence consists of GSGATG (SEQ ID NO: 34). 
     In some embodiments, where the β-TCP-binding polypeptide comprises two or more or any of SEQ ID Nos. 2-19 and a sequence of Formula I (excluding SEQ ID NO: 1), a linker sequence (e.g., any of the exemplary linker sequences described herein or known in the art) can be between any of the pairs (e.g., all of the pairs) of neighboring sequences selected from the group of SEQ ID NOs: 2-19 and a sequence of Formula I (excluding SEQ ID NO: 1). 
     In some embodiments, the β-TCP-binding polypeptide can include a signal sequence at its N-terminus. In some embodiments, the β-TCP-binding polypeptide can further include a tag sequence (e.g., a poly-His tag, chitin-binding protein (CBP), maltose-binding protein (MBP), strep-tag, glutathione-S-transferase (GST), thioredoxin, or Fc region). Additional examples of tags are known in the art. 
     The β-TCP-binding polypeptides described herein can bind to β-TCP (e.g., any of the types of β-TCP described herein) with a dissociation equilibrium constant (K d ) of about 1 pM to about 100 μM (or any of the subranges of this range described herein) (e.g., as measured using SPR in phosphate buffered saline). 
     In some embodiments, the β-TCP-binding polypeptides described herein can have a total length of about 11 amino acids to about 1400 amino acids, about 11 amino acids to about 1350 amino acids, about 11 amino acids to about 1300 amino acids, about 11 amino acids to about 1250 amino acids, about 11 amino acids to about 1200 amino acids, about 11 amino acids to about 1150 amino acids, about 11 amino acids to about 1100 amino acids, about 11 amino acid to about 1050 amino acids, about 11 amino acids to about 1000 amino acids, about 11 amino acids to about 950 amino acids, about 11 amino acids to about 900 amino acids, about 11 amino acids to about 850 amino acids, about 11 amino acids to about 800 amino acids, about 11 amino acids to about 750 amino acids, about 11 amino acids to about 700 amino acids, about 11 amino acids to about 650 amino acids, about 11 amino acids to about 600 amino acids, about 11 amino acids to about 550 amino acids, about 11 amino acids to about 500 amino acids, about 11 amino acids to about 450 amino acids, about 11 amino acids to about 400 amino acids, about 11 amino acids to about 350 amino acids, about 11 amino acids to about 300 amino acids, about 11 amino acids to about 250 amino acids, about 11 amino acids to about 200 amino acids, about 11 amino acids to about 150 amino acids, about 11 amino acids to about 100 amino acids, about 11 amino acids to about 90 amino acids, about 11 amino acids to about 80 amino acids, about 11 amino acids to about 70 amino acids, about 11 amino acids to about 60 amino acids, about 11 amino acids to about 50 amino acids, about 11 amino acids to about 45 amino acids, about 11 amino acids to about 40 amino acids, about 11 amino acids to about 35 amino acids, about 11 amino acids to about 30 amino acids, about 11 amino acids to about 25 amino acids, about 11 amino acids to about 20 amino acids, about 11 amino acids to about 18 amino acids, about 11 amino acids to about 16 amino acids, about 11 amino acids to about 14 amino acids, about 12 amino acids to about 1400 amino acids, about 12 amino acids to about 1350 amino acids, about 12 amino acids to about 1300 amino acids, about 12 amino acids to about 1250 amino acids, about 12 amino acids to about 1200 amino acids, about 12 amino acids to about 1150 amino acids, about 12 amino acids to about 1100 amino acids, about 12 amino acid to about 1050 amino acids, about 12 amino acids to about 1000 amino acids, about 12 amino acids to about 950 amino acids, about 12 amino acids to about 900 amino acids, about 12 amino acids to about 850 amino acids, about 12 amino acids to about 800 amino acids, about 12 amino acids to about 750 amino acids, about 12 amino acids to about 700 amino acids, about 12 amino acids to about 650 amino acids, about 12 amino acids to about 600 amino acids, about 12 amino acids to about 550 amino acids, about 12 amino acids to about 500 amino acids, about 12 amino acids to about 450 amino acids, about 12 amino acids to about 400 amino acids, about 12 amino acids to about 350 amino acids, about 12 amino acids to about 300 amino acids, about 12 amino acids to about 250 amino acids, about 12 amino acids to about 200 amino acids, about 12 amino acids to about 150 amino acids, about 12 amino acids to about 100 amino acids, about 12 amino acids to about 90 amino acids, about 12 amino acids to about 80 amino acids, about 12 amino acids to about 70 amino acids, about 12 amino acids to about 60 amino acids, about 12 amino acids to about 50 amino acids, about 12 amino acids to about 45 amino acids, about 12 amino acids to about 40 amino acids, about 12 amino acids to about 35 amino acids, about 12 amino acids to about 30 amino acids, about 12 amino acids to about 25 amino acids, about 12 amino acids to about 20 amino acids, about 12 amino acids to about 18 amino acids, about 12 amino acids to about 16 amino acids, about 12 amino acids to about 14 amino acids, about 14 amino acids to about 1400 amino acids, about 14 amino acids to about 1350 amino acids, about 14 amino acids to about 1300 amino acids, about 14 amino acids to about 1250 amino acids, about 14 amino acids to about 1200 amino acids, about 14 amino acids to about 1150 amino acids, about 14 amino acids to about 1100 amino acids, about 14 amino acid to about 1050 amino acids, about 14 amino acids to about 1000 amino acids, about 14 amino acids to about 950 amino acids, about 14 amino acids to about 900 amino acids, about 14 amino acids to about 850 amino acids, about 14 amino acids to about 800 amino acids, about 14 amino acids to about 750 amino acids, about 14 amino acids to about 700 amino acids, about 14 amino acids to about 650 amino acids, about 14 amino acids to about 600 amino acids, about 14 amino acids to about 550 amino acids, about 14 amino acids to about 500 amino acids, about 14 amino acids to about 450 amino acids, about 14 amino acids to about 400 amino acids, about 14 amino acids to about 350 amino acids, about 14 amino acids to about 300 amino acids, about 14 amino acids to about 250 amino acids, about 14 amino acids to about 200 amino acids, about 14 amino acids to about 150 amino acids, about 14 amino acids to about 100 amino acids, about 14 amino acids to about 90 amino acids, about 14 amino acids to about 80 amino acids, about 14 amino acids to about 70 amino acids, about 14 amino acids to about 60 amino acids, about 14 amino acids to about 50 amino acids, about 14 amino acids to about 45 amino acids, about 14 amino acids to about 40 amino acids, about 14 amino acids to about 35 amino acids, about 14 amino acids to about 30 amino acids, about 14 amino acids to about 25 amino acids, about 14 amino acids to about 20 amino acids, about 14 amino acids to about 18 amino acids, about 14 amino acids to about 16 amino acids, about 16 amino acids to about 1400 amino acids, about 16 amino acids to about 1350 amino acids, about 16 amino acids to about 1300 amino acids, about 16 amino acids to about 1250 amino acids, about 16 amino acids to about 1200 amino acids, about 16 amino acids to about 1150 amino acids, about 16 amino acids to about 1100 amino acids, about 16 amino acid to about 1050 amino acids, about 16 amino acids to about 1000 amino acids, about 16 amino acids to about 950 amino acids, about 16 amino acids to about 900 amino acids, about 16 amino acids to about 850 amino acids, about 16 amino acids to about 800 amino acids, about 16 amino acids to about 750 amino acids, about 16 amino acids to about 700 amino acids, about 16 amino acids to about 650 amino acids, about 16 amino acids to about 600 amino acids, about 16 amino acids to about 550 amino acids, about 16 amino acids to about 500 amino acids, about 16 amino acids to about 450 amino acids, about 16 amino acids to about 400 amino acids, about 16 amino acids to about 350 amino acids, about 16 amino acids to about 300 amino acids, about 16 amino acids to about 250 amino acids, about 16 amino acids to about 200 amino acids, about 16 amino acids to about 150 amino acids, about 16 amino acids to about 100 amino acids, about 16 amino acids to about 90 amino acids, about 16 amino acids to about 80 amino acids, about 16 amino acids to about 70 amino acids, about 16 amino acids to about 60 amino acids, about 16 amino acids to about 50 amino acids, about 16 amino acids to about 45 amino acids, about 16 amino acids to about 40 amino acids, about 16 amino acids to about 35 amino acids, about 16 amino acids to about 30 amino acids, about 16 amino acids to about 25 amino acids, about 16 amino acids to about 20 amino acids, about 16 amino acids to about 18 amino acids, about 18 amino acids to about 1400 amino acids, about 18 amino acids to about 1350 amino acids, about 18 amino acids to about 1300 amino acids, about 18 amino acids to about 1250 amino acids, about 18 amino acids to about 1200 amino acids, about 18 amino acids to about 1150 amino acids, about 18 amino acids to about 1100 amino acids, about 18 amino acid to about 1050 amino acids, about 18 amino acids to about 1000 amino acids, about 18 amino acids to about 950 amino acids, about 18 amino acids to about 900 amino acids, about 18 amino acids to about 850 amino acids, about 18 amino acids to about 800 amino acids, about 18 amino acids to about 750 amino acids, about 18 amino acids to about 700 amino acids, about 18 amino acids to about 650 amino acids, about 18 amino acids to about 600 amino acids, about 18 amino acids to about 550 amino acids, about 18 amino acids to about 500 amino acids, about 18 amino acids to about 450 amino acids, about 18 amino acids to about 400 amino acids, about 18 amino acids to about 350 amino acids, about 18 amino acids to about 300 amino acids, about 18 amino acids to about 250 amino acids, about 18 amino acids to about 200 amino acids, about 18 amino acids to about 150 amino acids, about 18 amino acids to about 100 amino acids, about 18 amino acids to about 90 amino acids, about 18 amino acids to about 80 amino acids, about 18 amino acids to about 70 amino acids, about 18 amino acids to about 60 amino acids, about 18 amino acids to about 50 amino acids, about 18 amino acids to about 45 amino acids, about 18 amino acids to about 40 amino acids, about 18 amino acids to about 35 amino acids, about 18 amino acids to about 30 amino acids, about 18 amino acids to about 25 amino acids, about 18 amino acids to about 20 amino acids, about 20 amino acids to about 1400 amino acids, about 20 amino acids to about 1350 amino acids, about 20 amino acids to about 1300 amino acids, about 20 amino acids to about 1250 amino acids, about 20 amino acids to about 1200 amino acids, about 20 amino acids to about 1150 amino acids, about 20 amino acids to about 1100 amino acids, about 20 amino acid to about 1050 amino acids, about 20 amino acids to about 1000 amino acids, about 20 amino acids to about 950 amino acids, about 20 amino acids to about 900 amino acids, about 20 amino acids to about 850 amino acids, about 20 amino acids to about 800 amino acids, about 20 amino acids to about 750 amino acids, about 20 amino acids to about 700 amino acids, about 20 amino acids to about 650 amino acids, about 20 amino acids to about 600 amino acids, about 20 amino acids to about 550 amino acids, about 20 amino acids to about 500 amino acids, about 20 amino acids to about 450 amino acids, about 20 amino acids to about 400 amino acids, about 20 amino acids to about 350 amino acids, about 20 amino acids to about 300 amino acids, about 20 amino acids to about 250 amino acids, about 20 amino acids to about 200 amino acids, about 20 amino acids to about 150 amino acids, about 20 amino acids to about 100 amino acids, about 20 amino acids to about 90 amino acids, about 20 amino acids to about 80 amino acids, about 20 amino acids to about 70 amino acids, about 20 amino acids to about 60 amino acids, about 20 amino acids to about 50 amino acids, about 20 amino acids to about 45 amino acids, about 20 amino acids to about 40 amino acids, about 20 amino acids to about 35 amino acids, about 20 amino acids to about 30 amino acids, about 20 amino acids to about 25 amino acids, about 25 amino acids to about 1400 amino acids, about 25 amino acids to about 1350 amino acids, about 25 amino acids to about 1300 amino acids, about 25 amino acids to about 1250 amino acids, about 25 amino acids to about 1200 amino acids, about 25 amino acids to about 1150 amino acids, about 25 amino acids to about 1100 amino acids, about 25 amino acid to about 1050 amino acids, about 25 amino acids to about 1000 amino acids, about 25 amino acids to about 950 amino acids, about 25 amino acids to about 900 amino acids, about 25 amino acids to about 850 amino acids, about 25 amino acids to about 800 amino acids, about 25 amino acids to about 750 amino acids, about 25 amino acids to about 700 amino acids, about 25 amino acids to about 650 amino acids, about 25 amino acids to about 600 amino acids, about 25 amino acids to about 550 amino acids, about 25 amino acids to about 500 amino acids, about 25 amino acids to about 450 amino acids, about 25 amino acids to about 400 amino acids, about 25 amino acids to about 350 amino acids, about 25 amino acids to about 300 amino acids, about 25 amino acids to about 250 amino acids, about 25 amino acids to about 200 amino acids, about 25 amino acids to about 150 amino acids, about 25 amino acids to about 100 amino acids, about 25 amino acids to about 90 amino acids, about 25 amino acids to about 80 amino acids, about 25 amino acids to about 70 amino acids, about 25 amino acids to about 60 amino acids, about 25 amino acids to about 50 amino acids, about 25 amino acids to about 45 amino acids, about 25 amino acids to about 40 amino acids, about 25 amino acids to about 35 amino acids, about 25 amino acids to about 30 amino acids, about 30 amino acids to about 1400 amino acids, about 30 amino acids to about 1350 amino acids, about 30 amino acids to about 1300 amino acids, about 30 amino acids to about 1250 amino acids, about 30 amino acids to about 1200 amino acids, about 30 amino acids to about 1150 amino acids, about 30 amino acids to about 1100 amino acids, about 30 amino acid to about 1050 amino acids, about 30 amino acids to about 1000 amino acids, about 30 amino acids to about 950 amino acids, about 30 amino acids to about 900 amino acids, about 30 amino acids to about 850 amino acids, about 30 amino acids to about 800 amino acids, about 30 amino acids to about 750 amino acids, about 30 amino acids to about 700 amino acids, about 30 amino acids to about 650 amino acids, about 30 amino acids to about 600 amino acids, about 30 amino acids to about 550 amino acids, about 30 amino acids to about 500 amino acids, about 30 amino acids to about 450 amino acids, about 30 amino acids to about 400 amino acids, about 30 amino acids to about 350 amino acids, about 30 amino acids to about 300 amino acids, about 30 amino acids to about 250 amino acids, about 30 amino acids to about 200 amino acids, about 30 amino acids to about 150 amino acids, about 30 amino acids to about 100 amino acids, about 30 amino acids to about 90 amino acids, about 30 amino acids to about 80 amino acids, about 30 amino acids to about 70 amino acids, about 30 amino acids to about 60 amino acids, about 30 amino acids to about 50 amino acids, about 30 amino acids to about 45 amino acids, about 30 amino acids to about 40 amino acids, about 30 amino acids to about 35 amino acids, about 35 amino acids to about 1400 amino acids, about 35 amino acids to about 1350 amino acids, about 35 amino acids to about 1300 amino acids, about 35 amino acids to about 1250 amino acids, about 35 amino acids to about 1200 amino acids, about 35 amino acids to about 1150 amino acids, about 35 amino acids to about 1100 amino acids, about 35 amino acid to about 1050 amino acids, about 35 amino acids to about 1000 amino acids, about 35 amino acids to about 950 amino acids, about 35 amino acids to about 900 amino acids, about 35 amino acids to about 850 amino acids, about 35 amino acids to about 800 amino acids, about 35 amino acids to about 750 amino acids, about 35 amino acids to about 700 amino acids, about 35 amino acids to about 650 amino acids, about 35 amino acids to about 600 amino acids, about 35 amino acids to about 550 amino acids, about 35 amino acids to about 500 amino acids, about 35 amino acids to about 450 amino acids, about 35 amino acids to about 400 amino acids, about 35 amino acids to about 350 amino acids, about 35 amino acids to about 300 amino acids, about 35 amino acids to about 250 amino acids, about 35 amino acids to about 200 amino acids, about 35 amino acids to about 150 amino acids, about 35 amino acids to about 100 amino acids, about 35 amino acids to about 90 amino acids, about 35 amino acids to about 80 amino acids, about 35 amino acids to about 70 amino acids, about 35 amino acids to about 60 amino acids, about 35 amino acids to about 50 amino acids, about 35 amino acids to about 45 amino acids, about 35 amino acids to about 40 amino acids, about 40 amino acids to about 1400 amino acids, about 40 amino acids to about 1350 amino acids, about 40 amino acids to about 1300 amino acids, about 40 amino acids to about 1250 amino acids, about 40 amino acids to about 1200 amino acids, about 40 amino acids to about 1150 amino acids, about 40 amino acids to about 1100 amino acids, about 40 amino acid to about 1050 amino acids, about 40 amino acids to about 1000 amino acids, about 40 amino acids to about 950 amino acids, about 40 amino acids to about 900 amino acids, about 40 amino acids to about 850 amino acids, about 40 amino acids to about 800 amino acids, about 40 amino acids to about 750 amino acids, about 40 amino acids to about 700 amino acids, about 40 amino acids to about 650 amino acids, about 40 amino acids to about 600 amino acids, about 40 amino acids to about 550 amino acids, about 40 amino acids to about 500 amino acids, about 40 amino acids to about 450 amino acids, about 40 amino acids to about 400 amino acids, about 40 amino acids to about 350 amino acids, about 40 amino acids to about 300 amino acids, about 40 amino acids to about 250 amino acids, about 40 amino acids to about 200 amino acids, about 40 amino acids to about 150 amino acids, about 40 amino acids to about 100 amino acids, about 40 amino acids to about 90 amino acids, about 40 amino acids to about 80 amino acids, about 40 amino acids to about 70 amino acids, about 40 amino acids to about 60 amino acids, about 40 amino acids to about 50 amino acids, about 40 amino acids to about 45 amino acids, about 45 amino acids to about 1400 amino acids, about 45 amino acids to about 1350 amino acids, about 45 amino acids to about 1300 amino acids, about 45 amino acids to about 1250 amino acids, about 45 amino acids to about 1200 amino acids, about 45 amino acids to about 1150 amino acids, about 45 amino acids to about 1100 amino acids, about 45 amino acid to about 1050 amino acids, about 45 amino acids to about 1000 amino acids, about 45 amino acids to about 950 amino acids, about 45 amino acids to about 900 amino acids, about 45 amino acids to about 850 amino acids, about 45 amino acids to about 800 amino acids, about 45 amino acids to about 750 amino acids, about 45 amino acids to about 700 amino acids, about 45 amino acids to about 650 amino acids, about 45 amino acids to about 600 amino acids, about 45 amino acids to about 550 amino acids, about 45 amino acids to about 500 amino acids, about 45 amino acids to about 450 amino acids, about 45 amino acids to about 400 amino acids, about 45 amino acids to about 350 amino acids, about 45 amino acids to about 300 amino acids, about 45 amino acids to about 250 amino acids, about 45 amino acids to about 200 amino acids, about 45 amino acids to about 150 amino acids, about 45 amino acids to about 100 amino acids, about 45 amino acids to about 90 amino acids, about 45 amino acids to about 80 amino acids, about 45 amino acids to about 70 amino acids, about 45 amino acids to about 60 amino acids, about 45 amino acids to about 50 amino acids, about 50 amino acids to about 1400 amino acids, about 50 amino acids to about 1350 amino acids, about 50 amino acids to about 1300 amino acids, about 50 amino acids to about 1250 amino acids, about 50 amino acids to about 1200 amino acids, about 50 amino acids to about 1150 amino acids, about 50 amino acids to about 1100 amino acids, about 50 amino acid to about 1050 amino acids, about 50 amino acids to about 1000 amino acids, about 50 amino acids to about 950 amino acids, about 50 amino acids to about 900 amino acids, about 50 amino acids to about 850 amino acids, about 50 amino acids to about 800 amino acids, about 50 amino acids to about 750 amino acids, about 50 amino acids to about 700 amino acids, about 50 amino acids to about 650 amino acids, about 50 amino acids to about 600 amino acids, about 50 amino acids to about 550 amino acids, about 50 amino acids to about 500 amino acids, about 50 amino acids to about 450 amino acids, about 50 amino acids to about 400 amino acids, about 50 amino acids to about 350 amino acids, about 50 amino acids to about 300 amino acids, about 50 amino acids to about 250 amino acids, about 50 amino acids to about 200 amino acids, about 50 amino acids to about 150 amino acids, about 50 amino acids to about 100 amino acids, about 50 amino acids to about 90 amino acids, about 50 amino acids to about 80 amino acids, about 50 amino acids to about 70 amino acids, about 50 amino acids to about 60 amino acids, about 60 amino acids to about 1400 amino acids, about 60 amino acids to about 1350 amino acids, about 60 amino acids to about 1300 amino acids, about 60 amino acids to about 1250 amino acids, about 60 amino acids to about 1200 amino acids, about 60 amino acids to about 1150 amino acids, about 60 amino acids to about 1100 amino acids, about 60 amino acid to about 1050 amino acids, about 60 amino acids to about 1000 amino acids, about 60 amino acids to about 950 amino acids, about 60 amino acids to about 900 amino acids, about 60 amino acids to about 850 amino acids, about 60 amino acids to about 800 amino acids, about 60 amino acids to about 750 amino acids, about 60 amino acids to about 700 amino acids, about 60 amino acids to about 650 amino acids, about 60 amino acids to about 600 amino acids, about 60 amino acids to about 550 amino acids, about 60 amino acids to about 500 amino acids, about 60 amino acids to about 450 amino acids, about 60 amino acids to about 400 amino acids, about 60 amino acids to about 350 amino acids, about 60 amino acids to about 300 amino acids, about 60 amino acids to about 250 amino acids, about 60 amino acids to about 200 amino acids, about 60 amino acids to about 150 amino acids, about 60 amino acids to about 100 amino acids, about 60 amino acids to about 90 amino acids, about 60 amino acids to about 80 amino acids, about 60 amino acids to about 70 amino acids, about 70 amino acids to about 1400 amino acids, about 70 amino acids to about 1350 amino acids, about 70 amino acids to about 1300 amino acids, about 70 amino acids to about 1250 amino acids, about 70 amino acids to about 1200 amino acids, about 70 amino acids to about 1150 amino acids, about 70 amino acids to about 1100 amino acids, about 70 amino acid to about 1050 amino acids, about 70 amino acids to about 1000 amino acids, about 70 amino acids to about 950 amino acids, about 70 amino acids to about 900 amino acids, about 70 amino acids to about 850 amino acids, about 70 amino acids to about 800 amino acids, about 70 amino acids to about 750 amino acids, about 70 amino acids to about 700 amino acids, about 70 amino acids to about 650 amino acids, about 70 amino acids to about 600 amino acids, about 70 amino acids to about 550 amino acids, about 70 amino acids to about 500 amino acids, about 70 amino acids to about 450 amino acids, about 70 amino acids to about 400 amino acids, about 70 amino acids to about 350 amino acids, about 70 amino acids to about 300 amino acids, about 70 amino acids to about 250 amino acids, about 70 amino acids to about 200 amino acids, about 70 amino acids to about 150 amino acids, about 70 amino acids to about 100 amino acids, about 70 amino acids to about 90 amino acids, about 70 amino acids to about 80 amino acids, about 80 amino acids to about 1400 amino acids, about 80 amino acids to about 1350 amino acids, about 80 amino acids to about 1300 amino acids, about 80 amino acids to about 1250 amino acids, about 80 amino acids to about 1200 amino acids, about 80 amino acids to about 1150 amino acids, about 80 amino acids to about 1100 amino acids, about 80 amino acid to about 1050 amino acids, about 80 amino acids to about 1000 amino acids, about 80 amino acids to about 950 amino acids, about 80 amino acids to about 900 amino acids, about 80 amino acids to about 850 amino acids, about 80 amino acids to about 800 amino acids, about 80 amino acids to about 750 amino acids, about 80 amino acids to about 700 amino acids, about 80 amino acids to about 650 amino acids, about 80 amino acids to about 600 amino acids, about 80 amino acids to about 550 amino acids, about 80 amino acids to about 500 amino acids, about 80 amino acids to about 450 amino acids, about 80 amino acids to about 400 amino acids, about 80 amino acids to about 350 amino acids, about 80 amino acids to about 300 amino acids, about 80 amino acids to about 250 amino acids, about 80 amino acids to about 200 amino acids, about 80 amino acids to about 150 amino acids, about 80 amino acids to about 100 amino acids, about 80 amino acids to about 90 amino acids, about 90 amino acids to about 1400 amino acids, about 90 amino acids to about 1350 amino acids, about 90 amino acids to about 1300 amino acids, about 90 amino acids to about 1250 amino acids, about 90 amino acids to about 1200 amino acids, about 90 amino acids to about 1150 amino acids, about 90 amino acids to about 1100 amino acids, about 90 amino acid to about 1050 amino acids, about 90 amino acids to about 1000 amino acids, about 90 amino acids to about 950 amino acids, about 90 amino acids to about 900 amino acids, about 90 amino acids to about 850 amino acids, about 90 amino acids to about 800 amino acids, about 90 amino acids to about 750 amino acids, about 90 amino acids to about 700 amino acids, about 90 amino acids to about 650 amino acids, about 90 amino acids to about 600 amino acids, about 90 amino acids to about 550 amino acids, about 90 amino acids to about 500 amino acids, about 90 amino acids to about 450 amino acids, about 90 amino acids to about 400 amino acids, about 90 amino acids to about 350 amino acids, about 90 amino acids to about 300 amino acids, about 90 amino acids to about 250 amino acids, about 90 amino acids to about 200 amino acids, about 90 amino acids to about 150 amino acids, about 90 amino acids to about 100 amino acids, about 100 amino acids to about 1400 amino acids, about 100 amino acids to about 1350 amino acids, about 100 amino acids to about 1300 amino acids, about 100 amino acids to about 1250 amino acids, about 100 amino acids to about 1200 amino acids, about 100 amino acids to about 1150 amino acids, about 100 amino acids to about 1100 amino acids, about 100 amino acid to about 1050 amino acids, about 100 amino acids to about 1000 amino acids, about 100 amino acids to about 950 amino acids, about 100 amino acids to about 900 amino acids, about 100 amino acids to about 850 amino acids, about 100 amino acids to about 800 amino acids, about 100 amino acids to about 750 amino acids, about 100 amino acids to about 700 amino acids, about 100 amino acids to about 650 amino acids, about 100 amino acids to about 600 amino acids, about 100 amino acids to about 550 amino acids, about 100 amino acids to about 500 amino acids, about 100 amino acids to about 450 amino acids, about 100 amino acids to about 400 amino acids, about 100 amino acids to about 350 amino acids, about 100 amino acids to about 300 amino acids, about 100 amino acids to about 250 amino acids, about 100 amino acids to about 200 amino acids, about 100 amino acids to about 150 amino acids, about 150 amino acids to about 1400 amino acids, about 150 amino acids to about 1350 amino acids, about 150 amino acids to about 1300 amino acids, about 150 amino acids to about 1250 amino acids, about 150 amino acids to about 1200 amino acids, about 150 amino acids to about 1150 amino acids, about 150 amino acids to about 1100 amino acids, about 150 amino acid to about 1050 amino acids, about 150 amino acids to about 1000 amino acids, about 150 amino acids to about 950 amino acids, about 150 amino acids to about 900 amino acids, about 150 amino acids to about 850 amino acids, about 150 amino acids to about 800 amino acids, about 150 amino acids to about 750 amino acids, about 150 amino acids to about 700 amino acids, about 150 amino acids to about 650 amino acids, about 150 amino acids to about 600 amino acids, about 150 amino acids to about 550 amino acids, about 150 amino acids to about 500 amino acids, about 150 amino acids to about 450 amino acids, about 150 amino acids to about 400 amino acids, about 150 amino acids to about 350 amino acids, about 150 amino acids to about 300 amino acids, about 150 amino acids to about 250 amino acids, about 150 amino acids to about 200 amino acids, about 200 amino acids to about 1400 amino acids, about 200 amino acids to about 1350 amino acids, about 200 amino acids to about 1300 amino acids, about 200 amino acids to about 1250 amino acids, about 200 amino acids to about 1200 amino acids, about 200 amino acids to about 1150 amino acids, about 200 amino acids to about 1100 amino acids, about 200 amino acid to about 1050 amino acids, about 200 amino acids to about 1000 amino acids, about 200 amino acids to about 950 amino acids, about 200 amino acids to about 900 amino acids, about 200 amino acids to about 850 amino acids, about 200 amino acids to about 800 amino acids, about 200 amino acids to about 750 amino acids, about 200 amino acids to about 700 amino acids, about 200 amino acids to about 650 amino acids, about 200 amino acids to about 600 amino acids, about 200 amino acids to about 550 amino acids, about 200 amino acids to about 500 amino acids, about 200 amino acids to about 450 amino acids, about 200 amino acids to about 400 amino acids, about 200 amino acids to about 350 amino acids, about 200 amino acids to about 300 amino acids, about 200 amino acids to about 250 amino acids, about 250 amino acids to about 1400 amino acids, about 250 amino acids to about 1350 amino acids, about 250 amino acids to about 1300 amino acids, about 250 amino acids to about 1250 amino acids, about 250 amino acids to about 1200 amino acids, about 250 amino acids to about 1150 amino acids, about 250 amino acids to about 1100 amino acids, about 250 amino acid to about 1050 amino acids, about 250 amino acids to about 1000 amino acids, about 250 amino acids to about 950 amino acids, about 250 amino acids to about 900 amino acids, about 250 amino acids to about 850 amino acids, about 250 amino acids to about 800 amino acids, about 250 amino acids to about 750 amino acids, about 250 amino acids to about 700 amino acids, about 250 amino acids to about 650 amino acids, about 250 amino acids to about 600 amino acids, about 250 amino acids to about 550 amino acids, about 250 amino acids to about 500 amino acids, about 250 amino acids to about 450 amino acids, about 250 amino acids to about 400 amino acids, about 250 amino acids to about 350 amino acids, about 250 amino acids to about 300 amino acids, about 300 amino acids to about 1400 amino acids, about 300 amino acids to about 1350 amino acids, about 300 amino acids to about 1300 amino acids, about 300 amino acids to about 1250 amino acids, about 300 amino acids to about 1200 amino acids, about 300 amino acids to about 1150 amino acids, about 300 amino acids to about 1100 amino acids, about 300 amino acid to about 1050 amino acids, about 300 amino acids to about 1000 amino acids, about 300 amino acids to about 950 amino acids, about 300 amino acids to about 900 amino acids, about 300 amino acids to about 850 amino acids, about 300 amino acids to about 800 amino acids, about 300 amino acids to about 750 amino acids, about 300 amino acids to about 700 amino acids, about 300 amino acids to about 650 amino acids, about 300 amino acids to about 600 amino acids, about 300 amino acids to about 550 amino acids, about 300 amino acids to about 500 amino acids, about 300 amino acids to about 450 amino acids, about 300 amino acids to about 400 amino acids, about 300 amino acids to about 350 amino acids, about 350 amino acids to about 1400 amino acids, about 350 amino acids to about 1350 amino acids, about 350 amino acids to about 1300 amino acids, about 350 amino acids to about 1250 amino acids, about 350 amino acids to about 1200 amino acids, about 350 amino acids to about 1150 amino acids, about 350 amino acids to about 1100 amino acids, about 350 amino acid to about 1050 amino acids, about 350 amino acids to about 1000 amino acids, about 350 amino acids to about 950 amino acids, about 350 amino acids to about 900 amino acids, about 350 amino acids to about 850 amino acids, about 350 amino acids to about 800 amino acids, about 350 amino acids to about 750 amino acids, about 350 amino acids to about 700 amino acids, about 350 amino acids to about 650 amino acids, about 350 amino acids to about 600 amino acids, about 350 amino acids to about 550 amino acids, about 350 amino acids to about 500 amino acids, about 350 amino acids to about 450 amino acids, about 350 amino acids to about 400 amino acids, about 400 amino acids to about 1400 amino acids, about 400 amino acids to about 1350 amino acids, about 400 amino acids to about 1300 amino acids, about 400 amino acids to about 1250 amino acids, about 400 amino acids to about 1200 amino acids, about 400 amino acids to about 1150 amino acids, about 400 amino acids to about 1100 amino acids, about 400 amino acid to about 1050 amino acids, about 400 amino acids to about 1000 amino acids, about 400 amino acids to about 950 amino acids, about 400 amino acids to about 900 amino acids, about 400 amino acids to about 850 amino acids, about 400 amino acids to about 800 amino acids, about 400 amino acids to about 750 amino acids, about 400 amino acids to about 700 amino acids, about 400 amino acids to about 650 amino acids, about 400 amino acids to about 600 amino acids, about 400 amino acids to about 550 amino acids, about 400 amino acids to about 500 amino acids, about 400 amino acids to about 450 amino acids, about 450 amino acids to about 1400 amino acids, about 450 amino acids to about 1350 amino acids, about 450 amino acids to about 1300 amino acids, about 450 amino acids to about 1250 amino acids, about 450 amino acids to about 1200 amino acids, about 450 amino acids to about 1150 amino acids, about 450 amino acids to about 1100 amino acids, about 450 amino acid to about 1050 amino acids, about 450 amino acids to about 1000 amino acids, about 450 amino acids to about 950 amino acids, about 450 amino acids to about 900 amino acids, about 450 amino acids to about 850 amino acids, about 450 amino acids to about 800 amino acids, about 450 amino acids to about 750 amino acids, about 450 amino acids to about 700 amino acids, about 450 amino acids to about 650 amino acids, about 450 amino acids to about 600 amino acids, about 450 amino acids to about 550 amino acids, about 450 amino acids to about 500 amino acids, about 500 amino acids to about 1400 amino acids, about 500 amino acids to about 1350 amino acids, about 500 amino acids to about 1300 amino acids, about 500 amino acids to about 1250 amino acids, about 500 amino acids to about 1200 amino acids, about 500 amino acids to about 1150 amino acids, about 500 amino acids to about 1100 amino acids, about 500 amino acid to about 1050 amino acids, about 500 amino acids to about 1000 amino acids, about 500 amino acids to about 950 amino acids, about 500 amino acids to about 900 amino acids, about 500 amino acids to about 850 amino acids, about 500 amino acids to about 800 amino acids, about 500 amino acids to about 750 amino acids, about 500 amino acids to about 700 amino acids, about 500 amino acids to about 650 amino acids, about 500 amino acids to about 600 amino acids, about 500 amino acids to about 550 amino acids, about 550 amino acids to about 1400 amino acids, about 550 amino acids to about 1350 amino acids, about 550 amino acids to about 1300 amino acids, about 550 amino acids to about 1250 amino acids, about 550 amino acids to about 1200 amino acids, about 550 amino acids to about 1150 amino acids, about 550 amino acids to about 1100 amino acids, about 550 amino acid to about 1050 amino acids, about 550 amino acids to about 1000 amino acids, about 550 amino acids to about 950 amino acids, about 550 amino acids to about 900 amino acids, about 550 amino acids to about 850 amino acids, about 550 amino acids to about 800 amino acids, about 550 amino acids to about 750 amino acids, about 550 amino acids to about 700 amino acids, about 550 amino acids to about 650 amino acids, about 550 amino acids to about 600 amino acids, about 600 amino acids to about 1400 amino acids, about 600 amino acids to about 1350 amino acids, about 600 amino acids to about 1300 amino acids, about 600 amino acids to about 1250 amino acids, about 600 amino acids to about 1200 amino acids, about 600 amino acids to about 1150 amino acids, about 600 amino acids to about 1100 amino acids, about 600 amino acid to about 1050 amino acids, about 600 amino acids to about 1000 amino acids, about 600 amino acids to about 950 amino acids, about 600 amino acids to about 900 amino acids, about 600 amino acids to about 850 amino acids, about 600 amino acids to about 800 amino acids, about 600 amino acids to about 750 amino acids, about 600 amino acids to about 700 amino acids, about 600 amino acids to about 650 amino acids, about 650 amino acids to about 1400 amino acids, about 650 amino acids to about 1350 amino acids, about 650 amino acids to about 1300 amino acids, about 650 amino acids to about 1250 amino acids, about 650 amino acids to about 1200 amino acids, about 650 amino acids to about 1150 amino acids, about 650 amino acids to about 1100 amino acids, about 650 amino acid to about 1050 amino acids, about 650 amino acids to about 1000 amino acids, about 650 amino acids to about 950 amino acids, about 650 amino acids to about 900 amino acids, about 650 amino acids to about 850 amino acids, about 650 amino acids to about 800 amino acids, about 650 amino acids to about 750 amino acids, about 650 amino acids to about 700 amino acids, about 700 amino acids to about 1400 amino acids, about 700 amino acids to about 1350 amino acids, about 700 amino acids to about 1300 amino acids, about 700 amino acids to about 1250 amino acids, about 700 amino acids to about 1200 amino acids, about 700 amino acids to about 1150 amino acids, about 700 amino acids to about 1100 amino acids, about 700 amino acid to about 1050 amino acids, about 700 amino acids to about 1000 amino acids, about 700 amino acids to about 950 amino acids, about 700 amino acids to about 900 amino acids, about 700 amino acids to about 850 amino acids, about 700 amino acids to about 800 amino acids, about 700 amino acids to about 750 amino acids, about 750 amino acids to about 1400 amino acids, about 750 amino acids to about 1350 amino acids, about 750 amino acids to about 1300 amino acids, about 750 amino acids to about 1250 amino acids, about 750 amino acids to about 1200 amino acids, about 750 amino acids to about 1150 amino acids, about 750 amino acids to about 1100 amino acids, about 750 amino acid to about 1050 amino acids, about 750 amino acids to about 1000 amino acids, about 750 amino acids to about 950 amino acids, about 750 amino acids to about 900 amino acids, about 750 amino acids to about 850 amino acids, about 750 amino acids to about 800 amino acids, about 800 amino acids to about 1400 amino acids, about 800 amino acids to about 1350 amino acids, about 800 amino acids to about 1300 amino acids, about 800 amino acids to about 1250 amino acids, about 800 amino acids to about 1200 amino acids, about 800 amino acids to about 1150 amino acids, about 800 amino acids to about 1100 amino acids, about 800 amino acid to about 1050 amino acids, about 800 amino acids to about 1000 amino acids, about 800 amino acids to about 950 amino acids, about 800 amino acids to about 900 amino acids, about 800 amino acids to about 850 amino acids, about 850 amino acids to about 1400 amino acids, about 850 amino acids to about 1350 amino acids, about 850 amino acids to about 1300 amino acids, about 850 amino acids to about 1250 amino acids, about 850 amino acids to about 1200 amino acids, about 850 amino acids to about 1150 amino acids, about 850 amino acids to about 1100 amino acids, about 850 amino acid to about 1050 amino acids, about 850 amino acids to about 1000 amino acids, about 850 amino acids to about 950 amino acids, about 850 amino acids to about 900 amino acids, about 900 amino acids to about 1400 amino acids, about 900 amino acids to about 1350 amino acids, about 900 amino acids to about 1300 amino acids, about 900 amino acids to about 1250 amino acids, about 900 amino acids to about 1200 amino acids, about 900 amino acids to about 1150 amino acids, about 900 amino acids to about 1100 amino acids, about 900 amino acid to about 1050 amino acids, about 900 amino acids to about 1000 amino acids, about 900 amino acids to about 950 amino acids, about 950 amino acids to about 1400 amino acids, about 950 amino acids to about 1350 amino acids, about 950 amino acids to about 1300 amino acids, about 950 amino acids to about 1250 amino acids, about 950 amino acids to about 1200 amino acids, about 950 amino acids to about 1150 amino acids, about 950 amino acids to about 1100 amino acids, about 950 amino acid to about 1050 amino acids, about 950 amino acids to about 1000 amino acids, about 1000 amino acids to about 1400 amino acids, about 1000 amino acids to about 1350 amino acids, about 1000 amino acids to about 1300 amino acids, about 1000 amino acids to about 1250 amino acids, about 1000 amino acids to about 1200 amino acids, about 1000 amino acids to about 1150 amino acids, about 1000 amino acids to about 1100 amino acids, about 1000 amino acid to about 1050 amino acids, about 1050 amino acids to about 1400 amino acids, about 1050 amino acids to about 1350 amino acids, about 1050 amino acids to about 1300 amino acids, about 1050 amino acids to about 1250 amino acids, about 1050 amino acids to about 1200 amino acids, about 1050 amino acids to about 1150 amino acids, about 1050 amino acids to about 1100 amino acids, about 1100 amino acids to about 1400 amino acids, about 1100 amino acids to about 1350 amino acids, about 1100 amino acids to about 1300 amino acids, about 1100 amino acids to about 1250 amino acids, about 1100 amino acids to about 1200 amino acids, about 1100 amino acids to about 1150 amino acids, about 1150 amino acids to about 1400 amino acids, about 1150 amino acids to about 1350 amino acids, about 1150 amino acids to about 1300 amino acids, about 1150 amino acids to about 1250 amino acids, about 1150 amino acids to about 1200 amino acids, about 1200 amino acids to about 1400 amino acids, about 1200 amino acids to about 1350 amino acids, about 1200 amino acids to about 1300 amino acids, about 1200 amino acids to about 1250 amino acids, about 1250 amino acids to about 1400 amino acids, about 1250 amino acids to about 1350 amino acids, about 1250 amino acids to about 1300 amino acids, about 1300 amino acids to about 1400 amino acids, about 1300 amino acids to about 1350 amino acids, or about 1350 amino acids to about 1400 amino acids. 
     For example, the β-TCP-binding polypeptide can include the amino acid sequence of LLADTTHHRPWTVIGESTHHRPWSIIGESSHHKPFTGLGDTTHERPWGILAESTHHKPWT ATGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 44). In some instances the β-TCP-binding polypeptide includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%) sequence identity to SEQ ID NO: 44. 
     For example, the β-TCP-binding polypeptide may include: LLADTTHERPWTGLGDTTHHRPWGLLADTTHHRPWTGLGDTTHHRPWGLLADTTHHR PWTTGGSGEGGTGASTGGSAGTGGSGGTTSGEAGGSSGAG (SEQ ID NO: 45). In some instances the β-TCP-binding polypeptide includes an amino acid sequence that has at least 70% (e.g., at least 75%, at least 80%, at least 85%, at least 90%, at least 95%, at least 96%, at least 97%, at least 98%, at least 99%) sequence identity to SEQ ID NO: 45. 
     A variety of different methods known in the art can be used to determine the K D  values of any of the β-TCP-binding polypeptides described herein for binding to β-TCP (e.g., any of the types of β-TCP described herein) (e.g., an electrophoretic mobility shift assay, a filter binding assay, surface plasmon resonance, and a biomolecular binding kinetics assay, etc.) 
     Nucleic Acids/Vectors 
     Also provided herein are nucleic acids that encode any of the chimeric polypeptides or (3-TCP-binding polypeptides described herein. 
     Also provided herein are vectors that include any of the nucleic acids provided herein. A “vector” according to the present disclosure is a polynucleotide capable of inducing the expression of a recombinant protein (e.g., any of the chimeric polypeptides or β-TCP-binding polypeptides described) in a host cell. A vector provided herein can be, e.g., in circular or linearized form. Non-limiting examples of vectors include plasmids, SV40 vectors, adenoviral viral vectors, and adeno-associated virus (AAV) vectors. Non-limiting examples of vectors include lentiviral vectors or retroviral vectors, e.g., gamma-retroviral vectors. See, e.g., Carlens et al.,  Exp. Hematol.  28(10:1137-1146, 2000; Park et al.,  Trends Biotechnol.  29(11):550-557, 2011; and Alonso-Camino et al.,  Mol. Ther. Nucleic Acids  2:e93, 2013. Non-limiting examples of retroviral vectors include those derived from Moloney murine leukemia virus, myeloproliferative sarcoma virus, murine embryonic stem cell virus, murine stem cell virus, spleen focus forming virus, or adeno-associated virus. Non-limiting examples of retroviral vectors are described in, e.g., U.S. Pat. Nos. 5,219,740 and 6,207,453; Miller et al.,  BioTechniques  7:980-990, 1989; Miller,  Human Gene Therapy  1:5-14, 1990; Scarpa et al.,  Virology  180:849-852, 1991; Burns et al.,  Proc. Natl. Acad. Sci. U.S.A.  90:8033-8037, 1993; and Boris-Lawrie et al.,  Cur. Opin. Genet. Develop.  3:102-109, 1993. Exemplary lentiviral vectors are described in, e.g., Wang et al.,  J. Immunother.  35(9):689-701, 2003; Cooper et al.,  Blood  101:1637-1644, 2003; Verhoeyen et al.,  Methods Mol. Biol.  506:97-114, 2009; and Cavalieri et al.,  Blood  102(2):497-505, 2003. 
     Exemplary vectors, in which any of the nucleic acids provided herein can be inserted, are described in, e.g., Ausubel et al., Eds. “Current Protocols in Molecular Biology” Current Protocols, 1993; and Sambrook et al., Eds. “Molecular Cloning: A Laboratory Manual,” 2nd ed., Cold Spring Harbor Press, 1989. 
     In some embodiments, the vectors further include a promoter and/or enhancer operably linked to any of the nucleic acids described herein. Non-limiting examples of promoters include promoters from human cytomegalovirus (CMV), mouse phosphoglycerate kinase 1, polyoma adenovirus, thyroid stimulating hormone α, vimentin, simian virus 40 (SV40), tumor necrosis factor, β-globin, α-fetoprotein, γ-globin, β-interferon, γ-glutamyl transferase, human ubiquitin C (UBC), mouse mammary tumor virus (MMTV), Rous sarcoma virus, glyceraldehyde-3-phosphate dehydrogenase, β-actin, metallothionein II (MT II), amylase, human EF1α, cathepsin, MI muscarinic receptor, retroviral LTR (e.g. human T-cell leukemia virus HTLV), AAV ITR, interleukin-2, collagenase, platelet-derived growth factor, adenovirus E2, stromelysin, murine MX, rat insulin, glucose regulated protein 78, human immunodeficiency virus, glucose regulated protein 94, α-2-macroglobulin, MEW class I, HSP70, proliferin, immunoglobulin light chain, T-cell receptor, HLA DQα, HLA DQβ, interleukin-2 receptor, MHC class II, prealbumin (transthyretin), elastase I, albumin, c-fos, neural cell adhesion molecule (NCAM), H2B histone, rat growth hormone, human serum amyloid (SAA), muscle creatinine kinase, troponin I (TN I), and Gibbon Ape Leukemia Virus (GALV). In some embodiments, the promoter may be an inducible promoter or a constitutive promoter. Additional examples of promoters are known in the art. 
     In some examples, the vectors provided herein further include a poly(A) sequence, which is operably linked and positioned 3′ to the sequence encoding the chimeric polypeptide or β-TCP-binding polypeptide. Non-limiting examples of a poly(A) sequence include those derived from bovine growth hormone (Woychik et al.,  Proc. Natl. Acad. Sci. U.S.A.  81(13): 3944-3948, 1984, and U.S. Pat. No. 5,122,458), mouse-β-globin, mouse-α-globin (Orkin et al.,  EMBO J.  4(2): 453-456, 1985), human collagen, polyoma virus (Batt et al.,  Mol. Cell Biol.  15(9):4783-4790, 1995), the Herpes simplex virus thymidine kinase gene (HSV TK), IgG heavy chain gene polyadenylation signal (U.S. Patent Application Publication No. 2006/0040354), human growth hormone (hGH) (Szymanski et al.,  Mol. Therapy  15(7):1340-1347, 2007), SV40 poly(A) site, e.g., SV40 late and early poly(A) site (Schek et al.,  Mol. Cell Biol.  12(12):5386-5393, 1992). In some embodiments, the poly(A) sequence includes a highly conserved upstream element (AATAAA). The this AATAAA sequence can, e.g., be substituted with other hexanucleotide sequences with homology to AATAAA which are capable of signaling polyadenylation, including, e.g., ATTAAA, AGTAAA, CATAAA, TATAAA, GATAAA, ACTAAA, AATATA, AAGAAA, AATAAT, AAAAAA, AATGAA, AATCAA, AACAAA, AATCAA, AATAAC, AATAGA, AATTAA, and AATAAG. See, e.g., WO 06012414 A2). A poly(A) sequence can, e.g., be a synthetic polyadenylation site. See, e.g., Levitt el al,  Genes Dev.  3(7): 1019-1025, 1989). In some examples, a poly(A) sequence can be the polyadenylation signal of soluble neuropilin-1: AAATAAAATACGAAATG (SEQ ID NO:111). Additional examples of poly(A) sequences are known in the art. Additional examples and aspects of vectors are also known in the art. 
     Methods of Making a Chimeric Polypeptide 
     Also provided herein are methods of making a chimeric polypeptide (e.g., any of the chimeric polypeptides described herein) or a β-TCP-binding polypeptide (e.g., any of the β-TCP-binding polypeptides described herein) that include: introducing into a cell a nucleic acid sequence encoding the chimeric polypeptide or the β-TCP-binding polypeptide to produce a recombinant cell; and culturing the recombinant cell under conditions sufficient for the expression of the chimeric polypeptide or β-TCP-binding polypeptide. In some embodiments, the introducing step includes introducing into a cell an expression vector including a nucleic acid sequence encoding the chimeric polypeptide or the β-TCP-binding polypeptide to produce a recombinant cell. In some embodiments, the expression vector includes chaperones (e.g., GroES, GroEL) and glutathione to aid with in vitro folding. 
     A chimeric polypeptide or β-TCP-binding polypeptide described herein can be produced by any cell, e.g., a eukaryotic cell or a prokaryotic cell. As used herein, the term “eukaryotic cell” refers to a cell having a distinct, membrane-bound nucleus. Such cells may include, for example, mammalian (e.g., rodent, non-human primate, or human), insect, fungal, or plant cells. In some embodiments, the eukaryotic cell is a yeast cell, such as  Saccharomyces cerevisiae . In some embodiments, the eukaryotic cell is a higher eukaryote, such as mammalian, avian, plant, or insect cells. In some embodiments, the eukaryotic cell is a mammalian cell (e.g., a Chinese Hamster Ovary (CHO) cell). As used herein, the term “prokaryotic cell” refers to a cell that does not have a distinct, membrane-bound nucleus. In some embodiments, the prokaryotic cell is a bacterial cell. In some embodiments, the bacterial cell is a chemically competent  E. coli  K12 cell (e.g., Shuffle® T7; New England BioLabs) or a BL21(DE3) pLysS chemically competent  E. coli  cell. 
     Methods of culturing cells are well known in the art. Cells can be maintained in vitro under conditions that favor proliferation, differentiation, and growth. Briefly, cells can be cultured by contacting a cell (e.g., any cell) with a cell culture medium that includes the necessary growth factors and supplements to support cell viability and growth. 
     Methods of introducing nucleic acids and expression vectors into a cell (e.g., a eukaryotic cell) are known in the art. Non-limiting examples of methods that can be used to introduce a nucleic acid into a cell include lipofection, transfection, electroporation, microinjection, calcium phosphate transfection, dendrimer-based transfection, cationic polymer transfection, cell squeezing, sonoporation, optical transfection, impalection, hydrodynamic delivery, magnetofection, viral transduction (e.g., adenoviral and lentiviral transduction), and nanoparticle transfection. 
     Provided herein are methods that further include isolation of the chimeric polypeptide or the β-TCP-binding polypeptide from a cell (e.g., a eukaryotic cell) using techniques well-known in the art (e.g., ammonium sulfate precipitation, polyethylene glycol precipitation, cobalt column, heparin column, ion-exchange chromatography (anion or cation), chromatography based on hydrophobic interaction, metal-affinity chromatography, ligand-affinity chromatography, and size exclusion chromatography). 
     In some embodiments, a hydrophobicity/hydrophilicity plot is constructed to determine variant β-TCP binding sequences that can be included in any of the chimeric polypeptides described herein. 
     β-TCP 
     Sintering of tricalcium phosphate, Ca 3 (PO 4 ) 2 , causes its structure to convert to β-TCP. β-TCP is an osteoconductive material that supports bone mineralization by easily dissolving at low pH and serves as a rigid substrate for cell attachment (see, e.g., Muschler et al.,  J. Bone Joint Surgery  86:1541-1558, 2004; Fleming Jr. et al., “Intraoperative Harvest and Concentration of Human Bone Marrow Osteoprogenitors for Enhancement of Spinal Fusion,” in Orthopedic Tissue Engineering: Basic Science and Practice, 2004). 
     β-TCP as described herein can be in a variety of different forms. Examples of such forms include a granular form, a porous form, a powder, a putty (e.g., a moldable putty), a paste, a scaffold, and/or a coating on a solid surface (e.g., a coating on a medical device). In addition, the β-TCP can be used in a variety of different shapes (e.g., a cross, a ladder, a sphere, an ellipsoid, a square, a triangular pyramid, a rod, a cone, a torus, or a wedge, or any combination thereof) and sizes (e.g., largest average diameter of about 1 mm, about 2 mm, about 3 mm, about 4 mm, about 5 mm, about 6 mm, about 7 mm, about 8 mm, about 9 mm, about 1 cm, about 2 cm, about 3 cm, about 4 cm, about 5 cm, about 6 cm, about 7 cm, about 8 cm, about 9 cm, or about 10 cm). In some embodiments, β-TCP can be porous (e.g., about 20% to about 80% porous, about 20% to about 75% porous, about 20% to about 70% porous, about 20% to about 65% porous, about 20% to about 60% porous, about 20% to about 55% porous, about 20% to about 50% porous, about 20% to about 45% porous, about 20% to about 40% porous, about 20% to about 35% porous, about 20% to about 30% porous, about 20% to about 25% porous, about 25% to about 80% porous, about 25% to about 75% porous, about 25% to about 70% porous, about 25% to about 65% porous, about 25% to about 60% porous, about 25% to about 55% porous, about 25% to about 50% porous, about 25% to about 45% porous, about 25% to about 40% porous, about 25% to about 35% porous, about 25% to about 30% porous, about 30% to about 80% porous, about 30% to about 75% porous, about 30% to about 70% porous, about 30% to about 65% porous, about 30% to about 60% porous, about 30% to about 55% porous, about 30% to about 50% porous, about 30% to about 45% porous, about 30% to about 40% porous, about 30% to about 35% porous, about 35% to about 80% porous, about 35% to about 75% porous, about 35% to about 70% porous, about 35% to about 65% porous, about 35% to about 60% porous, about 35% to about 55% porous, about 35% to about 50% porous, about 35% to about 45% porous, about 35% to about 40% porous, about 40% to about 80% porous, about 40% to about 75% porous, about 40% to about 70% porous, about 40% to about 65% porous, about 40% to about 60% porous, about 40% to about 55% porous, about 40% to about 50% porous, about 40% to about 45% porous, about 45% to about 80% porous, about 45% to about 75% porous, about 45% to about 70% porous, about 45% to about 65% porous, about 45% to about 60% porous, about 45% to about 55% porous, about 45% to about 50% porous, about 50% to about 80% porous, about 50% to about 75% porous, about 50% to about 70% porous, about 50% to about 65% porous, about 50% to about 60% porous, about 50% to about 55% porous, about 55% to about 80% porous, about 55% to about 75% porous, about 55% to about 70% porous, about 55% to about 65% porous, about 55% to about 60% porous, about 60% to about 80% porous, about 60% to about 75% porous, about 60% to about 70% porous, about 60% to about 65% porous, about 65% to about 80% porous, about 65% to about 75% porous, about 65% to about 70% porous, about 70% to about 80% porous, about 70% to about 75% porous, or about 75% to about 80% porous). For example, β-TCP can have an average pore size of about 1 nm to about 50 mm, about 1 nm to about 45 mm, about 1 nm to about 40 mm, about 1 nm to about 35 mm, about 1 nm to about 30 mm, about 1 nm to about 25 mm, about 1 nm to about 20 mm, about 1 nm to about 15 mm, about 1 nm to about 10 mm, about 1 nm to about 5 mm, about 1 nm to about 1 mm, about 1 nm to about 900 Tm, about 1 nm to about 800 Tm, about 1 nm to about 700 Tm, about 1 nm to about 600 Tm, about 1 nm to about 500 Tm, about 1 nm to about 400 Tm, about 1 nm to about 300 Tm, about 1 nm to about 200 Tm, about 1 nm to about 100 Tm, about 1 nm to about 50 Tm, about 1 nm to about 10 Tm, about 1 nm to about 5 Tm, about 1 nm to about 1 Tm, about 1 nm to about 900 nm, about 1 nm to about 800 nm, about 1 nm to about 700 nm, about 1 nm to about 600 nm, about 1 nm to about 500 nm, about 1 nm to about 400 nm, about 1 nm to about 300 nm, about 1 nm to about 200 nm, about 1 nm to about 100 nm, about 1 nm to about 50 nm, about 1 nm to about 25 nm, about 1 nm to about 10 nm, about 1 nm to about 5 nm, about 5 nm to about 50 mm, about 5 nm to about 45 mm, about 5 nm to about 40 mm, about 5 nm to about 35 mm, about 5 nm to about 30 mm, about 5 nm to about 25 mm, about 5 nm to about 20 mm, about 5 nm to about 15 mm, about 5 nm to about 10 mm, about 5 nm to about 5 mm, about 5 nm to about 1 mm, about 5 nm to about 900 Tm, about 5 nm to about 800 Tm, about 5 nm to about 700 Tm, about 5 nm to about 600 Tm, about 5 nm to about 500 Tm, about 5 nm to about 400 Tm, about 5 nm to about 300 Tm, about 5 nm to about 200 Tm, about 5 nm to about 100 Tm, about 5 nm to about 50 Tm, about 5 nm to about 10 Tm, about 5 nm to about 5 Tm, about 5 nm to about 1 Tm, about 5 nm to about 900 nm, about 5 nm to about 800 nm, about 5 nm to about 700 nm, about 5 nm to about 600 nm, about 5 nm to about 500 nm, about 5 nm to about 400 nm, about 5 nm to about 300 nm, about 5 nm to about 200 nm, about 5 nm to about 100 nm, about 5 nm to about 50 nm, about 5 nm to about 25 nm, about 5 nm to about 10 nm, about 10 nm to about 50 mm, about 10 nm to about 45 mm, about 10 nm to about 40 mm, about 10 nm to about 35 mm, about 10 nm to about 30 mm, about 10 nm to about 25 mm, about 10 nm to about 20 mm, about 10 nm to about 15 mm, about 10 nm to about 10 mm, about 10 nm to about 5 mm, about 10 nm to about 1 mm, about 10 nm to about 900 Tm, about 10 nm to about 800 Tm, about 10 nm to about 700 Tm, about 10 nm to about 600 Tm, about 10 nm to about 500 Tm, about 10 nm to about 400 Tm, about 10 nm to about 300 Tm, about 10 nm to about 200 Tm, about 10 nm to about 100 Tm, about 10 nm to about 50 Tm, about 10 nm to about 10 Tm, about 10 nm to about 5 Tm, about 10 nm to about 1 Tm, about 10 nm to about 900 nm, about 10 nm to about 800 nm, about 10 nm to about 700 nm, about 10 nm to about 600 nm, about 10 nm to about 500 nm, about 10 nm to about 400 nm, about 10 nm to about 300 nm, about 10 nm to about 200 nm, about 10 nm to about 100 nm, about 10 nm to about 50 nm, about 10 nm to about 25 nm, about 25 nm to about 50 mm, about 25 nm to about 45 mm, about 25 nm to about 40 mm, about 25 nm to about 35 mm, about 25 nm to about 30 mm, about 25 nm to about 25 mm, about 25 nm to about 20 mm, about 25 nm to about 15 mm, about 25 nm to about 10 mm, about 25 nm to about 5 mm, about 25 nm to about 1 mm, about 25 nm to about 900 Tm, about 25 nm to about 800 Tm, about 25 nm to about 700 Tm, about 25 nm to about 600 Tm, about 25 nm to about 500 Tm, about 25 nm to about 400 Tm, about 25 nm to about 300 Tm, about 25 nm to about 200 Tm, about 25 nm to about 100 Tm, about 25 nm to about 50 Tm, about 25 nm to about 10 Tm, about 25 nm to about 5 Tm, about 25 nm to about 1 Tm, about 25 nm to about 900 nm, about 25 nm to about 800 nm, about 25 nm to about 700 nm, about 25 nm to about 600 nm, about 25 nm to about 500 nm, about 25 nm to about 400 nm, about 25 nm to about 300 nm, about 25 nm to about 200 nm, about 25 nm to about 100 nm, about 25 nm to about 50 nm, about 50 nm to about 50 mm, about 50 nm to about 45 mm, about 50 nm to about 40 mm, about 50 nm to about 35 mm, about 50 nm to about 30 mm, about 50 nm to about 25 mm, about 50 nm to about 20 mm, about 50 nm to about 15 mm, about 50 nm to about 10 mm, about 50 nm to about 5 mm, about 50 nm to about 1 mm, about 50 nm to about 900 Tm, about 50 nm to about 800 Tm, about 50 nm to about 700 Tm, about 50 nm to about 600 Tm, about 50 nm to about 500 Tm, about 50 nm to about 400 Tm, about 50 nm to about 300 Tm, about 50 nm to about 200 Tm, about 50 nm to about 100 Tm, about 50 nm to about 50 Tm, about 50 nm to about 10 Tm, about 50 nm to about 5 Tm, about 50 nm to about 1 Tm, about 50 nm to about 900 nm, about 50 nm to about 800 nm, about 50 nm to about 700 nm, about 50 nm to about 600 nm, about 50 nm to about 500 nm, about 50 nm to about 400 nm, about 50 nm to about 300 nm, about 50 nm to about 200 nm, about 50 nm to about 100 nm, about 100 nm to about 50 mm, about 100 nm to about 45 mm, about 100 nm to about 40 mm, about 100 nm to about 35 mm, about 100 nm to about 30 mm, about 100 nm to about 25 mm, about 100 nm to about 20 mm, about 100 nm to about 15 mm, about 100 nm to about 10 mm, about 100 nm to about 5 mm, about 100 nm to about 1 mm, about 100 nm to about 900 Tm, about 100 nm to about 800 Tm, about 100 nm to about 700 Tm, about 100 nm to about 600 Tm, about 100 nm to about 500 Tm, about 100 nm to about 400 Tm, about 100 nm to about 300 Tm, about 100 nm to about 200 Tm, about 100 nm to about 100 Tm, about 100 nm to about 50 Tm, about 100 nm to about 10 Tm, about 100 nm to about 5 Tm, about 100 nm to about 1 Tm, about 100 nm to about 900 nm, about 100 nm to about 800 nm, about 100 nm to about 700 nm, about 100 nm to about 600 nm, about 100 nm to about 500 nm, about 100 nm to about 400 nm, about 100 nm to about 300 nm, about 100 nm to about 200 nm, about 200 nm to about 50 mm, about 200 nm to about 45 mm, about 200 nm to about 40 mm, about 200 nm to about 35 mm, about 200 nm to about 30 mm, about 200 nm to about 25 mm, about 200 nm to about 20 mm, about 200 nm to about 15 mm, about 200 nm to about 10 mm, about 200 nm to about 5 mm, about 200 nm to about 1 mm, about 200 nm to about 900 Tm, about 200 nm to about 800 Tm, about 200 nm to about 700 Tm, about 200 nm to about 600 Tm, about 200 nm to about 500 Tm, about 200 nm to about 400 Tm, about 200 nm to about 300 Tm, about 200 nm to about 200 Tm, about 200 nm to about 100 Tm, about 200 nm to about 50 Tm, about 200 nm to about 10 Tm, about 200 nm to about 5 Tm, about 200 nm to about 1 Tm, about 200 nm to about 900 nm, about 200 nm to about 800 nm, about 200 nm to about 700 nm, about 200 nm to about 600 nm, about 200 nm to about 500 nm, about 200 nm to about 400 nm, about 200 nm to about 300 nm, about 300 nm to about 50 mm, about 300 nm to about 45 mm, about 300 nm to about 40 mm, about 300 nm to about 35 mm, about 300 nm to about 30 mm, about 300 nm to about 25 mm, about 300 nm to about 20 mm, about 300 nm to about 15 mm, about 300 nm to about 10 mm, about 300 nm to about 5 mm, about 300 nm to about 1 mm, about 300 nm to about 900 Tm, about 300 nm to about 800 Tm, about 300 nm to about 700 Tm, about 300 nm to about 600 Tm, about 300 nm to about 500 Tm, about 300 nm to about 400 Tm, about 300 nm to about 300 Tm, about 300 nm to about 200 Tm, about 300 nm to about 100 Tm, about 300 nm to about 50 Tm, about 300 nm to about 10 Tm, about 300 nm to about 5 Tm, about 300 nm to about 1 Tm, about 300 nm to about 900 nm, about 300 nm to about 800 nm, about 300 nm to about 700 nm, about 300 nm to about 600 nm, about 300 nm to about 500 nm, about 300 nm to about 400 nm, about 400 nm to about 50 mm, about 400 nm to about 45 mm, about 400 nm to about 40 mm, about 400 nm to about 35 mm, about 400 nm to about 30 mm, about 400 nm to about 25 mm, about 400 nm to about 20 mm, about 400 nm to about 15 mm, about 400 nm to about 10 mm, about 400 nm to about 5 mm, about 400 nm to about 1 mm, about 400 nm to about 900 Tm, about 400 nm to about 800 Tm, about 400 nm to about 700 Tm, about 400 nm to about 600 Tm, about 400 nm to about 500 Tm, about 400 nm to about 400 Tm, about 400 nm to about 300 Tm, about 400 nm to about 200 Tm, about 400 nm to about 100 Tm, about 400 nm to about 50 Tm, about 400 nm to about 10 Tm, about 400 nm to about 5 Tm, about 400 nm to about 1 Tm, about 400 nm to about 900 nm, about 400 nm to about 800 nm, about 400 nm to about 700 nm, about 400 nm to about 600 nm, about 400 nm to about 500 nm, about 500 nm to about 50 mm, about 500 nm to about 45 mm, about 500 nm to about 40 mm, about 500 nm to about 35 mm, about 500 nm to about 30 mm, about 500 nm to about 25 mm, about 500 nm to about 20 mm, about 500 nm to about 15 mm, about 500 nm to about 10 mm, about 500 nm to about 5 mm, about 500 nm to about 1 mm, about 500 nm to about 900 Tm, about 500 nm to about 800 Tm, about 500 nm to about 700 Tm, about 500 nm to about 600 Tm, about 500 nm to about 500 Tm, about 500 nm to about 400 Tm, about 500 nm to about 300 Tm, about 500 nm to about 200 Tm, about 500 nm to about 100 Tm, about 500 nm to about 50 Tm, about 500 nm to about 10 Tm, about 500 nm to about 5 Tm, about 500 nm to about 1 Tm, about 500 nm to about 900 nm, about 500 nm to about 800 nm, about 500 nm to about 700 nm, about 500 nm to about 600 nm, about 600 nm to about 50 mm, about 600 nm to about 45 mm, about 600 nm to about 40 mm, about 600 nm to about 35 mm, about 600 nm to about 30 mm, about 600 nm to about 25 mm, about 600 nm to about 20 mm, about 600 nm to about 15 mm, about 600 nm to about 10 mm, about 600 nm to about 5 mm, about 600 nm to about 1 mm, about 600 nm to about 900 Tm, about 600 nm to about 800 Tm, about 600 nm to about 700 Tm, about 600 nm to about 600 Tm, about 600 nm to about 500 Tm, about 600 nm to about 400 Tm, about 600 nm to about 300 Tm, about 600 nm to about 200 Tm, about 600 nm to about 100 Tm, about 600 nm to about 50 Tm, about 600 nm to about 10 Tm, about 600 nm to about 5 Tm, about 600 nm to about 1 Tm, about 600 nm to about 900 nm, about 600 nm to about 800 nm, about 600 nm to about 700 nm, about 700 nm to about 50 mm, about 700 nm to about 45 mm, about 700 nm to about 40 mm, about 700 nm to about 35 mm, about 700 nm to about 30 mm, about 700 nm to about 25 mm, about 700 nm to about 20 mm, about 700 nm to about 15 mm, about 700 nm to about 10 mm, about 700 nm to about 5 mm, about 700 nm to about 1 mm, about 700 nm to about 900 Tm, about 700 nm to about 800 Tm, about 700 nm to about 700 Tm, about 700 nm to about 600 Tm, about 700 nm to about 500 Tm, about 700 nm to about 400 Tm, about 700 nm to about 300 Tm, about 700 nm to about 200 Tm, about 700 nm to about 100 Tm, about 700 nm to about 50 Tm, about 700 nm to about 10 Tm, about 700 nm to about 5 Tm, about 700 nm to about 1 Tm, about 700 nm to about 900 nm, about 700 nm to about 800 nm, about 800 nm to about 50 mm, about 800 nm to about 45 mm, about 800 nm to about 40 mm, about 800 nm to about 35 mm, about 800 nm to about 30 mm, about 800 nm to about 25 mm, about 800 nm to about 20 mm, about 800 nm to about 15 mm, about 800 nm to about 10 mm, about 800 nm to about 5 mm, about 800 nm to about 1 mm, about 800 nm to about 900 Tm, about 800 nm to about 800 Tm, about 800 nm to about 700 Tm, about 800 nm to about 600 Tm, about 800 nm to about 500 Tm, about 800 nm to about 400 Tm, about 800 nm to about 300 Tm, about 800 nm to about 200 Tm, about 800 nm to about 100 Tm, about 800 nm to about 50 Tm, about 800 nm to about 10 Tm, about 800 nm to about 5 Tm, about 800 nm to about 1 Tm, about 800 nm to about 900 nm, about 900 nm to about 50 mm, about 900 nm to about 45 mm, about 900 nm to about 40 mm, about 900 nm to about 35 mm, about 900 nm to about 30 mm, about 900 nm to about 25 mm, about 900 nm to about 20 mm, about 900 nm to about 15 mm, about 900 nm to about 10 mm, about 900 nm to about 5 mm, about 900 nm to about 1 mm, about 900 nm to about 900 Tm, about 900 nm to about 800 Tm, about 900 nm to about 700 Tm, about 900 nm to about 600 Tm, about 900 nm to about 500 Tm, about 900 nm to about 400 Tm, about 900 nm to about 300 Tm, about 900 nm to about 200 Tm, about 900 nm to about 100 Tm, about 900 nm to about 50 Tm, about 900 nm to about 10 Tm, about 900 nm to about 5 Tm, about 900 nm to about 1 Tm, about 1 Tm to about 50 mm, about 1 Tm to about 45 mm, about 1 Tm to about 40 mm, about 1 Tm to about 35 mm, about 1 Tm to about 30 mm, about 1 Tm to about 25 mm, about 1 Tm to about 20 mm, about 1 Tm to about 15 mm, about 1 Tm to about 10 mm, about 1 Tm to about 5 mm, about 1 Tm to about 1 mm, about 1 Tm to about 900 Tm, about 1 Tm to about 800 Tm, about 1 Tm to about 700 Tm, about 1 Tm to about 600 Tm, about 1 Tm to about 500 Tm, about 1 Tm to about 400 Tm, about 1 Tm to about 300 Tm, about 1 Tm to about 200 Tm, about 1 Tm to about 100 Tm, about 1 Tm to about 50 Tm, about 1 Tm to about 10 Tm, about 1 Tm to about 5 Tm, about 5 Tm to about 50 mm, about 5 Tm to about 45 mm, about 5 Tm to about 40 mm, about 5 Tm to about 35 mm, about 5 Tm to about 30 mm, about 5 Tm to about 25 mm, about 5 Tm to about 20 mm, about 5 Tm to about 15 mm, about 5 Tm to about 10 mm, about 5 Tm to about 5 mm, about 5 Tm to about 1 mm, about 5 Tm to about 900 Tm, about 5 Tm to about 800 Tm, about 5 Tm to about 700 Tm, about 5 Tm to about 600 Tm, about 5 Tm to about 500 Tm, about 5 Tm to about 400 Tm, about 5 Tm to about 300 Tm, about 5 Tm to about 200 Tm, about 5 Tm to about 100 Tm, about 5 Tm to about 50 Tm, about 5 Tm to about 10 Tm, about 10 Tm to about 50 mm, about 10 Tm to about 45 mm, about 10 Tm to about 40 mm, about 10 Tm to about 35 mm, about 10 Tm to about 30 mm, about 10 Tm to about 25 mm, about 10 Tm to about 20 mm, about 10 Tm to about 15 mm, about 10 Tm to about 10 mm, about 10 Tm to about 5 mm, about 10 Tm to about 1 mm, about 10 Tm to about 900 Tm, about 10 Tm to about 800 Tm, about 10 Tm to about 700 Tm, about 10 Tm to about 600 Tm, about 10 Tm to about 500 Tm, about 10 Tm to about 400 Tm, about 10 Tm to about 300 Tm, about 10 Tm to about 200 Tm, about 10 Tm to about 100 Tm, about 10 Tm to about 50 Tm, about 50 Tm to about 50 mm, about 50 Tm to about 45 mm, about 50 Tm to about 40 mm, about 50 Tm to about 35 mm, about 50 Tm to about 30 mm, about 50 Tm to about 25 mm, about 50 Tm to about 20 mm, about 50 Tm to about 15 mm, about 50 Tm to about 10 mm, about 50 Tm to about 5 mm, about 50 Tm to about 1 mm, about 50 Tm to about 900 Tm, about 50 Tm to about 800 Tm, about 50 Tm to about 700 Tm, about 50 Tm to about 600 Tm, about 50 Tm to about 500 Tm, about 50 Tm to about 400 Tm, about 50 Tm to about 300 Tm, about 50 Tm to about 200 Tm, about 50 Tm to about 100 Tm, about 100 Tm to about 50 mm, about 100 Tm to about 45 mm, about 100 Tm to about 40 mm, about 100 Tm to about 35 mm, about 100 Tm to about 30 mm, about 100 Tm to about 25 mm, about 100 Tm to about 20 mm, about 100 Tm to about 15 mm, about 100 Tm to about 10 mm, about 100 Tm to about 5 mm, about 100 Tm to about 1 mm, about 100 Tm to about 900 Tm, about 100 Tm to about 800 Tm, about 100 Tm to about 700 Tm, about 100 Tm to about 600 Tm, about 100 Tm to about 500 Tm, about 100 Tm to about 400 Tm, about 100 Tm to about 300 Tm, about 100 Tm to about 200 Tm, about 200 Tm to about 50 mm, about 200 Tm to about 45 mm, about 200 Tm to about 40 mm, about 200 Tm to about 35 mm, about 200 Tm to about 30 mm, about 200 Tm to about 25 mm, about 200 Tm to about 20 mm, about 200 Tm to about 15 mm, about 200 Tm to about 10 mm, about 200 Tm to about 5 mm, about 200 Tm to about 1 mm, about 200 Tm to about 900 Tm, about 200 Tm to about 800 Tm, about 200 Tm to about 700 Tm, about 200 Tm to about 600 Tm, about 200 Tm to about 500 Tm, about 200 Tm to about 400 Tm, about 200 Tm to about 300 Tm, about 300 Tm to about 50 mm, about 300 Tm to about 45 mm, about 300 Tm to about 40 mm, about 300 Tm to about 35 mm, about 300 Tm to about 30 mm, about 300 Tm to about 25 mm, about 300 Tm to about 20 mm, about 300 Tm to about 15 mm, about 300 Tm to about 10 mm, about 300 Tm to about 5 mm, about 300 Tm to about 1 mm, about 300 Tm to about 900 Tm, about 300 Tm to about 800 Tm, about 300 Tm to about 700 Tm, about 300 Tm to about 600 Tm, about 300 Tm to about 500 Tm, about 300 Tm to about 400 Tm, about 400 Tm to about 50 mm, about 400 Tm to about 45 mm, about 400 Tm to about 40 mm, about 400 Tm to about 35 mm, about 400 Tm to about 30 mm, about 400 Tm to about 25 mm, about 400 Tm to about 20 mm, about 400 Tm to about 15 mm, about 400 Tm to about 10 mm, about 400 Tm to about 5 mm, about 400 Tm to about 1 mm, about 400 Tm to about 900 Tm, about 400 Tm to about 800 Tm, about 400 Tm to about 700 Tm, about 400 Tm to about 600 Tm, about 400 Tm to about 500 Tm, about 500 Tm to about 50 mm, about 500 Tm to about 45 mm, about 500 Tm to about 40 mm, about 500 Tm to about 35 mm, about 500 Tm to about 30 mm, about 500 Tm to about 25 mm, about 500 Tm to about 20 mm, about 500 Tm to about 15 mm, about 500 Tm to about 10 mm, about 500 Tm to about 5 mm, about 500 Tm to about 1 mm, about 500 Tm to about 900 Tm, about 500 Tm to about 800 Tm, about 500 Tm to about 700 Tm, about 500 Tm to about 600 Tm, about 600 Tm to about 50 mm, about 600 Tm to about 45 mm, about 600 Tm to about 40 mm, about 600 Tm to about 35 mm, about 600 Tm to about 30 mm, about 600 Tm to about 25 mm, about 600 Tm to about 20 mm, about 600 Tm to about 15 mm, about 600 Tm to about 10 mm, about 600 Tm to about 5 mm, about 600 Tm to about 1 mm, about 600 Tm to about 900 Tm, about 600 Tm to about 800 Tm, about 600 Tm to about 700 Tm, about 700 Tm to about 50 mm, about 700 Tm to about 45 mm, about 700 Tm to about 40 mm, about 700 Tm to about 35 mm, about 700 Tm to about 30 mm, about 700 Tm to about 25 mm, about 700 Tm to about 20 mm, about 700 Tm to about 15 mm, about 700 Tm to about 10 mm, about 700 Tm to about 5 mm, about 700 Tm to about 1 mm, about 700 Tm to about 900 Tm, about 700 Tm to about 800 Tm, about 800 Tm to about 50 mm, about 800 Tm to about 45 mm, about 800 Tm to about 40 mm, about 800 Tm to about 35 mm, about 800 Tm to about 30 mm, about 800 Tm to about 25 mm, about 800 Tm to about 20 mm, about 800 Tm to about 15 mm, about 800 Tm to about 10 mm, about 800 Tm to about 5 mm, about 800 Tm to about 1 mm, about 800 Tm to about 900 Tm, about 900 Tm to about 50 mm, about 900 Tm to about 45 mm, about 900 Tm to about 40 mm, about 900 Tm to about 35 mm, about 900 Tm to about 30 mm, about 900 Tm to about 25 mm, about 900 Tm to about 20 mm, about 900 Tm to about 15 mm, about 900 Tm to about 10 mm, about 900 Tm to about 5 mm, about 900 Tm to about 1 mm, about 1 mm to about 50 mm, about 1 mm to about 45 mm, about 1 mm to about 40 mm, about 1 mm to about 35 mm, about 1 mm to about 30 mm, about 1 mm to about 25 mm, about 1 mm to about 20 mm, about 1 mm to about 15 mm, about 1 mm to about 10 mm, about 1 mm to about 5 mm, about 5 mm to about 50 mm, about 5 mm to about 45 mm, about 5 mm to about 40 mm, about 5 mm to about 35 mm, about 5 mm to about 30 mm, about 5 mm to about 25 mm, about 5 mm to about 20 mm, about 5 mm to about 15 mm, about 5 mm to about 10 mm, about 10 mm to about 50 mm, about 10 mm to about 45 mm, about 10 mm to about 40 mm, about 10 mm to about 35 mm, about 10 mm to about 30 mm, about 10 mm to about 25 mm, about 10 mm to about 20 mm, about 10 mm to about 15 mm, about 15 mm to about 50 mm, about 15 mm to about 45 mm, about 15 mm to about 40 mm, about 15 mm to about 35 mm, about 15 mm to about 30 mm, about 15 mm to about 25 mm, about 15 mm to about 20 mm, about 20 mm to about 50 mm, about 20 mm to about 45 mm, about 20 mm to about 40 mm, about 20 mm to about 35 mm, about 20 mm to about 30 mm, about 20 mm to about 25 mm, about 25 mm to about 50 mm, about 25 mm to about 45 mm, about 25 mm to about 40 mm, about 25 mm to about 35 mm, about 25 mm to about 30 mm, about 30 mm to about 50 mm, about 30 mm to about 45 mm, about 30 mm to about 40 mm, about 30 mm to about 35 mm, about 35 mm to about 50 mm, about 35 mm to about 45 mm, about 35 mm to about 40 mm, about 40 mm to about 50 mm, about 40 mm to about 45 mm, or about 45 mm to about 50 mm. 
     In some embodiments, the β-TCP is about 50% to about 70% porous, with the pores having a mean pore diameter of about 50 Tm to about 70 Tm (e.g., about 55 Tm to about 65 Tm, or about 60 Tm). 
     Compositions and Kits 
     Also provided herein are compositions (e.g., pharmaceutical compositions) that include any of the chimeric polypeptides or β-TCP-binding polypeptides described herein. In some examples, the compositions can further include β-TCP (e.g., any of the types of β-TCP described herein). In some examples, the β-TCP is formulated as a powder, a putty (e.g., a moldable putty), a paste, a scaffold (e.g., a porous scaffold), a sponge, and/or a coating on a solid surface (e.g., a coating on a medical device). In some examples, the β-TCP can be disposed on or in a scaffold, a mesh, or a sponge (e.g., a resorbable sponge). 
     In some instances, the compositions (e.g., pharmaceutical compositions) are disposed in a sterile vial or a pre-loaded syringe. 
     In some instances, the compositions (e.g., pharmaceutical compositions) are formulated for different routes of administration (e.g., intraarticular, injection into a joint, or injection proximal to a bone (issue or fracture). Single or multiple administrations of any of the pharmaceutical compositions described herein can be given to a subject depend on, for example: the dosage and frequency as required and tolerated by the subject. A dosage of the pharmaceutical composition should provide a sufficient quantity of the chimeric polypeptide to effective treat or ameliorate conditions (e.g., bone defects, bone fractures, cartilage defects, or cartilage loss), or symptoms. 
     Also provided herein are kits that include any of the chimeric polypeptides or any of the β-TCP-binding polypeptides described herein, or any of the compositions (e.g., pharmaceutical compositions) described herein. In some embodiments, the kits can include instructions for performing any of the methods described herein. In some instances, the kits can include at least one dose of any of the compositions (e.g., pharmaceutical compositions) described herein. In some embodiments, the kits can include a syringe for administering any of the pharmaceutical compositions described herein. The kits described herein are not so limited; other variations will be apparent to one of ordinary skill in the art. 
     Methods of Making a Composition 
     Also provided herein are methods of producing any of the compositions described herein. Any of the compositions provided herein can be produced using the methods described herein or methods known in the art. For example, to create a β-TCP scaffold, granulated β-TCP powder can be sintered, sieved, and fabricated into a desired shape (e.g., any of the shapes described herein). In some examples, the purity of the β-TCP present in any of the compositions described herein can be greater than about 75%, greater than 80%, greater than 85%, greater than 90%, greater than 95%, or greater than 99% pure. In some examples, the purity of β-TCP present in any of the compositions described herein can be greater than 1%, greater than 2%, greater than 3%, greater than 4%, greater than 5%, greater than 6%, greater than 7%, greater than 8%, greater than 9%, greater than 10%, greater than 12%, greater than 14%, greater than 15%, greater than 16%, greater than 18%, greater than 20%, greater than 22%, greater than 24%, greater than 25%, greater than 26%, greater than 28%, greater than 30%, greater than 32%, greater than 34%, greater than 35%, greater than 36%, greater 38%, greater 40%, greater than 42%, greater than 44%, greater than 45%, greater than 46%, greater than 48%, greater than 50%, greater than 52%, greater than 54%, greater than 55%, greater than 56%, greater than 58%, greater than 60%, greater than 62%, greater than 64%, greater than 65%, greater than 66%, greater than 68%, greater than 70%, greater than 72%, greater than 74%. In some examples, the β-TCP is made using a similar method but as a composite with other agents, such as a biocompatible polymer, e.g., polylactide-co-glycolide. 
     As will be apparent to those of skill in the art, the composition can further include one or more pore forming agents. Examples of pore forming agents include, e.g., inorganic salts, such as sodium chloride, saccharides (e.g., sucrose or glucose), gelatin (e.g., gelatin spheres), or paraffin (e.g., paraffin spheres). 
     The compositions described herein can be generated by contacting any of the chimeric polypeptides or any of the β-TCP-binding polypeptides to any of the types of β-TCP described herein. In some embodiments, the β-TCP can be in the form of a granular/powder form, a porous form, a putty (e.g., a moldable putty), a paste, a scaffold, and/or a coating on a solid surface (e.g., a coating on a medical device). 
     Methods of Treatment 
     Provided herein are methods of promoting bone or cartilage formation in a subject in need thereof that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. Some embodiments of these methods can further include first selecting a subject in need of bone or cartilage formation. In some embodiments, the composition is administered to the subject proximal to the desired site of bone or cartilage formation in the subject. 
     Also provided herein are methods of replacing and/or repairing bone or cartilage in a subject in need thereof that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. Some embodiments of these methods can further include first selecting a subject in need of bone replacement, bone repair, cartilage replacement, or cartilage repair. In some embodiments, the composition is administered to the subject proximal to the desired site of bone or cartilage replacement or repair in the subject. 
     Also provided herein are methods of treating a bone fracture or bone loss in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of any of the compositions described herein. Some embodiments of these methods can further include first selecting a subject having a bone fracture or bone loss. In some embodiments, the composition is administered to the subject proximal to the bone fracture or the site of bone loss in the subject. 
     Also provided herein are methods of repairing soft tissue in a subject in need thereof that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. Some embodiments of these methods can further include first selecting a subject having a bone fracture or bone loss. In some embodiments, the composition is administered to the subject proximal to the bone fracture or the site of bone loss in the subject. 
     Also provided herein are methods of localized delivery of a therapeutic to a subject in need thereof that include: administering to the subject a therapeutically effective amount of any of the compositions described herein. Some embodiments of these methods can further include first selecting a subject having a bone fracture or bone loss. In some embodiments, the composition is administered to the subject proximal to the bone fracture or the site of bone loss in the subject. 
     In some instances, the subject has a bone fracture or a bone defect. 
     In some instances, the subject requires a vertebral fusion of the spine. 
     In some instances, the subject has a cartilage tear or cartilage defect. 
     In other instances, the subject has cartilage loss. 
     Methods of determining the efficacy of treatment of a bone fracture or bone loss in a subject are known in the art and include, e.g., imaging techniques (e.g., magnetic resonance imaging, X-ray, or computed tomography). 
     Methods of detecting bone or cartilage formation, or replacement or repair of bone or cartilage in a subject are also known in the art and include, e.g., imaging techniques (e.g., magnetic resonance imaging, X-ray, or computed tomography). 
     Suitable animal models for treatment of a bone fraction or bone loss, bone or cartilage formation, or bone or cartilage replacement or repair are known in the art. Non-limiting examples of such animal models are described in the Examples and in, e.g., Drosse et al.,  Tissue Engineering Part C  14(1):79-88, 2008; Histing et al.,  Bone  49:591-599, 2011; and Poser et al., Hindawi Publishing Corporation, BioMed Research International; Article ID 348635, 2014. 
     The invention is further described in the following examples, which do not limit the scope of the invention described in the claims. 
     EXAMPLES 
     Example 1. A Preclinical Study of tBMP-2 in a 13-TCP Carrier in a Rat Critical Size Femoral Defect Model 
     The aim of this study was to examine the safety and effect of modified recombinant human bone morphogenetic protein (rhBMP) known as tBMP in a beta-tricalcium phosphate (β-TCP) putty matrix in the replacement and repair of bone in a rat critical size defect model. The tBMP-2 variant exhibits very tight binding to calcium phosphate ceramics and thus allows for targeted delivery of tBMP-2 to implant sites. This was achieved by surgically creating the defect using the RatFix internal fixator system, then filling that defect with tBMP+β-TCP putty, or β-TCP putty alone as a control. The positive control was a dose-adjusted commercially available (Medtronic) preparation for human use of rhBMP with an absorbable collagen sponge (ACS). The animals were monitored clinically and had bi-weekly radiographs until their scheduled end-points at four or eight weeks post-administration of treatment. Ex vivo histology was conducted on organs and tissues, and the treated leg was subjected to μCT, histomorphometry, and/or mechanical strength testing. 
     This report covers animal arrival, assignment to groups, surgical creation of defect and administration of test, reference or control item. In addition, this report covers the post-operative period up to and including Week 8, and end-point in vivo and ex vivo measurements. Included are the clinical summaries, radiographs, end-point clinical pathology and organ histopathology, histomorphometry of treated legs (odd-numbered animals), and mechanical strength testing of treated legs (even-numbered animals). 
     On arrival at the Test Facility, all animals underwent a Veterinary health check and were weighed. Based on the weights, the animals were assigned to groups A) tBMP+β-TCP putty; B) rhBMP+ACS; or C) β-TCP putty alone. The animals then had at least five days to acclimatize to their new surroundings and diet. 
     On the day of surgery, the animals were anaesthetized, the defect was created and the bone supported with the internal fixator following the method supplied by the manufacturer with some refinements to the surgical procedure. The pre-prepared test, reference or control item was then inserted into the defect. The surgical site was closed and the animal went immediately for X-ray. Following completion of the baseline radiograph, post-operative pain relief was administered and the animal was returned to its cage for recovery. Post-operative analgesia and antibiotic therapy were continued for at least two days, and longer when required. 
     A number of the original animals were removed from the study and replaced prior to surgery as they were getting too large for the fixator system specifications. The second, replacement group also had a thorough Veterinary health check and were weighed prior to being assigned to groups. The allocation of animals to either four or eight-week end-point groups was adjusted to include animals from both weight ranges at both end-points. 
     A total of 61 animals were successfully administered assigned treatment and recovered from surgery. Of these, one animal was euthanized five days post-operatively due to poor recovery and inappetence. The animal was replaced. Two animals which were found to have dislodged bone plates during their 2-week post-operative radiographs were humanely killed and not replaced. Two animals did not successfully recover from surgery, one died immediately post-surgery, and the other had an unstable bone plate which could not be fixed, and so was humanely killed. Both of these animals were replaced immediately. 
     The animals were monitored at least once daily, and their clinical signs scored. Any animal with unusual findings, or considered to be not eating and gaining weight normally was monitored more frequently, and veterinary advice was sought. When unusual findings were noted, this resulted in possible treatment with additional antibiotic or analgesic therapy, fluid supplementation), and in four cases euthanasia (three broken bones and one with continued weight loss). 
     All relevant animals received bone-labelling dyes at 10 days (calcein green) and 3 days (xylenol orange) prior to their scheduled end-point date. All animals had end-point blood samples collected. There were no clinically significant differences found between any of the groups for any biochemical or haematological parameter at either end-point time. Three haematology samples were clotted and could not be analysed. 
     In all specimens examined, there was evidence of extensive mineralization akin to mature trabecular bone in samples from animals in the tBMP+β-TCP putty group (Group A). This mineralization appears to be lamella (mature) bone rather than the woven bone that occurs in early callus formation (presence of osteocytes). Group A animals also had osteoclasts present (suggesting active remodelling), and red blood cells and adipocytes, indicating angiogenesis and infiltration of cells to most regions of the callus. Whilst there is mineralized bone in the specimens from the rhBMP+ACS group animals, there are extensive regions of un-mineralized fibrous and cartilaginous tissue within the callus region. The callus development in these samples appears to be at an earlier stage than that observed in the Group A animals. The Group C (β-TCP putty) samples show no evidence of mineralization, bone formation or bone remodeling even at eight weeks post-application of treatment. 
     The mechanical testing analyses showed the tBMP+β-TCP group animals (Group A) had significantly stronger bones at the four and eight week end-point times than either of the other treatment groups. 
     In conclusion, the bone specimens form the tBMP+β-TCP putty group clearly demonstrated vastly improved bone healing at 4 and 8 weeks post-surgery when compared to samples from animals in the rhBMP+ACS or the β-TCP putty alone treatment groups. The aim of this study was to evaluate the performance of a modified variant of recombinant human BMP-2 (rhBMP-2) called tBMP-2. The tBMP-2 variant exhibits very tight binding to calcium phosphate ceramics and thus allows for targeted delivery of tBMP-2 to implant sites. The ability to tether BMP-2 in this manner will allow for longer persistence times, lower doses, and, it is expected, superior outcomes. 
     Animals 
     The rat is a validated animal model for assessing the effect of treatments on critical-sized defects in the femur (4-6). Sixty male rats (plus spares) were required: ten animals in each group per time point. One animal was replaced after successful administration of the test item at day 5 post-surgery as he was losing weight and not eating. Animals that were euthanized or humanely killed after successful administration of the test item were necropsied and had tissue collected for histopathology. The number of animals used in this study was considered sufficient for evaluation of results. 
     The animals were housed in conventional conditions (targeted temperature 22±3° C., 12/12-hour light/dark cycle) in standard open top cages that satisfy the size requirements specified in the Animal Welfare Regulations (Animal Welfare Act 1985, v 15.10.2015. Attorney General&#39;s Department, Gouverment of South Australia). Animals were housed individually for the entirety of the experiment. The animals had access to standard laboratory rat chow (Specialty Feeds, Glen Forest, Australia) 25-30 g/day. Immediately post-operatively, and when rats were not thriving, the food was soaked in water for easier palatability. Chlorinated tap water was provided to the animals ad libitum. Food and water were not withheld at any time. 
     Each animal was uniquely identified by a subcutaneously implanted microchip which was scanned using a barcode reader. For the purpose of the study, each animal was also given a number from 1-70 (to include replacement and spared required). As the initial batch of animals gained weight too quickly, some animals were replaced prior to surgery. The replacement animals were given the number of the animal they replaced and the suffix (a) was added. Numbers went up to 68a with a couple of gaps. 
     Animals were assigned to groups by a weight-ordered distribution. The heavier animals were used first. The animals gained weight rapidly, even on the restricted food allowance. Two weeks into the surgeries, it was deemed necessary to remove some animals from the study (n=16) as these animals were already too heavy (&gt;425 g). These animals were replaced with animals in the 250-300 g range. The replacement animals were also assigned to treatment groups on a weight-ordered distribution. As the first surgical group had originally been assigned to the 8-week end-point group, animals were reassigned to either 4- or 8-week end-points to ensure the lighter animals were evenly distributed amongst the treatment and end-point times. 
     Analgesia/Antibiotic Therapy 
     All interventional procedures were performed under isoflurane in 02 anaesthesia. Induction and maintenance of surgical depth anesthesia was at 2-4% isoflurane (Baxter International, Sydney, Australia) in a flow of 1-2 L/minute 02. Post-operatively, after closure of the wound, a topical application of local anesthetic in the form of Marcaine (Bupivacaine, 0.5%, AstraZeneca, Frewville, SA, Australia) up to 2.5 mg/Kg was applied to the area around the wound. The animals received 0.1 mg/kg buprenorphine (Temgesic, Reckitt-Benckiser, Melrose Park, Australia) subcutaneously post-operatively after X-ray. They also received 0.1 mg/kg subcutaneously twice daily for two days post-operatively. Additionally, they were given a non-steroidal anti-inflammatory treatment in the form of Carprieve (Carprofen, 50 mg/mL, Norbrook Laboratories, Tullamarine, Australia) at a dose of 5 mg/kg subcutaneously post-operatively and once daily for at least two days post-surgery. 
     All animals received cephalosporin (Cefazolin, Hospira Inc, Lake Forest Ill., USA) 20 mg/kg subcutaneously intra-operatively and twice daily for two days post-operatively. Any animals that needed re-suturing of their wounds received antibiotic treatment for up to fourteen days post-repair. Antibiotic therapy was ceased if suspected to be causing diarrhea and/or weight loss. 
     Microchip Implantation 
     The microchip was inserted into the scruff of the neck (after clipping hair) using a microchip implanter. The microchip was inserted until completely covered by skin. The wounds were closed with one or two wound clips if required. The area was swabbed with betadine. This was performed under isoflurane in 02 anaesthesia at the same time as the defect surgery and test- or reference-item placement. 
     Critical-Size Defect Creation 
     The defects were created in the right femur of all rats as described for the RatFix RISystem. Briefly, all anaesthetized rats were placed on a warming pad in lateral recumbency with the right leg facing upwards. The surgical site was shaved and aseptically prepared with iodine or chlorhexidine scrub and solution. A skin incision between the greater trochanter and the knee joint was made and the superficial fascia incised. The intermuscular plane between the vastus lateralis and the biceps femoris was separated and the periosteum of the femur incised. The PEEK plate was fitter into the jug and secured with suture material. The jig-plate assembly was fixed to the craniolateral surface of the femur by pulling the sutures through under the femur, allowing the assembly to be tightened to the femur. 
     After predilling the holes in the PEEL plate using the supplied drill bit, the plate was attached to the femur by six bicortical titanium screws. Standardised 6-mm defects were created (marked on the plate) using the Gigli wire saw guided by the sawing device of the jig. After defect sawing, the jig and bone piece were removed. The fresh defect was flushed with sterile saline and dried with gauze in preparation of test item or reference item, or vehicle administration into the defect size. In the event that the plate itself was damaged with the cutting wire, reducing stability, that animal would be replaced. No replacements due to plate damage were required. 
     Baseline Radiographs 
     Baseline radiographs were taken immediately after creation of the defect and administration of the test or reference item to show position of treatment articles (where visible), and placement of the plate, whilst the animal was still under anaesthesia. 
     Radiographic Assessments 
     X-rays were taken on the anaesthetized animals (isoflurane) immediately after surgery, and at 2, 4 (end-point for half of the animals), 6 and 8 weeks (end-point for the remaining animals) post-operatively. The radiographs were taken in lateromedial and craiocaudal projections for assessment of bone healing and to exclude implant loosening or failure. All in-life radiographs were taken using a Villa Visitor Mobile X-ray Unit (Villa Sistemi Medicali, Buccinasco, Italy), using a dental image capture device (Soredex, Digora Optime, Tuusula, Finland). The images were transferred to the PIRL picture archiving and communication system (PACS, Carestream Vue Motion, Rochester, USA) by the radiographer for storage and access. 
     Bone Labelling 
     At 10 days prior to their prescribed end-point, all animals received an intraperitoneal injection of calcein green (25 mg/kg in saline). At 3 days prior to their prescribed end-point all animals received an injection of xylenol orange (10 mg/mL, 25 mg/kg, intraperitoneal) to double-label the bone for histomorphometric analyses. 
     Blood Collection/Haematology 
     All blood collections were performed on anaesthetized animals at their end-point radiograph. Blood was collected via cardiac puncture. 
     Blood samples were evaluated for the parameters specified in Tables 1 and 2. For Table 1, samples of approximately 2 mL were collected into tubes containing K 2 EDTA anticoagulant for haemotological analyses. Analyses were performed on an Abbott Cell Dyn. 3700 (Abbott Laboratories, North Ryde, Australia). For Table 2, samples of approximately 5 mL were collected into tubes containing a clot activator for biochemical analysis. Analyses were performed on a Siemens Advia 1800 (Siemens Healthcare Diagnostics Inc., Flanders, N.J., USA). 
     
       
         
           
               
             
               
                 TABLE 1 
               
               
                   
               
             
            
               
                 Haematology Parameters to be reported 
               
            
           
           
               
               
            
               
                 Haemoglobin (Hb) 
                 White Cell Count (WCC) 
               
               
                 Erythrocyte count (RBC) 
                 Mean Corpuscular Volume (MCV) 
               
               
                 Packed Cell Volume (PCV)/ Haematocrit 
                 Mean Corpuscular Haemoglobin (MCH)* 
               
               
                 (HCT) 
                   
               
               
                 Mean Corpuscular Haemoglobin 
                 Red Cell Distribution Width (RDW) 
               
               
                 Concentration (MCHC)* 
                   
               
               
                 Platelets (Plt) 
                   
               
            
           
           
               
            
               
                 White Blood Cell Differential: Neutrophils, Lymphocytes, Monocytes, Eosinophils, Basophils 
               
               
                 *Calculated values 
               
               
                   
               
            
           
         
       
     
     
       
         
           
               
             
               
                 TABLE 2 
               
               
                   
               
             
            
               
                 Serum Chemistry Parameters to be reported 
               
            
           
           
               
               
               
            
               
                 Electrolytes: 
                 Anion Gap* (AG) 
                 Albumin (Alb) 
               
               
                 Sodium (Sod) 
                 Glucose (Gluc) 
                 Globulin* (Glob) 
               
               
                 Potassium (Pot) 
                 Urea 
                 Protein (Tot Prot) 
               
               
                 Chloride (Chl) 
                 Creatinine (Creat) 
                 Total bilirubin (Tot Bili) 
               
               
                 Bicarbonate (Bicarb) 
                 Cholesterol (Chol) 
                 Lactate Dehydrogenase (LD) 
               
               
                 Lipid Studies: 
                 Urate (Uric Acid, UA) 
                 Alkaline phosphatase (ALP) 
               
               
                 Triglycerides (Trig) 
                 Phosphate (Phos) 
                 Total Calcium (Tot. Ca) 
               
               
                 High Density 
                 Gamma glutamyltransferase 
                 Alanine aminotransferase 
               
               
                 Lipoproteins (HDL) 
                 (GGT) 
                 (ALT) 
               
               
                 Low Density Lipoproteins 
                 Asparatate aminotransferase 
                   
               
               
                 (LDL) 
                 (AST) 
                   
               
               
                 Chol/HDL* 
                 *Calculated values 
               
               
                   
               
            
           
         
       
     
     Mechanical Strength Testing 
     This was performed on half of the animals at each time point. All tissue was placed in 0.9% NaCl-soaked gauzed in 50-mL sterile urine pots to avoid freezer burn and stored frozen at −20° C. until testing. Tissue was prepared immediately and frozen within one hour of collection to avoid autolysis. Immediately before testing, tissues were thawed, and the internal fixator device carefully cut in the middle section. Tissue was test at room temperature (approximately 23° C.). The ultimate breaking strength was measured by using a load frame (model 5542, Instron, Canton, Mass.) and a 3-point bend fixture (model 2810-400, Instron) at a crosshead speed of 10 mm/min. The load cell for this testing (Instron 2530-416) had a maximum capacity of 500 N. The data (force in kg and extension in mm) was collected and analysed with a vendor-provided commercial mathematical software package (Bluehill2, Instron). 
     Histological Analyses 
     Specimen were fixed in 10% formalin for 7 days prior to processing. Formalin-fixed bones were cut using a slow-speed saw (Buehler Ltd, IL, USA) along the sagittal plane using a diamond-tipped cutting blade before being submerged in 70% ethanol. Subsequently, bones were processed for resin embedding via several dehydration steps. Briefly, bones were submerged in 2×90% ethanol and 1×100% ethanol steps over 48 hours. Bones were then transferred into a solution containing methymethacrylate (MMA) and 10% v/v polyethylene glycol (PEG) and stored at room temperature for 10-14 days. Resin embedding then occurs by preparing a solution of MMA, 10% PEG, and 0.4% peroxydicarbonate (Perkadox) and incubation at 37° C. for 24 hours to allow the resin to harden. The exposed cut surface was placed facing down in the tube. The resin-set bones were then removed from their tubes and fixed to stubs for sectioning. For each bone, 5-μm thick sections were cut using a tungsten-carbide blade (Leica RM2255, Wetzlar, GER). Sections were placed on to gel-coated slides and dipped 2 times in a spreading solution (70% ethanol/30% 2-ethoxyethanol) heated to 70° C. To ensure adherence to the slide, sections were flattended, covered by strips of polyethylene and clamped together separated by blotting paper, before being placed into a 37° C. oven. Prior to commencing staining procedures, sections were placed in acetone for 15 minutes, unless otherwise stated. All sections were digitally scanned at 100× magnification (3D Histech scanner, TMA-MASTER01). 
     Von Koss+Haemaotoxylin and Eosin (H&amp;E) Staining 
     Acetone treated sections were rinsed in demineralised water for 2 minutes. Sections were then placed in a 1% silver nitrate solution and placed in front of a UV lamp for 60 minutes. Washed slides were then treated with 2.5% sodium thiosulphate solution for 5 minutes. Washed slides were then counterstained with H&amp;E. To stain for H&amp;E, sections were placed in haematoxylin for 8 minutes to stain cell nuclei before being rinsed in demineralised water for 2 minutes and dipped in acid alcohol (%), typically, 4-5 minutes. After rinsing in demineralised water, sections were dipped in lithium carbonate 4-5 times and placed in eosin for 4 minutes. Once removed, excess eosin was removed with a squeeze bottle of absolute alcohol, sections were hydrated, placed in xylene and mounted in xylene-based mounting medium. 
     Tartrate-Resistant Acid Phosphatase (TRAP) Stain for Analysis of Osteoclasts 
     Acetone treated sections underwent a 60-minute incubation in Tris-HCL buffer (pH 9.4) at 37° C. for 60 minutes in an acid phosphatase (AcP) stain prepared by adding 0.0355 g of tartaric acid dissolved in 35 mL of sodium acetate (pH 5.2) to 100 μL basic fucshin in a 100 μL solution containing 0.4 mg of sodium nitrite. This solution was then added to a solution containing 0.04 g Napthol ASBI phosphate (Sigma-Aldrich, Missouri, USA) in 2 mL dimethylformamide. Subsequently, two washed were performed before the sections were counterstained in haematoxylin for 8 minutes, then rinsed in demineralised water, then dipped in acid alcohol 4 times, rinsed again, dipped in lithium carbonate 4 times and then dehydrated, placed in xylene and mounted in DPX. Quantification of osteoclast number per bone perimeter mm was performed by identifying cells (stained pink-red) on the surface of bone (stained blue-purple) and calculated by the OsteoMeasure histomorphometry system. 
     Double Fluorochrome Labelling of Bone Sections for Measures of Bone Formation 
     Acetone sections were immediately placed in xylene and mounted in DPX. Slides were viewed under a fluorescent microscope (Olympus BX53; Olympus, Tokyo, JP). 
     Histomorphometry 
     Those animals which did not have mechanical testing of femurs will undergo histological analysis of the defect and treatments. Following μCT of the femurs, they were opened at the wound site, and the internal fixator device carefully removed. They were placed in 70% ethanol. Femurs were placed in PMMA, polymethyl methacrylate (10% polyethylene glycol [PEG] in methylmethacrylate) for 10-14 days, then polymerized in PMMA containing 10% Perkadox 16 (di[4-tert-butylcyclohexyl]peroxydicarbonate) at 37° C. for 24 hours. Sections were stained with H&amp;E, and tartrate resistant acid phosphatase (TRAP) for analysis. 
     Humane Killing 
     Animals were humanely killed on day 28±2 days (n=30) or day 56±3 (n=30) immediately following their end-point radiograph and blood collection, and whilst still under anaesthesia, with an intracariac injection of a lethal dose of sodium pentobarbitone of 60 mg/mL formulation (Lethabarb®) at 200 mg/kg. Death was confirmed by lack of respiration and palpable heartbeat, loss of corneal reflex and loss of colour of mucous membranes. 
     Necropsy 
     All animals were subjected to a comprehensive necropsy. A comprehensive necropsy is defined as examination of the external surface of the body, all offices, and the cranial, thoracic, and abdominal cavities, and their contents. If abnormalities were found in tissues or organs other than those listed below, they were also collected for histology. 
     Organ and Tissue Collection 
     Whole organs, sections of the issues listed in Table 3 below were dissected free and fixed in 10% neutral buffered formalin. This was done for twelve animals from each groups (six animals from each group at each time-point). The animals were selected such that at least one from each group was selected at each end-point (staggered as surgeries were staggered). 
     
       
         
           
               
             
               
                 TABLE 3 
               
               
                   
               
             
            
               
                 Organ and Tissue Samples Collected From Each Animal 
               
            
           
           
               
               
               
            
               
                 Adrenal gland 
                 Lesions 
                 Skin (containing 
               
               
                   
                   
                 implant[s]) 
               
               
                 Brain 
                 Liver 
                 Spinal cord (cervical, 
               
               
                   
                   
                 thoracic, and lumbar) 
               
               
                 Cecum 
                 Lymph node (mesenteric) 
                 Spleen 
               
               
                 Duodenum 
                 Pancreas 
                 Sternum (+ bone marrow) 
               
               
                 Eye 
                 Pituitary Gland 
                 Stomach 
               
               
                 Heart 
                 Rectum 
                 Thymus 
               
               
                 Ileum 
                 Salivary gland (mandibular) 
                 Tongue 
               
               
                 Jejunum 
                 Sciatic nerve 
                 Epididymis 
               
               
                 Kidney 
                 Skeletal muscle (thigh) 
                   
               
               
                 Femur with bone  
                 Lung (with mainstem bronchi) 
                 Prostate/seminal vesicles, 
               
               
                 marrow(articular 
                   
                   
               
               
                 surface of the 
                   
                 bladder, testes 
               
               
                 distal end) 
               
               
                   
               
            
           
         
       
     
     Treated Limb Collection and Storage 
     Immediately following confirmation of death, the treated leg was removed and placed in either 10% neutral buffered formalin (n=5 animals/group/time point), or wrapped in saline-soaked gauze and placed at −20° C. for at least 48 hours (n=10 animals/group/time point). 
     μCT 
     All legs had μCT measurements (Bruker Skyscan 1076, Brussels, Belgium) of the defect performed to quantify newly mineralized bone volume. This was done on all animals at each end-point time. The bones were either formalin-fixed (105 neutral buffered formalin) or frozen at −20° C. for 3-5 days prior to testing. The plate was adjusted to the longitudinal axis of the device. Scanning parameters and intensity were recorded and were in the vicinity of a source voltage of 70 kV with an intensity of 114 μA. The end-point μCT was manually and subjectively scored as described by Chhabra et al. (2005) using the grading system described in Table 4. 
     
       
         
           
               
             
               
                 TABLE 4 
               
             
            
               
                   
               
               
                 Radiographic Grading Scale of Fracture Callus Formation 
               
            
           
           
               
               
               
               
            
               
                   
                 Amount of Callus 
                   
                   
               
               
                 Grade 
                 Formation 
                 Grade 
                 Amount of Callus Formation 
               
               
                   
               
               
                 0 
                 No callus 
                 3 
                 Bridging periosteal callus 
               
               
                 1 
                 Little-to-moderate callus 
                 4 
                 Mature callus with 
               
               
                   
                   
                   
                 interfragmentary bridging 
               
               
                 2 
                 Profuse callus tissue 
                 5 
                 Callus resorption after solid union 
               
               
                   
               
            
           
         
       
     
     Study Design 
     The study was performed as outlined in Table 5. There were three groups with 20 animals/group. All animals underwent surgery to create a critical-size defect (6-mm) in the mid diaphysis of the right femur (RatFix RISystem), and had inserted into the defect test item, reference item or vehicle. The animals were monitored at least once daily and were weighed at least twice weekly. They underwent radiographic evaluation immediately post-operatively, and at 2, 4, 6, and 8 weeks post-surgery. Ten animals from each group (n=30 animals) were scheduled to have end-point data (XT, mechanical testing, histomorphometry, clinical pathology) collected 4 weeks post-operatively and the remaining animals (n=30 animals) were scheduled for end-point data collection 8-weeks post operatively. Of these, six from each group (chosen such that there was a representative from each group from the majority of surgical days) at each end-point had tissues and organs collected for histology. 
     
       
         
           
               
             
               
                 TABLE 5 
               
             
            
               
                   
               
               
                 Study design 
               
            
           
           
               
               
               
               
            
               
                 Group 
                 Treatment 
                 Nomenclature 
                 End-Point (n) 
               
            
           
           
               
               
               
               
               
            
               
                   
                   
                   
                 Week 4 
                 Week 8 
               
               
                   
               
            
           
           
               
               
               
               
               
            
               
                 A 
                 tBMβ-2 + β-TCP putty 
                 tBMβ-2 
                 10 
                 10 
               
               
                   
                   
                 + β-TCP putty 
                   
                   
               
               
                 B 
                 rhBMβ-2 + absorbable 
                 rhBMP2 +ACS 
                 10 
                 10 
               
               
                   
                 collagen sponge (ACS) 
                   
                   
                   
               
               
                 C 
                 β-TCP putty 
                 β-TCP putty 
                 10 
                 10 
               
               
                   
               
            
           
         
       
     
     Group A animals received tBMP-2+β-TCP (0.615-0.620 mg tBMP-2 in β-TCP putty to fill defect); Group B animals received InFUSE™ Bone Graft of rhBMP-2+ACS (2 μg rhBMP-2 on ACS to fill defect); Group C animals received β-TCP to fill the defect. All test and control items were mixed on the day of surgery (tBMP-coated β-TCP to putty or rhBMP to ACS). Following administration of the treatment article, the wounds were closed in two muscle layers with subcutis and intracutaneous vicryl sutures. The wounds were closed exteriorly with intradermal sutures to prevent chewing by the rats. The wounds were washed with liberal amounts chlorhexidine solution. A small amount of tea tree oil was applied to the area surrounding the actual wound to prevent the animals from worrying the suture side. 
     Route of Administration 
     The anticipated route of human administration is by surgical implantation into a bone defect. Therefore, that route was used in this study. The bone defects were surgically created, the area flushed with saline, then the test or control items were placed in the defect immediately. 
     Preparation of Test Item (tBMP-2+β-TCP Putty) 
     For each rat, 195 μL of tBMP-2 (stock 3.53 mg/mL) were added to a pre-weighed aliquot of 47 mg β-TCP granules and mixed gently for 2-3 hours. All liquid was removed, and retained for analysis. The pellet was washed with 1 mL of sterile phosphate-buffered saline (PBS pH 7.4) and mixed gently to wash away any excess unbound protein. As much as possible of the liquid was removed with a pipette, and sterile pre-weighed putty was added to the protein-coated β-TCP. β-TCP and putty were mixed 1:1. The entire tBMP-2+β-TCP putty formulation was placed in the surgically-created defect. Assuming approximately 90% binding, the final dose of tBMP which was administered to the rat in the defect was 615-620 μg. Sterility was maintained at all steps. β-TCP binding to tBMP-2 was done no more than 48 hours prior to surgery. If β-TCP was bound/washed the day before surgery, it was stored at 4° C. β-TCP and putty were not mixed more than one hour prior to implantation, as it will dehydrate with time and become less malleable. 
     Reference Item 
     Recombinant human bone morphogenetic protein+absorbable collagen sponge (InFUSE′ Bone Graft; size XX small; Medtronic Sofamor Danek, Inc) was used as per packet insert with modifications as described below. BMP-2 vial contents were reconstituted with the provided sterile water to give 1.5 mg/mL rhBMP-2. This concentration is intended for human use. To bring this concentration to the range typically used in rats, it was diluted 1 in 60 with PBS (25 μg/mL). A defect volume of approximately 75.5 mm 3  was assumed, therefore the ACS was trimmed to form a 6-mm×4-mm block for insertion into the defect. Diluted rhBMP solution (80 μL) were added to the ACS in a dropwise fashion at least 15 minutes prior to insertion into the defect. This resulted in 2 μg tBMP-2 in the defect. Sterility was maintained. 
     β-TCP Putty 
     β-TCP granules (46-48 mg aliquots), carboxymethyl cellulose putty (48-50 mg aliquots). Under sterile conditions, the β-TCP granules were washed with 1 mL of sterile PBS and mixed gently. As much as possible of the liquid was removed using a pipette. Pre-weighed sterile carboxymethyl cellulose (approximately 2 mg more than the β-TCP putty formulation was inserted into the defect. 
     Dose Formulation 
     The rhBMP-2+absorbable collagen sponge and the tBMP-2+β-TCP putty were prepared as described above. The final dose each rat received of the BMP-2 formulations was 2 μg rhBMP-2 for the reference item and approximately 615-620 μg tBMP of the test item. 
     Animal Assignments and Body Weights 
     On arrival, the initial animals were numbered 1-63, of which 60 were assigned to the study. The animals were fed ad lib on arrival, but this was reduced to 35-30 g when it was found at their third weighing that they were gaining weight too quickly. The initial surgeries were delayed by one week, and as the animals weights continued to increase, the decision was made to remove the heaviest sixteen animals from the study and get replacement animals. The replacement animals were assigned numbers. 
     All animals were weighed on arrival and assigned to one of three groups on a weight-ordered distribution. All allocations to group and end-point times were done to ensure there were no significant differences in weight prior to the surgical intervention between any of the groups in terms of treatment to be administered, or time to end-point (either 4- or 8-weeks post-surgery). There were no significant differences in weights at assignment to study between any of the groups for either the initial group of animals or the replacement group, or at any time for the duration of the study ( FIG. 1A ,  FIG. 1B  and  FIG. 1C ). 
     Example 2. Radiographic, Mechanical, Histomorphometric and Histological Analyses of 4 and 8 Week Post-Fracture Healing in Three Experimental Rat Fracture Groups (A, B and C) 
     To assess the extent of mineralized bone material within the callus region of fractures in three experimental rat groups (A, B and C), radiographic scoring of callus formation, mechanical testing of the callus strength, high resolution micro computed tomography (μACT), and quantitative histological analyses of bone formation and resorption were conducted. 
     Radiographic Assessment 
     Sagittal radiographic images were generated using a Faxitron X-ray with fixed exposure settings. Radiographic scoring specifically on callus formation healing was based on Chhabra et al. (2005)  J Orthop Trauma  19(9): 629-634, and modified from Marino et al. (1979)  Clin Orthop Relat Res  (145): 239-244 and Makley et al. (1967)  J Bone Joint Surg Am  49(5): 903-914 (Table 4). Scoring was performed in one session on de-identified, randomised radiographs. Both the posterior and anterior aspect of the cortex at the site of fracture was scored. The average score for each specimen was recorded. 
     Baseline radiographs were taken on all animals as soon as possible after surgery whilst still under anaesthetic, at two weeks, four weeks (end-point for half of the animals), six weeks and eight weeks (end-point for remaining animals) post-surgery. They were taken in lateromedial and craniocaudal views.  FIG. 2  shows representative radiographs of animals from all groups at 0, 2, 4, 6, and 8 weeks post-surgery. The defect was only visible in Group B animals that received the rhBMP+ACS. The putty (with or without protein) in animals from Groups A and C appear to be outside the confines of the defect (more obvious in mediolateral view). This was the case in all animals, even when the surgeon reported that the putty appeared to be completely contained within the defect, and touching the muscle tissue had been completely avoided on insertion of the test or control items. 
     Ex vivo radiographs, as with the in vivo radiographs showed that the putty and/or bone growth was not confined to the defect area in Groups A and C, as it was in Group B images ( FIG. 2 ). 
     At 4-weeks post-surgery, Group A routinely demonstrated bridging of the periosteal callus and frequently demonstrated mature callus with interfragmentary bridging ( FIG. 3A ). This as in clear contrast to Groups B and C where only callus tissue and little or no callus scores were observed respectively. At 8-weeks post-surgery, while there appears to be no significant radiographic change in the scoring of the mature callus, Group A remained advanced in the healing stage when compared to Group B and C, both of which only marginally improved their scores in the intervening 4 weeks ( FIG. 3B ). It is worth noting that in Group A, frequent larger boney callus volumes were observed intact but distal to the fracture site suggesting that the treatment in this group was not contained to the fracture region. Representative images from each group at 4- and 8-weeks post-surgery are located in  FIGS. 3A and 3B . A schematic of the varied callus formations is represented in  FIG. 4 . 
     Micro-Computed Tomography 
     To quantify the total callus and bone mineral volumes, each specimen was scanned by high resolution μCT (Skyscan, Model 1174, Bruker microCT). Specimens were wrapped in PBS-soaked gauze and secured within a humidified tube prior to scanning. All scans were performed at 6.4 μm voxel resolution and X-ray tube potential of 50 kV and 800 μA. Images were acquired over 180 degrees with intervals of 0.8 degrees and frames were averaged from 2 images taken at each step. For each scan, the images were then reconstructed into a z-stack of images to represent the transverse plane of the femur (N-Recon software, Bruker microCT). All reconstructions used a modified Feldkamp cone-beam algorithm with a smoothing setting of 1, a ring artefact reduction level set to 12, a beam hardening level of 20% and a post-alignment balue of no greater than ±1.0. Reconstructions of the callus region excluded the adjacent screws which secured the rat-fix plate, in order to remove the interfering signal of the titanium screws from subsequent analyses. Uniform realignment of datasets were performed using Dataviewer v.1.5.1 (Bruker, BEL). Reconstructed z-stack images for each specimen were then analysed using CTan software (Bruker microCT). Analyses of bone volume in the fracture region were performed by three manually defined volumes of interest (VOI&#39;s). Prior to 3D analyses, all volumes of interest binarised using an adaptive thresholding technique using a specimen-specific hydroxyapatite standard control. 3D analyses were performed to establish total volume and bone volume fractions in each volume of interest. 
     During necropsy, all treated legs were removed, and placed in either 10% neutral-buffered formalin and kept at room temperature, or gauze-soaked saline and frozen at −20° C., for μCT imaging and mechanical strength testing. All legs were also X-rayed (Faxitron X-ray Imager) and the images graded as per Table 3 above.  FIG. 4  shows a graphical representation of bridging of periosteal callus. Moderate callus was observed in Group B samples, whereas Group C samples showed little or no callus. 
     Analyses of the μCT images for bone volume in the fracture region showed that the total callus volume and the bone mineral volume were significantly higher in Group A (tBMP+(3-TCP putty-treated) animals than in either the β-TCP putty (Group C) or the rhBMP+ACS-treated animals (p&lt;0.01 in both cases). There were no significant differences between the Group B and Group C animals for either total callus volume or bone mineral volume. These are shown in  FIG. 5A  and  FIG. 5B . When restricting the region to the interpolated shaft region, in both Group A and Group B, the bone mineral volume as a percentage of the tissue volume (BV/TV) was approximately 2-fold greater than Group C (P&lt;0.05). The BV/TV for Group A was trending to be increased by 15% when compared to Group B (P=0.059) ( FIG. 6A ). When restricting the region to the interpolated cortical bone region only, in Group A, the cortical bone mineral volume, in BV/TV terms, was 4-fold greater than levels in Group B (P&lt;0.05) but not significantly greater than in Group C ( FIG. 6B ). 
     At 8-weeks post-surgery, TCB was markedly increased in Group A when compared to Groups B and C ( FIG. 7A  and  FIG. 7B ). However, BMV in Group A is not significantly increased when compared to Group B. These data suggested that while a larger bony callus existed in Group A, the density of bone mineral was more comparable to Group B. 
     Mechanical Strength Testing of Treated Femur 
     The mechanical strength testing of femoral callus was performed using 3 point bending method (5940 and BlueHill 3 software, v3.25, Instron, Mass., USA). Each specimen was stored in PBS-soaked gauze at −80° C. until ready for testing. Prior to testing, specimens were gradually thawed to 4° C. over three days to maintain tissue integrity. On the day of testing, samples were scanned by micro-CT in a humidified chamber and kept cool prior to allowing specimens to reach room temperature for mechanical testing. For each specimen, the rat-fix plate was cut immediately prior to testing using a slow speed rotary diamond tipped saw lubricated with cooled phosphate buffered saline. The mid-point of the rat-fix plate was cut to remove the support of the plate in the fracture stabilization. This cut was done so as to cause minimal disturbance to the surrounding callus. After cutting the plate, each bone was then loaded into the 3-point jig with the rat-fix plate in contact with the low anvils with a 10 mm span such that the upper anvil was positioned directly above the cut-point on the plate. The downward motion of the upper anvil tests the resistance, and thus the strength, of the callus. As the bone deforms during testing, the plate separates at the mid-point cut, minimizing the contribution of the plate to the measure of Ultimate Load to Failure (ULF). T Compression testing was performed by gradually increasing the force applied, at a rate of 0.01 mm per second. ULF was determined by the peak force immediately prior to the failure of callus as determined by the force-displacement curve. 
     The mechanical testing of femoral strength in each fracture specimen required that the contribution of the rat-fix plate be removed without disturbing the callus. Typically this would involve removing the rat-fix plate altogether. However, in numerous samples, in particular in Group A, the extent of callus enveloped the plate making removal impractical. Thus, the compromise was to cut the plate exactly at the mid-point such that it no longer contributed to femoral support. The cut was done in such a way as to only cause minimal damage to the callus. The downward motion of the upper anvil thus tests the resistance, and thus the strength, of the callus. Group A exhibited markedly increased ULF at 4 and 8 week post-surgery when compared to Groups B and C ( FIG. 8 ). At 8 weeks post-surgery, Group A exhibited 2.5-fold increase in ULF when compared to Group B at the same time point (P&lt;0.001). Group B demonstrated increased ULF when compared to Group C and both time points. At 8 weeks post-surgery, in Group B, a trend for increased ULF was observed when compared to 4 weeks post-surgery (P=0.059). 
     Histomorphometry of Treated Femur 
     At ten days prior to end-point, all animals were administered calcein green (25 mg/kg of 10 mg/mL), with the exception of Rat #6, 8, 9, 10, 18, 20, 23, 30 and 50, which were inadvertently administered 12.5 mg/Kg of 10 mg/mL solution. All rats received 100 mg/Kg of xylenol orange (100 mg/mL solution) at three days prior to end-point. All administrations were intraperitoneal. 
     At 4 weeks post-surgery, Group A exhibits extensive evidence of mineralization akin to mature trabecular bone ( FIG. 9A ). Significant remodelling of bone was observed by the presence of osteoclasts ( FIG. 9B , white arrows), and the presence of osteocytes in Group A specimens ( FIG. 9B , yellow arrows) which is indicative of mature mineralized bone. Osteoblastic activity was observed in the form of double-fluorochrome labelled mineral accretion. The osteoblastic bone formation was frequently observed as ‘lines’ colored green and red which are in association with each other ( FIG. 9B , blue arrows). This represented the formation of lamella (mature) bone, rather than the ad-hoc mineralization of woven bone that occurs in early callus formation, a common observation in Group B. Furthermore, the presence of red-blood cells, and adipocytes indicated that an angiogenesis has occurred and suggested good infiltration of cells to most regions of the callus in Group A specimens. 
     In Group B, while bone mineral was observed, there were extensive regions of fibrous and cartilage tissue which was unmineralized within the callus region ( FIG. 9A ). Where new bone mineral occurs, double labels were observed indicating bone formation. However, these double labels were frequently disorganized and often occurred as single labels suggesting that woven bone formation (i.e. initial bone callus formation) was continuing to be formed at this time point ( FIG. 9B ). While not quantified, it appeared that osteoclasts predominantly existed in regions between the unmineralized and mineralized portions of the callus which suggested an earlier stage of callus development than what was observed for Group A animals. 
     In Group C, there was no evidence of mineralization, bone formation or bone remodelling. Indeed, there was no evidence of cartilage formation. A fibrous-like material with foreign mineralized spicules existed within the fracture site. There were some instances where osteoclasts as present on the surface of the foreign material, suggesting that this material could be resorbed ( FIG. 9B ). 
     At 8 weeks post-surgery, the same pattern of activity between the groups was continued ( FIG. 10A  and  FIG. 10B ). Of note, however, in Group A, there appeared to be greater distribution of mature bone across all sections, consistent with μCT analyses. Also, a degree of intra-trabecular, or intra-cortical labelling of mineral ( FIG. 10B , orange arrows) suggested a further maturing of bone consistent with late-stage bone healing. Also of note, Group B specimens appeared to exhibit all stages of callus formation and remodelling. That is, there was evidence of lack of periosteal bridging at times, the presence of cartilage, woven bone, lamellae bone, and evidence of remodelling as well. In Group C, the persistent lack of healing suggested that this group contained a treatment which was most comparable to a critical-sized defect model without any scaffold of healing agents. 
     In summary, sixty-one animals were successfully treated with one of three test items following surgical creation of a critical size defect in the right femur. The post operative recovery was unremarkable in the majority of animals. The test items were all placed within the defects, but on X-ray, it could be seen that the compounds containing the β-TCP putty were spread out of the defect area and into the surrounding tissue. As the collagen sponge was not visible on X-ray, it was not possible to judge if the sponge had moved out of the defect area. 
     Most animals recovered from surgery well and in most cases were moving as per usual within 24 hours of surgery. A number of the animals were larger than the recommended weight for the plates, but the femurs were not so large that the screws of the internal fixator system were not going through the whole bone, so there should not have been loss of stability while new bone was forming at the site. Two animals had evidence of displaced bones on the two week radiographs, these animals were not heavier than others. One animal was in the rhBMP+ACS group, the other was in the β-TCP putty group. Another animal (Group C) had a broken screw and displaced bone at the six-week post-operative time point. There was no obvious reason why this had occurred. 
     There were no differences between any of the groups in any clinical pathology parameters or histological analyses of organs and tissues. 
     Radiographic and histological examination of the treated femurs showed that the Group A animals (tBMP-2+β-TCP putty) had the most evidence of formation of mature bone in the defect site compared to the other two groups. This was shown by bridging of the periosteal callus, increased mineralization, presence of osteocytes, active remodelling of the bone (as shown by the presence of osteoclasts) and evidence of angiogenesis (shown by the presence of red blood cells and adipocytes). Whilst some evidence of mineralization of callus is present in the Group B (rhBMP+ACS) samples, this appeared to be less developed than for Group A. Group C (β-TCP putty) showed no evidence of mineralization, suggesting that having a scaffold alone could not induce new bone growth within eight weeks of application into a critical-sized defect. 
     Group A animals also had significantly stronger bones than either Group B or Group C animals as evidenced by ultimate load to failure tests. This was evident at both four and eight weeks post-treatment. 
     The differences in callus formation in the process of healing are distinct between all three groups, clearly indicating that there were unambiguous differences in the treatments of fracture in each group. 
     In Group C, a frank lack of periosteal bridging and minimal bony callus formation at both 4 and 8 weeks was associated with a lack of cellular activity within the fracture. These observations were consistent with the near complete absence of mechanical integrity at either time point. 
     In Group B, the mineralized callus was more extensive than the levels in Group C both 4 and 8 weeks post-surgery. This was evident in the radiographic and histomorphometric analyses. Furthermore, while periosteal bridging was observed only in some Group B specimens at 8 week post-surgery, there was a clear and overt difference in the histological assessment at both time points with regards to bone formation and cellular activity. Unlike in Group C, the presence of bone formation, frequently in the form of woven bone and occasionally as lamellae bone, was associated with increase in mechanical strength when compared to Group C. Interestingly, neither radiographic nor mechanical strength measures were significantly improved at 8 weeks when compared to 4 weeks post-surgery. This suggested that the majority of activity in callus formation and structural integrity occurred in the first 4 weeks. 
     Group A exhibited the most advanced healing when compared to the other groups. At 4 weeks post-surgery radiographic evidence of periosteal bridging was a measure that no samples achieved in Group C and often was not observed in Group B, even at 8 weeks post-surgery. Interestingly, while radiographic scores at 8 weeks post-surgery were comparable to 4 week scores, the mechanical strength of the callus was more than double the levels at 4 weeks post-surgery and at least 3-fold greater than levels in Group B, suggesting that considerable bone mineralization occurred within the callus region in the second 4 week period. This observation was consistent with high levels of lamellae bone formation in Group A at 4 and 8 weeks post-surgery, which was distinct from the weaker woven bone formation that occurred in Group B, even at 8 weeks post-surgery. It is important to note that callus volume at 8 weeks of age was lower than levels at 4 weeks post-surgery, suggesting that callus volume was being remodelled into a more compact callus at the site of fracture. In Group A, this was consistent with fewer observations of extraneous mineralized callus distal to the fracture site at 8 weeks post-surgery. With regards to the histological assessment of Group A specimens, observations of osteoclastic none resorption adjacent to regions of bone undergoing bone formation is entirely typical of bone undergoing remodelling which is known to be done to provide a stronger and more efficient structure for skeletal integrity. The additional observations of the presence of osteocytes as well as other cellular structures such as vascular structures and adipocytes clearly makes the bone often indistinguishable from endogenous trabecular micro-anatomy. 
     In conclusion, the bone specimens form the tBMP-2+β-TCP putty group clearly demonstrated vastly improved bone healing at 4- and 8-weeks post-surgery when compared to samples from animals in the rhBMP+ACS or the β-TCP putty alone treatment groups. 
     Example 3. Overview of Chimeric β-TCP Polypeptides 
     The present inventors found that chimeric polypeptides maintained activity of the tethered protein. The chimeric polypeptide (10×β-TCP-histidine rich glycoprotein HRG) refolded at 22° C. in buffer 10, and following incubation of the chimeric polypeptide with MCF-7 breast cancer cells, Akt activity was detected ( FIG. 11 ). This result indicated that the chimeric polypeptide stimulated signalling activity in the target cell and was able to cause Akt phosphorylation. Next, the Akt activity was determined in 10×β-TCP-HRG bound to a β-TCP peptide ( FIG. 12 ). The β-TCP peptide on its own was unable to cause Akt phosphorylation in MCF-7 cells, however, incubation of MCF-7 cells with β-TCP peptide bound to 10×β-TCP-HRG led to Akt phosphorylation. Interestingly, the extent of Akt phosphorylation was not affected whether the chimeric polypeptide was bound to a β-TCP peptide or not. 
     Example 4. Binding Affinity of tBMP2 to Various Substrate Materials 
     Binding assays were performed to quantify the affinity of tBMP2 protein to various substrates, including commercially available bone graft materials, ceramic powders, 3D printable scaffold materials, and a plasma-sprayed hydroxyapatite coating. First, 10 mg of each material was washed with deionized water followed by acetate buffer. Then either a 150 μg or 250 μg load of tBMP2 protein was applied to each material and allowed to bind under light agitation for 90-120 minutes. The flow through was aspirated (removing the tBMP2 which did not bind to the substrate material), and a wash was conducted with acetate buffer. A subsequent overnight elution was done by immersing the substrate material in a sodium phosphate buffer (100 mM NaPhos, 4 M Urea, 1 M NaCl, 10% 1,6 Hexanediol, pH=8) to remove the bound protein from the substrate for measurement. 
     The bound tBMP2 was quantified by either 1) running non-reducing SDS Page gel electrophoresis and comparing the eluted tBMP2 band to the tBMP2 load band with Image J Gel Analysis tool, or 2) conducting a Bradford assay (with a BSA standard curve) on the eluted tBMP2 and tBMP2 load. Dividing the eluted tBMP2 quantity by the original tBMP2 load quantity and multiplying by 100 gave the % of tBMP2 load that was strongly tethered to the substrate after the binding incubation step. 
     Table 6 summarizes the materials that were evaluated as well as the % of tBMP2 load which was effectively tethered to the substrate (% Bound). 
     
       
         
           
               
             
               
                 TABLE 6 
               
             
            
               
                   
               
               
                 Summary of Binding Activity 
               
            
           
           
               
               
               
               
               
               
            
               
                   
                   
                   
                 Load tBMP2 
                 Method of  
                 % of tBMP2 
               
               
                   
                   
                   
                 Applied to 
                 measurement 
                 load bound to 
               
               
                 Product 
                 Description 
                 Manufacturer 
                 Material 
                   
                 material 
               
               
                   
               
               
                 Mastergraft 
                 Biphasic TCP 
                 Medtronic 
                 15 μg tBMP2/mg 
                 Bradford 
                 69% 
               
               
                 Strip 
                 (85% β- 
                   
                 material 
                 Assay 
                   
               
               
                   
                 Tricalcium 
                   
                   
                   
                   
               
               
                   
                 Phosphate:15% 
                   
                   
                   
                   
               
               
                   
                 Hydroxyapatite 
                   
                   
                   
                   
               
               
                   
                 )/Type I bovine 
                   
                   
                   
                   
               
               
                   
                 collagen 
                   
                   
                   
                   
               
               
                   
                 composite 
                   
                   
                   
                   
               
               
                 Vitoss 
                 β-Tricalcium 
                 Stryker 
                 15 μg tBMP2/mg 
                 Bradford 
                 82% 
               
               
                 Foam Pack 
                 Phosphate/Typ 
                   
                 material 
                 Assay 
                   
               
               
                   
                 e I bovine 
                   
                   
                   
                   
               
               
                   
                 collagen 
                   
                   
                   
                   
               
               
                   
                 composite 
                   
                   
                   
                   
               
               
                 chronOS 
                 β-Tricalcium 
                 DePuy Synthes 
                 15 μg tBMP2/mg 
                 Image J Gel 
                 75% 
               
               
                 Strip 
                 Phosphate/poly 
                   
                 material 
                 Analysis Tool 
                   
               
               
                   
                 (lactide co-ε- 
                   
                   
                   
                   
               
               
                   
                 caprolactone) 
                   
                   
                   
                   
               
               
                   
                 composite 
                   
                   
                   
                   
               
               
                 Vitoss 
                 β-Tricalcium 
                 Stryker 
                 15 μg tBMP2/mg 
                 Image J Gel 
                 74% 
               
               
                 Micromors 
                 Phosphate 
                   
                 material 
                 Analysis Tool 
                   
               
               
                 els 
                 granules 
                   
                   
                   
                   
               
               
                   
                 (1mm-2mm) 
                   
                   
                   
                   
               
               
                 LifeInk 500 
                 Calcium 
                 Advanced 
                 15 μg tBMP2/mg 
                 Image J Gel 
                 87% 
               
               
                   
                 Phosphate 
                 Biomatrix 
                 material 
                 Analysis Tool 
                   
               
               
                   
                 Cement 3D 
                   
                   
                   
                   
               
               
                   
                 printable ink 
                   
                   
                   
                   
               
               
                 Hyperelasti 
                 Hydroxapatite/ 
                 Dimension Inx 
                 15 μg tBMP2/mg 
                 Image J Gel 
                 58% 
               
               
                 c Bone 
                 Poly(lactic-co- 
                   
                 material 
                 Analysis Tool 
                   
               
               
                   
                 glycolic acid) 
                   
                   
                   
                   
               
               
                   
                 3D printable 
                   
                   
                   
                   
               
               
                   
                 ink 
                   
                   
                   
                   
               
               
                 Bioactive 
                 Combeite 45S5 
                 Stryker 
                 25 μg tBMP2/mg 
                 Image J Gel 
                 49% 
               
               
                 Glass 
                 Bioactive 
                   
                 material 
                 Analysis Tool 
                   
               
               
                   
                 Glass powder 
                   
                   
                   
                   
               
               
                 Silicon 
                 Si 3 N 4  powder, 
                 Chemsavers 
                 25 μg tB1V1132/mg 
                 Image J Gel 
                 54% 
               
               
                 Nitride 
                 99% purity 
                   
                 material 
                 Analysis Tool 
                   
               
               
                 Powder 
                   
                   
                   
                   
                   
               
               
                 β-TCP 
                 β-Tricalcium 
                 CaP 
                 25 μg tBMP2/mg 
                 Image J Gel 
                 79% 
               
               
                 Powder 
                 Phosphate 
                 Biomaterials 
                 material 
                 Analysis Tool 
                   
               
               
                   
                 powder, 3-5 
                   
                   
                   
                   
               
               
                   
                 p.m particle 
                   
                   
                   
                   
               
               
                   
                 size 
                   
                   
                   
                   
               
               
                 β-TCP 
                 β-Tricalcium 
                 CaP 
                 25 μg tBMP2/mg 
                 Image J Gel 
                 78% 
               
               
                 Spray 
                 Phosphate 
                 Biomaterials 
                 material 
                 Analysis Tool 
                   
               
               
                 Dried 
                 spray dried 
                   
                   
                   
                   
               
               
                 Powder 
                 powder, &lt;38 
                   
                   
                   
                   
               
               
                   
                 p.m particle 
                   
                   
                   
                   
               
               
                   
                 size 
                   
                   
                   
                   
               
               
                 Hydroxyap 
                 Hydroxyapatite 
                 CaP 
                 25 μg tBMP2/mg 
                 Image J Gel 
                 57% 
               
               
                 atite 
                 powder, 3-5 
                 Biomaterials 
                 material 
                 Analysis Tool 
                   
               
               
                 Powder 
                 p.m particle 
                   
                   
                   
                   
               
               
                   
                 size 
                   
                   
                   
                   
               
               
                 HA-coated 
                 Hydroxyapatite 
                 Citieffe 
                 25 μg tBMP2/mg 
                 Bradford 
                 44% 
               
               
                 Bone 
                 plasma spray- 
                 material 
                 Assay 
                   
                   
               
               
                 Screw 
                 coated 
                   
                   
                   
                   
               
               
                   
                 stainless steel 
                   
                   
                   
                   
               
               
                   
                 bone screw (6 
                   
                   
                   
                   
               
               
                   
                 mm dia x 5 
                   
                   
                   
                   
               
               
                   
                 mm long piece 
                   
                   
                   
                   
               
               
                   
                 cut from 
                   
                   
                   
                   
               
               
                   
                 screw) 
                   
                   
                   
                   
               
               
                 β-TCP 
                 β-Tricalcium 
                 CaP 
                 15 μg tBMP2/mg 
                 Bradford 
                 70% 
               
               
                 Granules 
                 Phosphate 
                 Biomaterials 
                 material 
                 Assay 
                   
               
               
                   
                 granules, 250-1000 μm 
                   
                   
                   
                   
               
               
                   
                 particle size 
                   
                   
                   
                   
               
               
                 Hydroxyap 
                 Hydroxyapatite 
                 CaP 
                 15 μg tBMP2/mg 
                 Bradford 
                 52% 
               
               
                 atite 
                 granules, 250- 
                 Biomaterials 
                 material 
                 Assay 
                   
               
               
                 Granules 
                 1000 
                 p.m 
                   
                   
                   
               
               
                   
                 particle size 
                   
                   
                   
                   
               
               
                 ReBOSSIS 
                 Cotton-like 
                 Orthorebirth 
                 15 μg tBMP2/mg 
                 Bradford 
                 83% 
               
               
                   
                 bone void 
                   
                 material 
                 Assay 
                   
               
               
                   
                 filler. Main 
                   
                   
                   
                   
               
               
                   
                 ingredients are 
                   
                   
                   
                   
               
               
                   
                 β-Tricalcium 
                   
                   
                   
                   
               
               
                   
                 Phosphate, 
                   
                   
                   
                   
               
               
                   
                 bioabsorbable 
                   
                   
                   
                   
               
               
                   
                 polymer, and 
                   
                   
                   
                   
               
               
                   
                 SiV (silicon- 
                   
                   
                   
                   
               
               
                   
                 containing 
                   
                   
                   
                   
               
               
                   
                 calcium 
                   
                   
                   
                   
               
               
                   
                 carbonate) 
               
               
                   
               
            
           
         
       
     
     OTHER EMBODIMENTS 
     It is to be understood that while the invention has been described in conjunction with the detailed description thereof, the foregoing description is intended to illustrate and not limit the scope of the invention, which is defined by the scope of the appended claims. Other aspects, advantages, and modifications are within the scope of the following claims.